Determinants of screening practice for cervical cancer among women in Addis Ababa, Ethiopia by Seble Tiku Ayka
DETERMINANTS OF SCREENING PRACTICE FOR CERVICAL CANCER AMONG 
















Submitted in accordance with the requirements 
 







































I declare that DETERMINANTS OF SCREENING PRACTICE FOR CERVICAL 
CANCER AMONG WOMEN IN ADDIS ABABA, ETHIOPIA is my own work and that all 
the sources that I have used or quoted have been indicated and acknowledged by 
means of complete references. 
 
I further declare that I submitted the dissertation to originality checking software and that 
it falls within the accepted requirements for originality. 
 
I further declare that I have not previously submitted this work, or part of it, for 
examination at Unisa for another qualification or at any other education institution. 
 
       13 November 2020 
.............................................................   ....................................... 
SIGNATURE       DATE 




DETERMINANTS OF SCREENING PRACTICE FOR CERVICAL CANCER AMONG 
WOMEN IN ADDIS ABABA, ETHIOPIA 
 
STUDENT NUMBER:  58562850 
STUDENT:  SEBLE TIKU AYKA 
DEGREE:   DOCTOR OF LITERATURE AND PHILOSOPHY 
DEPARTMENT:  HEALTH STUDIES 




Cervical cancer is the second most commonly diagnosed cancer and the third leading 
cause of cancer death among women in less developed countries. Screening for 
cervical cancer is the most accepted and successful strategy for cervical cancer control.  
 
The purpose of the study was to investigate factors that determine cervical cancer 
screening practice among women in Addis Ababa, Ethiopia and develop guidelines to 
improve the utilisation of cervical cancer screening services.  
 
The researcher used the health belief model (HMB) as the theoretical foundation of the 
study and a convergent parallel mixed methods design. Quantitative data was obtained 
from screened and not screened women attending maternal health services at selected 
public health centres.  Statistical Package for Social Sciences (SPSS) Version 23 was 
used for entry and analysis of data Qualitative data was obtained in key informant 
interviews from health service professionals on their perceptions of women‟s cervical 
cancer screening uptake at the health centres.  
 
The study found that higher age >35 years category (X2=33.618 and p-value <0.001), 
contraceptive use (X2value=20.7 and p-value <0.001), having two or more children, and 
knowledge of cervical cancer and screening (chi-value X2=51.649, p-value=0.001) were 
strongly associated with screening practice. In addition, women‟s perception of 
susceptibility (t-test=3.42 and 3.432, p-value=0.001) was a predictor of screening. Lack 
of awareness was a serious barrier to cervical cancer screening and health service 
providers‟ information was a strong promoter of screening.  
 
The study recommends promoting and facilitating health education on cervical cancer at 
all health facilities; organising awareness campaigns, education programmes, and 
iv 
 
community mobilisation to raise awareness of cervical cancer screening; integrating 
cervical cancer screening with other reproductive health services, and capacitating the 
health professionals in order to increase utilisation of cervical cancer screening 
services.  
 
Consequently, the researcher used the findings of the study to develop guidelines to 
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Cancer is one of the leading causes of morbidity and mortality worldwide and most 
deaths from cancer occur in low- and middle-income countries (Ferlay, Soerjomataram, 
Ervik, Dikshit, Eser, Mathers, Rebelo, Parkin, Forman & Bray 2012:E359; Bray, Ferlay, 
Soerjomataram, Siegel, Torre & Ahmedin 2018:394). Cervical cancer is the fourth most 
frequently diagnosed cancer and the fourth leading cause of cancer death in women, 
with with the vast majority of these countries found in sub-Saharan Africa. Cervical 
cancer kills an estimated 342,000 women with 604,000 new cases worldwide in 2020. 
Sub-Saharan Africa has the highest regional incidence and mortality, with rates 
particularly high in Eastern Africa, Southern Africa, and Middle Africa. The rate of 
occurrence is 7 to 10 times higher than in Northern America (Sung, Ferlay, Siegel, 
Laversanne, Soerjomataram, Jemal & Bray 2021:231). 
 
In Sub-Saharan Africa very few women have ever been screened for cervical cancer. 
Routine cervical cancer screening and early treatment can prevent up to 80% of cervical 
cancer if abnormalities of the cervix are identified at stages when they can be easily 
treated. The World Health Organization (WHO) (2014a:131) recommends screening for 
all women aged 30 to 49 years to identify precancerous lesions, which are usually 
asymptomatic. The human papilloma virus (HPV) vaccination is vital but does not 
replace the necessity of cervical cancer screening and early treatment in women (WHO 
2014b:465). Aging and risk factors, such as smoking, obesity, physical inactivity, and 
reproductive behaviours, increase the burden of cervical cancer. Population growth is 
estimated to increase considerably by the year 2030 and cervical cancer is predicted to 
be a progressively significant cause of morbidity and mortality (WHO 2016:9). 
 
In Kisimu, Kenya and Zimbabwe, socio-demographic characteristics, such as age, 
marital status, parity, education level, awareness of cervical cancer and of cervical 
cancer screening, knowledge of prevention of cervical cancer, and perception of higher 




women (Morema, Atieli, Onyango, Omondi & Ouma 2014:335; Mupepi, Sampselle & 
Johnson 2011:948). 
 
In Ethiopia, the most prevalent cancers among the adult population are breast cancer 
(30.2%), cancer of the cervix (13.4%) and colorectal cancer (5.7%). Approximately two-
thirds of reported annual cancer deaths occur among women (FMOH 2015b:14). 
 
In 2015, the Federal Ministry of Health (FMOH) introduced a cancer control strategy and 
the National health sector transformation plan, 2015-2020 for Ethiopia. To address the 
issue of reproductive tract cancers, cervical cancer diagnosis and treatment services 
were introduced (FMOH 2015a: 8). The cervical cancer screening services were free of 
charge in government health facilities and women could utilise services through self-
referral, referral by health extension workers, and referral by other health care 
professionals (nurses, midwives, doctors and public health professionals). Local and 
national media also disseminated information regarding cervical cancer (FMOH 
2015a:6).  
 
1.2 BACKGROUND TO THE PROBLEM  
 
In Ethiopia, cervical cancer is the second leading cancer among women. Approximately 
6,294 new cases are diagnosed with about 4,884 cervical cancer deaths annually 
(Bruni, Albero, Serrano, Mena, Gómez, Muñoz, Bosch & De Sanjosé 2019:6). 
 
Public health systems in the country have conventionally concentrated on the control of 
communicable diseases, not non-communicable diseases (NCDs). Non-communicable 
diseases, including cancer, have only received attention as public health issues since 
the introduction of the national health sector transformation plan (HSTP), 2015-2020 
and the Ethiopian national cancer control plan (FMOH 2015a:2; 2015b:15). The silent 
epidemic of NCDs has placed a double burden of disease on the country that threatens 
to overwhelm it unless addressed.  
 
About 80% of reported cases of cancer are identified at advanced stages at the only 
oncology centre in the country, the Tikur Abessa (Black Lion) Specialized Hospital 
(TASH) (FMOH 2015b:14). This is largely due to low awareness of cancer signs and 




insufficient diagnostic facilities, and poorly structured referral systems. The reason for 
this is that the cancer treatment set-up in Ethiopia is inadequate and cancer 
management opportunities are not well established within the health care system. 
Cancer is treated with medical, surgical or radiation therapy (FMOH 2015b:15). 
 
1.3 STATEMENT OF THE PROBLEM  
 
Most people with cervical cancer in developing countries, including Ethiopia, present 
late with advanced stage, at which time management treatment may involve multiple 
modalities, such as surgery, radiotherapy, and chemotherapy, which would lessen 
chances of success. In Ethiopia, the oncology unit at the Tikur Anbessa (Black Lion) 
Specialized Hospital (TASH), in Addis Ababa, is the only oncology unit for the country. 
In a retrospective review of cancer cases registered at TASH between 1997 and 2012, 
Abate (2015:104) found that 5,293 were cervical cancer cases. The study found that 
new cases had increased between 1997 and 2012; the peak age of incidence was 40-
49 years; the number of cases per region depended on their distance from Addis 
Ababa, and Addis Ababa, Oromia, and Amhara had the highest numbers (Abate 
2015:104). Several factors, such as low level of awareness, educational status, financial 
capability and presence of health care facilities, determine the stage at which patients 
with cancer present to the health facility.  
 
Screening for cervical cancer is the most accepted and successful strategy for cervical 
cancer control (Habtu, Yohannes & Laelago 2018:256). When cervical cancer is found 
early, it is highly treatable and associated with long survival and good quality of life 
(Centres for Disease Control and Prevention 2017a:1). Well-organised screening is 
cost-effective as well as a proven strategy in terms of its effectiveness in reducing the 
incidence and mortality of cervical cancer, but is underutilised by women who most 
need it. Low coverage of cervical cancer screening is a serious problem and a major 
barrier to reducing the mortality and morbidity in developing countries (Campos, 
Sharma, Clark, Lee, Geng, Regan, Kim & Resch 2016:3).  
 
Early detection of cervical cancer can easily be made by an examination of swabs or 
smears from the cervix surface, which could be done at a gynaecological examination. If 
identified early, treatment and management of cervical cancer is simple, uncomplicated 




to have regular periodical screening (Marth et al 2017:5). Ethiopia coverage of 
screening for cervical cancer has been very low the estimated coverage of cytology-
based cervical cancer screening in Ethiopia was 1.6% in urban settings and 0.4% in 
rural areas (FMOH 2015b:10). Strategies are needed to increase the number of women 
who attend screening. 
 
This study investigated factors that affected cervical cancer screening practice among 
women in Addis Ababa, reasons for non-utilisation, and health professionals‟ 
perceptions of women‟s utilisation of cervical cancer screening. Based on the findings 
the researcher wished to develop guidelines to assist in promoting women‟s screening 
practice for cervical cancer. 
 
1.4 PURPOSE OF THE STUDY 
 
The purpose of the study was to investigate factors that determine cervical cancer 
screening practice among women in Addis Ababa, Ethiopia and develop guidelines to 
improve the utilisation of cervical cancer screening services.  
 
1.4.1 Research objectives  
 
Phase 1: Quantitative approach 
 Identify and discuss the determining factors of screening practice for cervical cancer 
among women in Addis Ababa, Ethiopia. 
 
Phase 2: Qualitative approach 
 Explore and describe health professionals‟ perceptions of cervical cancer screening 
utilisation among eligible women in Addis Ababa, Ethiopia. 
 
Phase 3: Based on the finding 
 Develop guidelines to improve the utilisation of cervical cancer screening by women 





1.4.1 Research questions 
 
In order to achieve the purpose and objectives, the study wished to answer the following 
questions: 
 
Phase 1: Quantitative 
 What are determining factors related to screening for cervical cancer among women 
in Addis Ababa, Ethiopia? 
 
Phase 2: Qualitative 
 What are health professionals‟ perceptions of cervical cancer screening utilisation 
among eligible women in Addis Ababa, Ethiopia? 
Phase 3: 
 What guidelines can be developed for health professionals, planners and 
policymakers to promote utilisation of cervical cancer screening services among 
women in Ethiopia? 
 
1.5 SIGNIFICANCE OF THE STUDY  
 
The study focused on identifying determining factors for cervical cancer screening by 
eligible woman in Addis Ababa where cervical cancer screening service is available. 
The findings provided information on women‟s knowledge and practices that affect 
utilisation of cervical cancer screening in order to detect the presence of disease at an 
early stage. The participant health care providers‟ experience and perceptions of 
cervical cancer screening utilisation should assist implementation of the guidelines. The 
guidelines should encourage compliance with screening, promote behavioural 
modification, and help save lives from cervical cancer. 
 
1.6 THEORETICAL FOUNDATION OF THE STUDY  
 
A framework is “an abstract, logical structure of meaning” (Burns & Grove 2011:116). 







1.6.1 Research paradigm  
 
A paradigm is a framework or set of beliefs about what should be studied, what 
methods should be used and how data should be interpreted for gaining knowledge of 
the natural or social world (Saks & Allsop 2013:19). Creswell (2013:18) describes a 
paradigm as a way of thinking about something or a belief system that guides the way 
we do things, or establishes a set of practices ranging from thought patterns to action. A 
paradigm is a way of looking at natural phenomena that encompasses a set of 
philosophical assumptions and guides a researcher‟s approach to inquiry (Polit & Beck 
2010:11). Polit and Beck (2010:15) add that paradigms are lenses that help to sharpen 
the researcher‟s focus on a phenomenon. The research paradigm and research 
approach are the same and may be qualitative, quantitative or mixed methods (Brink, 
Van der Walt & Van Rensburg 2018:55). 
 
Table 1.1 Overview of pragmatism 
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Action research  
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Table 1.1 outlines the application of pragmatism in the study. In this study, the 
researcher adopted pragmatism as the research paradigm. Pragmatism is a worldview 
or a set of assumptions about how things work; a basic set of beliefs that guide action 
(Creswell 2013:35). Pragmatism believes that reality is constantly renegotiated, 
debated, interpreted, and therefore the best method to use is the one that solves the 




available to understand the problem (Creswell 2013:36). Using a pragmatist paradigm, 
the researcher collected both quantitative and qualitative data.  
 
1.6.2  Theoretical framework 
 
The study was based on the conceptual framework of the Health Belief Model (HBM). 
The HBM is based on people‟s beliefs about whether or not they are susceptible to a 
disease or condition and how their perceptions of the benefits of trying to avoid it 
influence their readiness to act (National Cancer Institute 2005:13). Health behaviour is 
based on perceived threat of disease (Rosenstock, Strecher & Becker 1988:177).  
 
The HBM is a psychological health behaviour model generated to explain and anticipate 
health-related behaviours, and helps clarify why individuals may accept or reject 
preventive health services or adopt healthy behaviours (Day, Van Dort & Tay-Teo 
2010:4). Abraham and Sheeran (2015:31) state that in terms of the HBM, people's 
beliefs about health problems, perceived benefits of action and barriers to action, and 
self-efficacy explain engagement (lack of engagement) in health-promoting behaviour. A 
stimulus or cue to action must also be present in order to activate health-promoting 
behaviour.  
 
The researcher considered the HBM appropriate for this study in order to determine 
women‟s knowledge and beliefs about cervical cancer screening (Day, Dort & Tay-Teo 
2010a:102; Tavafian 2012:5; Glanz & Rimer 2008:5). The HBM has fundamental 
constructs: perceived susceptibility; perceived seriousness; perceived benefits; 
















Figure 1.1  Health belief model 
(Abraham & Sheeran 2015:32) 
 
The HBM explains preventive health behaviours rather than behaviours in time of illness 
Figure 1.1 shows the health belief model. The HBM helps to clarify why individuals may 
accept or reject preventive health services or adopt healthy behaviours (Abraham & 
Sheeran 2015:32).  
 
 Perceived susceptibility  
 
Perceived susceptibility refers to subjective assessment of risk of developing a health 
problem. The HBM proposes that individuals who perceive a given health problem as 
serious are more likely to engage in behaviours to prevent the health problem from 
occurring (or reduce its severity) (Glanz & Rimer 2008:45). Perceived contracting a 
disease refers to individuals‟ subjective perception of their susceptibility to the disease 
(Day et al 2010b:4). The HBM predicts that women will be more liable to accept (the 
suggestion of) cervical cancer screening if they believe that they are prone to cervical 
cancer (Glanz & Rimer 2008:45). Individuals who believe they have risk factors for 
developing cervical cancer and perceived susceptibility to an illness are more likely to 
take action to prevent a negative health outcome. Therefore, women must consider that 



















 Perceived severity  
 
Perceived severity refers to the individual‟s assessment of the severity of a health 
problem and its potential consequences (Rosenstock 1974:328). The HBM holds that 
individuals who perceive that they are susceptible to a particular health problem will 
engage in behaviours to reduce their risk of developing the condition. Individuals‟ 
perception or evaluation of the severity of a health problem and acquiring an illness, or 
of leaving it untreated and the possible consequences affect health behaviour. 
Consequently, if women think that cervical cancer is a severe disease and believe that 
getting cervical cancer would have serious medical, social and economic consequences 
for them, they are more likely to undergo cervical cancer screening (Tavafian 2012:5). 
 
 Perceived benefit  
 
Perceived benefit refers to individuals‟ assessment of the value or efficacy of engaging 
in a health-promoting behaviour to decrease risk of disease. Health-related behaviours 
are influenced by the perceived benefits of taking action (Glanz & Rimer 2008:45). If 
individuals believe that a particular action will reduce their susceptibility to a health 
problem or decrease its seriousness, they are likely to engage in that behaviour 
regardless of the effectiveness of the action. Individuals who believe they are 
susceptible to a disease and that it is severe will take health action if they also perceive 
the action as potentially beneficial by reducing the threat (Tavafian 2012:5). Therefore, 
women must accept that a course of protective behaviours for cervical cancer would be 
beneficial in decreasing the risk of acquiring it. 
 
 Perceived barriers 
 
Perceived barriers refer to individuals‟ evaluation of the difficulties to behaviour 
modification (Glanz & Rimer 2008:48). Perceived barriers refer to the cost of taking 
action and individuals must believe the cost is outweighed by the benefits (Tavafian 
2012:6). Thus, the joint action of susceptibility and severity offer the energy of power to 
take action and the perception of benefits gives an extended path of action (Glanz & 
Rimer 2008:45). Therefore, if women believe that the predictable benefit of carrying out 




behaviours, they are more likely to undergo cervical cancer screening (Tavafian 
2012:6).  
 
 Modifying variables 
 
Individual characteristics, including demographic, psychological and structural variables, 
can affect perceptions of seriousness, susceptibility, benefits, and barriers of health-
related behaviours (Rosenstock 1974:328). Demographic variables include age, sex, 
race, ethnicity, and education; psychosocial variables include personality, social class, 
and peer and reference group pressure; structural variables include knowledge about a 
given disease and prior contact with the disease. These modifying variables can affect 
health-related behaviours indirectly either by mediating or moderating the key HBM 
constructs by affecting perceived seriousness, susceptibility, benefits, and barriers 
(Glanz, Rimer & Viswanath 2015:75). Tavafian (2012:10) states that race; knowledge, 
education and demographic, socio-psychological, cultural, and structural variables may 
influence perception and indirectly affect health-related behaviour. Thus, socio-
demographic factors may indirectly impact individuals‟ behaviour of cervical cancer 
screening by influencing their perception of susceptibility to the disease, severity of the 
disease and benefits of screening.  
 
 Cues to action 
 
The HBM holds that a cue or trigger is necessary for timely involvement in health-
promoting behaviours. Readiness to action (perceived susceptibility and perceived 
benefits) is prompted by other factors or cues to initiate action (Glanz & Rimer 2008:49). 
Cues to action are events, or environmental events such as media publicity that move 
people to change their behaviour (Tavafian 2012:7). Thus, women would be more likely 
to take preventive action of cervical cancer screening if they were encouraged or 
reminded by family members, friends, mass media or heath care service providers.  
 
According to the HBM (Rosenstock et al 1988:177), people (in this study, women) are 
ready to act if: 
 





 They believe the condition has serious consequences (perceived severity of 
contracting cervical cancer). 
 They believe taking action will reduce their susceptibility to the condition or its 
severity (perceived benefits of cervical cancer screening). Health-related behaviours 
are influenced by the perceived benefits of taking action (Glanz & Rimer 2008:45). 
 They believe the cost of taking action (perceived barriers) is outweighed by the 
benefits. 
 They are exposed to prompt actions (cues to action in preventing the disease and 
prompting recovery, diagnosis and effective treatment of cervical cancer). 
 They are confident in their ability to successfully perform an action (self-efficacy). 
Individual characteristics, including demographic, psychological, socio-cultural, 
education, and structural variables, may influence perception and thus indirectly 
affect the health-related behaviour (Day et al 2010a:102; Tavafian 2012:5). 
 
1.7 RESEARCH DESIGN 
 
A research design is the overall plan for addressing a research question, including the 
specifications for enhancing the integrity of the study (Polit & Beck 2014:741). Grove, 
Burns and Gray (2013:214) refer to a research design as a blueprint for carrying out a 
study that takes advantage of control over factors that could interfere with the validity of 
the findings. 
 
Study designs are types of inquiry that provide precise direction for procedures in a 
research design, it is a technique used to gather information to resolve research 
problems including qualitative, quantitative, and mixed methods techniques (Creswell 
2013:41). According to Creswell (2017:32), a study may be more qualitative than 
quantitative, or vice versa, Mixed methods research falls somewhere in the middle of 
this spectrum because it combines elements of both qualitative and quantitative 
approaches. The researcher selected a mixed methods research design for the study in 
order to collect quantitative and qualitative data. 
 
Mixed methods design. According to Creswell (2013:32), mixed methods studies 
investigate quantitative and qualitative data, integrating the two forms of data. The field 
of mixed methods research is relatively new with major work in developing it stemming 





Many designs exist in the mixed methods, the convergent parallel design, the 
explanatory sequential design, the exploratory sequential design, the embedded design, 
the transformative design and the multiphase design. The way in which this data is 
combined will depend upon the nature of the inquiry and the philosophical outlook of the 
person conducting the research (Creswell 2013:44). 
 
Convergent parallel design is a form of mixed methods design in which the researcher 
converges or merges quantitative and qualitative data in order to provide a 
comprehensive analysis of the research problem. In this design, the investigator 
typically collects both forms of data at roughly the same time and then integrates the 
information in the interpretation of the overall results. Contradictions or incongruent 
findings are explained or further probed in this design (Creswell 2013:44). 
 
According to Creswell (2013:44), explanatory sequential design is one in which the 
researcher first conducts quantitative research, analyses the results, and then builds on 
the findings to explain them in more detail with qualitative research. It is considered 
explanatory because the initial quantitative data results are explained further with the 
qualitative data. It is considered sequential because the initial quantitative phase is 
followed by the qualitative phase. 
 
The exploratory sequential approach starts with a qualitative research phase in which 
the researcher explores the views of participants (Creswell 2013:44). The data is then 
analysed, and the results are used to construct a second, quantitative phase. The 
qualitative phase may be used to develop an instrument that is best suited to the 
sample under study, to identify appropriate instruments for use in the follow-up 
quantitative phase, or to identify variables that must be included in a follow-up 
quantitative study. Particular challenges to this design reside in focusing in on the 
appropriate qualitative findings to use and the sample selection for both phases of 
research (Creswell and Plano Clark 2011:84). 
 
Embedded design, as to Creswell (2013:44) state, the intent is to collect quantitative 
and qualitative data concurrently or sequentially, with one type of data acting as a 




arguments or supports the primary form of data. The supportive data may either 
qualitative or quantitative. 
 
Transformative mixed methods design is one that incorporates a theoretical lens 
based on social justice or power as an overarching perspective into a design that 
includes both quantitative and qualitative data. In this type of research, the data might 
be converged or arranged consecutively, one building after the other (Creswell 
2013:44).  
 
A multiphase mixed methods design is common in the fields of evaluation and 
program interventions. In this advanced design, concurrent or sequential strategies are 












Figure 1.2  Convergent parallel mixed method design of the study 
 
Explanation of figure 1.2 
 
In this study, convergent parallel design was utilised. Both quantitative and qualitative 
research phases were administered concurrently, the finding compared or related each 
other and interpreted, and then the interpreted finding used to develop guidlines was 
developed.  
 
A convergent parallel mixed method: Is a form of mixed methods design in which the 
researcher converges or merges quantitative and qualitative data in order to deliver a 












Quantitative: Data collected from respodants women attending maternal health 
services using close ended questionnars. 
 
Qualitative: Data collected from participants; the health provides using open ended 
questions. 
 
Compared or related: Collected data from both findings compared each other. 
 
Interpretation: Compared findings incorporated from both qualitative and quantitative 
data interpreted. In this study the women‟s knowledge, views and perceptions regarding 
cervical cancer screening compared and interpreted with the health provides‟s views; 
experiences and perception.  
 
Guidelines: interpreted findings used for development of guidelines which used to 
improve cervical cancer screening utilisation. 
 
The reason for using converging parallel study design in this study is, in this approach, 
the researcher gathers both quantitative and qualitative data simultaneously and then 
analyses the results compare or relate to see whether the findings validate or disprove 
each other. The researcher was interested in combining the strengths of quantitative 
and qualitative methodologies, as well as triangulating the methods to create a direct 
comparison and identify conflicts between qualitative and quantitative findings. 
(Creswell 2013:44) (see Chapter 3 for further discussion).  
 
In this research design, the researcher typically collected both forms of data 
concurrently and then provided details on interpreting typical outcomes  
 
1.8 RESEARCH METHODOLOGY 
 
Research methodology is the plan for conducting the specific steps of a study and 
research methods are “the techniques researchers use to structure a study and to 
gather and analyse information relevant to the research question” (Polit & Beck 




sample, data collection, data analysis and interpretation, and findings. Chapter 3 




At the time of the study, 14 public health centres in Addis Ababa were providing cervical 
cancer screening free of charge. The study was conducted at six (6) selected public 
health centres that had started cervical cancer screening two years prior to data 
collection.  
 
1.8.2 Population and sampling  
 
The study collected quantitative data from patients and qualitative data from health care 
providers. Quantitative data was obtained in order to identify determinants of cervical 
screening practice. The population for this stage of the study was all women aged 18 
years and above, screened and not screened, who attended maternal health services in 
the selected health centres in Addis Ababa. The researcher collected a sample from 
both screened and unscreened patients to allow for comparison between the two 
groups, using the sample size-calculation formula for sample size n. By using two 
proportion sample size calculations, the normal distribution at α/2 for a confidence level 
of 95%, for a power of 80%, ratio of sample size of group 2 to group 1 was 1.5. Using 
as p1=56% assuming there is 12 difference p2=44%. A group of 249 screened and 372 
not screened participants were selected (Tadesse 2014:33).  
 
Qualitative data provides culturally specific information about the values, opinions, 
behaviours, and social contexts of particular populations (Moriarty 2011:2; Creswell 
2013:42). Qualitative data was obtained from selected health professionals (nurses, 
midwives, health officers) at the selected health centres by means of key informant 
interviews (Mack, Woodsong, Macqueen, Guest & Namey 2011:3). The purpose of the 
interviews was to obtain the respondents‟ perceptions of women‟s uptake of cervical 





1.8.3 Data collection  
 
The data was collected from the respondents at the selected health centres that provide 
antenatal care, family planning, immunisation, and post-natal care from December 1, to 
30, 2018. The quantitative data was collected by 12 research assistants, using a 
questionnaire. The researcher conducted a two-day training programme with the 
research assistants and supervisors having informed them of the purpose of the study 
and the ethical considerations.  
 
The researcher collected the qualitative data in interviews with health professional 
respondents at the selected health centres, using a semi-structured interview guide.  
 
1.8.4 Data analysis  
 
A statistician analysed the quantitative data, using the Statistical Package for Social 
Sciences (SPSS) Version 23. Bi-variate analysis was performed to assess statistical 
associations depending on variable and to identify factors significantly associated with 
uptake of cervical cancer screening. The level of statistical significance was set at 𝑝 
value less than 0.05 and results presented in graphs, percentages and tables (see 
Chapter 3). 
 
The researcher analysed the qualitative data by reading, categorising, and tabulating 
the transcribed interviews. 
 
Finally, based on the quantitative and qualitative findings and the literature reviewed, 
the researcher developed guidelines to improve cervical cancer screening in Ethiopia. 
The participant health care providers‟ experience and perceptions of cervical cancer 
screening utilisation should assist implementation of the guidelines. The guidelines 
should encourage compliance with screening, promote behavioural modification, and 
help save lives from cervical cancer. The guidelines are designed to inform policies, 





1.9 SCOPE OF THE STUDY  
 
The study was conducted in selected public health centres in Addis Ababa with women, 
18 years and older, who attended maternal health services, and nurses, midwives and 
health officers who worked in maternal health services in the health centres. The health 
care providers were the heads of each unit of maternal health services of each health 
centre, namely pre-cervical screening, family planning, abortion, ANC, childbirth and 
post-natal units. 
 
The study explored and described the respondents‟ experience and perceptions of 
cervical cancer screening service utilisation. The study identified factors contributing to 
low utilisation of services and developed guidelines to improve the utilisation of cervical 
cancer screening services in Ethiopia. 
 
1.10 DEFINITION OF KEY TERMS 
 
For the purposes of this study, the following key terms are used as defined below. 
 
Cervical cancer: The Centres for Disease Control and Prevention (CDC 2017a:1) 
defines cervical cancer as one type of cancer in the lower, narrow uterine cells that link 
to the vagina, which occurs in the cervix cells. This is a disorder in which cervical cells 
are dysfunctional and continue to develop uncontrollably. 
 
In this study, cervical cancer referred to a cervical lesion that was confirmed 
pathologically in the women aged 18 and above who participated in the study. 
 
Determinants: Dicker and Coronado (2012:2) define determinants as the range of 
factors or causes, whether incidents, feature, or other definable entity, that affects the 
health condition of subjects. Collins English Dictionary (1991:430) defines determinant 
as “1 (adj) serving to determine or affect; 2 (n) a factor, circumstance, etc that 
influences or determines”. 
 
In this study, determinants referred to all factors (demographic, social, economic, 
cultural, psychological and environmental) or conditions that hinder awareness, 




screening or promote acceptance for undergoing cervical cancer screening among 
women. 
 
Ethiopia: Ethiopia is the oldest independent and second most populous country in 
Africa. It has a unique cultural heritage with a diverse population mix of ethnicity and 
religion. It served as a symbol of African independence throughout the colonial period, 
and was a founding member of the United Nations and the African base for many 
international organisations (FMOH 2015a:18). 
 
Screening: Mosby’s Medical and Nursing Dictionary (1988:1017) defines screening as 
“(1) a preliminary procedure, as a test or examination, to detect the most characteristic 
sign or signs of a disorder that may require further investigation; (2) the examination of 
a large sample of a population to detect a specific disease or disorder, as hypertension”.  
Collins English Dictionary (1991:1391) defines screen as “(vb tr) to examine for the 
presence of a disease, weapon, etc” and screening test as “(n) a simple test performed 
on a large number of people to identify those who have or are likely to develop a 
specific disease”. 
 
In this study, screening referred to women, 18 years of age and older, who had 
undergone some sort of screening test for cervical cancer once in their lifetime, 
regardless of the outcome, whether positive or negative.  
 
Practice: The Oxford Advanced Learner’s Dictionary (2010:1148) defines practice as “a 
way of doing something that is the usual or expected way in a particular organisation or 
situation; a thing that is done regularly”. Collins English Dictionary (1991:1221) defines 
practice as “(n) a usual or customary action or proceeding”. 
 
In this study, practice referred to the established customs of women in the community, 
aged 18 and older, in relation to preventive behaviour by participation in cervical cancer 
screening tests.  
 
Woman: Collins English Dictionary (1991:1764) defines woman as “(n. pl women) an 





In this study, women referred to adult human beings, biologically female, aged 18 and 
above, who attended maternal health services in the selected health centres in Addis 
Ababa. The women might have had cervical cancer screening or not in their lifetime.  
 
1.11 OPERATIONAL DEFINITIONS 
 
In this study the following terms were operationally defined as follows:  
 
Awareness: Collins English Dictionary (1991:106) defines aware as “(adj) (1) having 
knowledge; cognizant; (2) informed of current developments; awareness (n)”. In this 
study, awareness referred to concern about and well-informed interest in cervical 
cancer screening. 
 
Guideline: Collins English Dictionary (1991:689) defines guideline (pl guidelines) as “a 
principle put forward to set standards or determine a course of action”. In this study, 
guidelines referred to the recommendations to determine a course of action to improve 
the utilisation of cervical cancer screening services. 
 
Health centre: Collins English Dictionary (1991:717) defines health centre as “(n) 
premises, owned by a local authority, providing health care for the local community and 
usually housing a general practice, nursing staff, a child-health clinic, etc”. In this study, 
health centres referred to the selected health centres/ health facilities within the primary 
health care (PHC) system that provide promotive, preventive, curative and rehabilitative 
outpatient care, including basic laboratory and pharmacy services. Health centres serve 
as referral centres for health posts, and provide supportive supervision for health 
extension workers (HEWs).  
 
Health professionals: Mosby’s Medical and Nursing Dictionary (1988:513) defines a 
health professional as “any person who has completed a course of study in a field of 
health, such as a registered nurse, physical therapist, or physician. The person is 
usually licensed by a government agency or certified by a professional organization.” In 
this study, health professionals referred to persons who provided maternal health 






Knowledge: In this study, knowledge referred to the patients‟ ability to correctly identify 
cervical cancer symptoms, causes, risk factors, prevention and treatment.  
 
Perception: In this study, perceptions referred to the health professionals‟ knowledge, 
understanding and observations of cervical cancer and women‟s participation in 
preventive measures particularly screening for cervical cancer. 
 
Utilisation of cervical cancer screening services: In this study, this referred to the 
use of cervical cancer prevention and control services by eligible women through 
cervical cancer screening.  
 
1.12 ETHICAL CONSIDERATIONS 
 
Ethics deals with matters of right and wrong. Ethical considerations are essential to any 
research involving human subjects in order to protect their rights (Polit & Beck 
2014:152). Human research should be intended to produce benefits for participants 
themselves or for other individuals or society as a whole (Polit & Beck 2014:152). 
Health research involves human activities which are governed by individual, community 
and social values. Therefore, research ethics should engage in the safety and dignity of 
subjects and the publication of the work in the research (Fouka & Mantzorou 2011:4).  
 
1.13 OUTLINE OF THE STUDY  
 
The study consists of seven chapters. 
 
 Chapter 1 introduces the study, briefly describing the problem, purpose and 
significance, research design and methodology of the study, and ethical 
considerations. 
 Chapter 2 discusses the literature review conducted for the study.  
 Chapter 3 describes the research design and methods 
 Chapter 4 discusses the quantitative data analysis and findings. 
 Chapter 5 discusses the qualitative data analysis and findings. 
 Chapter 6 discusses the guidelines to improve cervical cancer screening 




 Chapter 7 presents the conclusions and limitations of the study and makes 




This chapter outlines the study introduction, background, and statement of the problem, 
purpose of the research, research objectives, research questions, significance of the 
study, definition of terms, theoretical foundation of the study, research design and 
methodology, data analysis, ethical consideration, scope of the study and finally it 
shows the overall structure of the thesis. Chapter 2 discusses the literature review 














Chapter 1 described the problem, purpose, research design and methodology of the 
study. This chapter discusses the literature review conducted for the study.  
 
A literature review is conducted to establish what is currently known about a topic. The 
review involves researching, reading and understanding literature relevant to the study 
(Brink et al 2018:55). In addition, it assists researchers to broaden their knowledge of 
the phenomenon under study as well as to compare their results with other findings 
(Creswell 2013:60; Polit et al 2014:105). 
 
Literature review is a scientific activity aiming at searching, reading, analysing, and 
evaluation of what is known, unknown, unrealised and gaps in the topics of the study. 
This involves the collection and review of documents which include evidence, ideas, 
information, and data on the topic of the study. Literature review also gives knowledge 
on the topic of the study and help identifies the gaps that should be filled by the study 
(Ridley, 2012:3). In this particular study, literature review focuses providing a fuller 
picture on PNC services, its contributions towards reducing maternal and neonatal 
mortality and on factors associated with its utilisation and quality 
 
The researcher reviewed literature on cervical cancer; cervical cancer screening 
determinants, knowledge, perceptions and cues of cervical cancer, early detection, 
treatment, screening, and the health belief model (HBM). The researcher conducted the 
literature review manually and electronically to obtain sources relevant to the topic, 
using Googlescholar and pubmed, journals, books, health reports, cancer registry and 
guidelines/manuals, using the search words: cervical cancer, aetiology, stages, signs 
and symptoms, risk factors, prevention of cervical cancer, diagnosis and available 
screening tests, treatment, and determinant factors in the health belief model.more 




cervical cancer screening services, its contributions towards reducing mortality and on 
factors associated with its utilisation and quality 
 
2.2 CERVICAL CANCER  
 
Cancer is defined as the uncontrolled proliferation of abnormal cells in any part of the 
body. Cancer cells, malignant cells, or tumour cells are all terms used to describe these 
aberrant cells. These cells have the ability to invade regular bodily tissues (Kumary 
2020:1). Cancer is mostly named for the part of the body where it starts, even if it 
metastasises further to other parts of body. If cancer starts in the cervix, it is called 
cervical cancer (CDC 2017a:1).  
 
 
Figure 2.1  Anatomy of female reproductive system 
(Ramírez, Vaamonde, Cunha, Varghese & Swanson 2016:22) 
 
As figure 2.1 indicates, anatomically, the cervix is the lower, narrow end of the uterus. 
The cervix connects the vagina (birth canal) to the upper part of the uterus or womb. 
The uterus is the hollow pear-shaped internal female organ of reproduction in which the 
fertilised ovum is implanted and the foetus develops during pregnancy. The uterus has 
two parts: a body and a cervix. The cervix has a vaginal portion, protruding into the 
vagina, and a supra-vaginal portion at the juncture of the lower uterine segment 





Although cervical cancer is a preventable disease, it is still one of the leading causes of 
morbidity and mortality among women in low- and middle-income countries worldwide 
(WHO 2014a:3).  
 
In 2013, the highest incidence rates of cervical cancer were found in Central and South 
America, Eastern Africa, South and South-East Asia and the Western Pacific (WHO 
2013:2). Although the incidence of cervical cancer has increased in most developing 
countries since the mid-1980s, cervical cancer rates have fallen in much of the 
developed world, largely as a result of screening and treatment programmes (WHO 
2014a:8). When cervical cancer is found early, it is treatable and associated with 
prolonged survival and good quality of life. Through successful cancer treatment 
programmes, survival rates for cervical cancer can be further increased. Women die far 
more frequently from cervical cancer in developing countries, with the greatest burden 
of the disease in Sub-Saharan Africa (WHO 2013:2).  
 
 
Figure 2.2  Geographical distribution of world age-standardised mortality rate of 
cervical cancer by country, estimated for 2018 
(Arbyn, Weiderpass, Bruni, De Sanjosé, Saraiya, Ferlay & Bray 2020:e194) 
 
Figure 2.2 illustrates the estimated global cervical cancer mortality incidence in 2018. 
Overall, the results from trends in cervical cancer incidence suggest that the incidence 





Cervical cancer remains a major public health issue affecting middle-aged women, 
particularly in low-income countries. Approximately 84% of all cervical cancers and 88 
% of all cervical cancer deaths occurred still in low-resource countries. In 2018, there 
were around 570 000 incidences and 311000 deaths occurred as a result of of cervical 
cancer disease (Arbyn et al 2020:e196) These figures mask a massive global disparity, 
with low- and middle-income countries accounting for 87 % of new cervical cancer 
cases and 91 % of cervical cancer deaths (LMICs). 
 
2.3 SITUATION IN ETHIOPIA  
 
In Ethiopia, the most prevalent cancers among the adult population are breast cancer 
(30.2%), cervical cancer (13.4%) and colorectal cancer (5.7%). Cancer accounts for 
about 5.8% of the total national mortality. Approximately two-thirds of reported annual 
cancer deaths occur among women (FMOH 2015b:14). Cervical cancer is the second 
leading cancer among women. Approximately 6,294 new cases are diagnosed (Bruni, 
Albero, Serrano, Mena, Gómez, Muñoz, Bosch & De Sanjosé 2019:6) and about 4,884 
cervical cancer deaths occurred annually (Bruni et al 2019:14).  
 
 






Figure 2.3 depicts the cancer trends between 1997 and 2012. In a retrospective review 
of cancer cases registered at the Tikur Anbessa (Black Lion) Specialized Hospital 
(TASH) between 1997 and 2012, Abate (2015:104) found that 5,293 were cervical 
cancer cases. New cases had increased between 1997 and 2012; the peak age of 
incidence was 40-49 years; the number of cases per region depended on their distance 
from Addis Ababa, and Addis Ababa, Oromia, and Amhara had the highest numbers 
(Abate 2015:104).  
 
In 2016, Ethiopia had an estimated population of 29.43 million women aged 15 years 
and older who were at risk of developing cervical cancer (Human Papilloma Virus [HPV] 
Centre 2017:1). Cervical cancer was the second most frequent cancer among women in 
all age groups, and the most frequent cancer among women between 15 and 44 years 
of age. Abate (2015:104) found an estimated 31.8% adult prevalence of cervical cancer 
between 1997 and 2012. 
 
Several factors, such as low level of awareness, educational status, financial capability 
and presence of health care facilities, determined the stage at which patients with 









Figure 2.4 shows estimated 5 years prevalence of adult cancer cases. Ferlay et al 
(2012:E381) reported that Cervical cancer remains the most common cancer in women 
in Eastern and Middle Africa and a 5 year prevalent cervical cancer in adult population 
was found about 13.4%.  
 
2.4 ETIOLOGY  
 
Cervical cancer is the most common human papillomavirus (HPV)-related disease 
(WHO 2014a:25). Nearly all cases of cervical cancer can be attributed to HPV infection. 
HPV is the most common viral infection of the reproductive tract which is spread 
through sexual intercourse. Most sexually active women and men will be infected at 
some point in their lives and some may be repeatedly infected. HPV is sexually 
transmitted, but penetrative sex is not required for transmission, skin-to-skin genital 
contact is a well-recognised mode of transmission. There are many different 
types/strains of HPV. Human Papilloma Virus 6 and 11 are considered low-risk genital 
types while HPV 16 and 18 contribute to malignancy and fall under the high-risk genital 
types which could cause cervical cancer. Infection with a high-risk or oncogenic HPV 
type is the primary cause of pre-cancerous and malignant cervical lesions. A significant 
prevalence of high-risk kinds, particularly HPV16 is found in Human populations (WHO 
2014a:39; HPV 2017:1; Zhang, Xu, Zhang & Qiao 2020:722). 
 
Virtually all cervical cancers are associated with human papilloma viruses (HPV). 
However, the majority of women with HPV do not develop cervical cancer. Women 
become susceptible to developing cervical cancer following HPV infection, but other 
environmental factors are required for the cancer to develop (Bray et al 2018:399). 
 
According to the WHO (2019:1), there is a risk for all women that HPV infection may 
become chronic and pre-cancerous lesions progress to invasive cervical cancer. It takes 
about 15 to 20 years for cervical cancer to develop in women with normal immune 
systems, but only 5 to 10 years in women with weakened immune systems, such as 
those with untreated human immunodeficiency virus (HIV) infection. Cervical cancer 
usually develops slowly. It starts as a precancerous condition called dysplasia, which 
can be detected by a Pap smear and is 100% treatable. It can take years for these 





2.5 STAGES OF CERVICAL CANCER  
 
Staging refers to the extent or spread of cancer at the time of diagnosis therefore proper 
staging is essential in determining the choice of therapy and assessing prognosis 
(American Cancer Society [ACS] 2016:8). The International Federation of Gynaecology 
and Obstetrics (FIGO) staging system is used most often for cancers of the female 
reproductive organs, including cervical cancer (Wibea, Dennyb & Thomasa 2012:S100). 
Staging is based mainly on the results of the doctor's physical examination and other 
tests that are done in some cases, such as cystoscopy and proctoscopy. It is not based 
on what is found during surgery. Information about the tumour (T), lymph nodes (N), 
and any cancer spread (M) is then combined to assign the cancer an overall stage. This 
process is called stage grouping. The stages are described using the number 0 and 
Roman numerals from I to IV. Some stages are divided into sub-stages indicated by 
letters and numbers. 
 
Additional imaging, such as computed tomography (CT), magnetic resonance imaging 
(MRI), or positron emission tomography (PET), was considered beneficial but not 
mandated for staging local findings, and the acquired findings were not taken into 
account when assessing the tumour stage. However, since the early tumour stage is the 
deciding significant predictor for patients, primary staging and precise determination of 
the tumour extent are highly important. As a result, the 2018 revision of the FIGO 
classification takes into account cross-sectional imaging methods for visualizing local 
findings for the first time when determining the primary stage. Furthermore, based on 
image processing, an already defined tumour stage can be adjusted (Merz, Bossart, 
Bamberg & Eisenblaetter 2020:939). 
 
1. Imaging techniques can be used in addition to histology and clinical examination to 
determine cancer stage. 
2. In stage I, the definition of microscopic pathological findings and size designations 
are being adapted to allow for the evaluation of cervical cancer using cross-
sectional imaging methods. 
3. Lymph nodes can be evaluated in stages I to III based on imaging and 
histopathological findings. If they are categorised as suspicious for malignant 
transformation, the case is classified as stage IIIC, regardless of the size and extent 




4. Currently, there is no recommendation for the repetitive use of imaging methods for 
cervical cancer local staging. On the basis of clinical findings, they can be 
performed in a supplementary capacity (Merz, et al 2020:940) 
 
Stage 0 (Tis, N0, M0) 
 
The cancer cells are only in the cells on the surface of the cervix (the layer of cells lining 
the cervix), without growing into (invading) deeper tissues of the cervix. This stage is 
also called carcinoma in situ (CIS) which is part of cervical intraepithelial neoplasia 
grade 3 (CIN3). Stage 0 does not exist in the FIGO system (America Cancer Society 
2016:11; Wiebea et al 2012:S100).   
 
Stage I (T1, N0, M0) 
 
In this stage the cancer has grown into (invaded) the cervix, but it is not growing outside 
the uterus (T1). The cancer is limited to the cervix it has not spread to nearby lymph 
nodes (N0) or distant sites (M0). 
 
Stage IA (T1a, N0, M0) 
 
This is the earliest form of stage I. There is a very small amount of cancer, and it can be 
seen only under a microscope. 
 
The cancer has not spread to nearby lymph nodes (N0) or distant sites (M0). 
 
 Stage IA1 (T1a1, N0, M0): The cancer is less than 3 mm (about 1/8-inch) deep 
and less than 7 mm (about 1/4-inch) wide (T1a1). The cancer has not spread to 
nearby lymph nodes (N0) or distant sites (M0). 
 Stage IA2 (T1a2, N0, M0): The cancer is between 3 mm and 5 mm (about 1/5-
inch) deep and less than 7 mm (about 1/4-inch) wide (T1a2). The cancer has not 





Stage IB (T1b, N0, M0) 
 
This includes stage I cancers that can be seen without a microscope as well as cancers 
that can only be seen with a microscope if they have spread deeper than 5 mm (about 
1/5 inch) into connective tissue of the cervix or are wider than 7 mm (T1b). These 
cancers have not spread to nearby lymph nodes (N0) or distant sites (M0). 
 
 Stage IB1 (T1b1, N0, M0): The cancer can be seen but it is not larger than 4 cm 
(about 1 3/5 inches) (T1b1). It has not spread to nearby lymph nodes (N0) or 
distant sites (M0). 
 Stage IB2 (T1b2, N0, M0): The cancer can be seen and is larger than 4 cm 
(T1b2). It has not spread to nearby lymph nodes (N0) or distant sites (M0). 
 
Stage II (T2, N0, M0) 
 
In this stage, the cancer has grown beyond the cervix and uterus, but has not spread to 
the walls of the pelvis or the lower part of the vagina. It has not spread to nearby lymph 
nodes (N0) or distant sites (M0). 
 
Stage IIA (T2a, N0, M0) 
 
The cancer has not spread into the tissues next to the cervix (the parametria), but it may 
have grown into the upper part of the vagina (T2a). It has not spread to nearby lymph 
nodes (N0) or distant sites (M0). 
 
 Stage IIA1 (T2a1, N0, M0): The cancer can be seen but is not larger than 4 cm 
(about 1 3/5 inches) (T2a1). It has not spread to nearby lymph nodes (N0) or 
distant sites (M0). 
 Stage IIA2 (T2a2, N0, M0): The cancer can be seen and is larger than 4 cm 
(T2a2). It has not spread to nearby lymph nodes (N0) or distant sites (M0). 
 Stage IIB (T2b, N0, M0): The cancer has spread into the tissues next to the 
cervix (the parametria) (T2b). It has not spread to nearby lymph nodes (N0) or 





Stage III (T3, N0, M0) 
 
The cancer has spread to the lower part of the vagina or the walls of the pelvis, and it 
may be blocking the ureters (tubes that carry urine from the kidneys to the bladder) 
(T3). It has not spread to nearby lymph nodes (N0) or distant sites (M0). 
 
 Stage IIIA (T3a, N0, M0): The cancer has spread to the lower third of the vagina but 
not to the walls of the pelvis (T3a). It has not spread to nearby lymph nodes (N0) or 
distant sites (M0). 
 
 Stage IIIB (T3b, N0, M0; OR T1-T3, N1, M0): 
− The cancer has grown into the walls of the pelvis and/or has blocked one or both 
ureters causing kidney problems (hydronephrosis) (T3b), or 
− The cancer has spread to lymph nodes in the pelvis (N1) but not to distant sites 
(M0). The tumour can be any size and may have spread to the lower part of the 




This is the most advanced stage of cervical cancer. The cancer has spread to nearby 
organs or other parts of the body. 
 
 Stage IVA (T4, N0, M0): The cancer has spread to the bladder or rectum, which 
are organs close to the cervix (T4). It has not spread to nearby lymph nodes (N0) 
or distant sites (M0). 
 Stage IVB (any T, any N, M1): The cancer has spread to distant organs beyond 
the pelvic area, such as the lungs or liver (M1). 
 
2.6 SIGNS AND SYMPTOMS CERVICAL CANCER 
 
Women with early cervical cancer and pre- cancer often do not have symptoms. The 
majority of HPV infections do not cause symptoms or disease and resolve 
spontaneously and take a long time after exposure to HPV infection (American Cancer 
Society [ACS] 2016:2). Symptoms of cervical cancer tend to appear only after the 




such as irregular, inter-menstrual (between periods) or abnormal vaginal bleeding after 
sexual intercourse; post-menopausal bleeding and pain during intercourse; leg or pelvic 
pain; fatigue, weight loss, loss of appetite vaginal discomfort or odorous discharge, and 
in some cases, just one swollen leg. More severe symptoms may arise at advanced 
stages (America Cancer Society 2016:2).  
 
In Soudi among 300 women with suspected cervical cancer were, the most common 
symptom was found to be vaginal bleeding (51.4%), followed by vaginal discharge 
(28.5%), and post-coital bleeding (13.9%) (Al-Madani, Ahmed, Arabi, Al Khodairy, Al 
Mutairi & Jazieh 2019:447). According to patients presented with symptoms related to 
cervical cancer, most common symptoms were found to be being abnormal vaginal 
bleeding, abdominal pain and vaginal discharge (Begoihn, Mathewos, Aynalem, 
Wondemagegnehu, Moelle, Gizaw, Wienke, Thomssen, Worku, Addissie & Jemal 
2019:6). The study done southern Ethiopia by Teka, Kote, Kejela and Getachew 
(2019:4) showed the most common symptoms being abnormal vaginal bleeding, 
abdominal pain and vaginal discharge, more of 91.1% of patients presented with 
abnormal vaginal bleeding.  
 
2.7 RISK FACTORS FOR CERVICAL CANCER  
 
A risk factor is anything that changes the chance of getting a disease (American Cancer 
Society 2020:1). Knowing about risk factors for cervical cancer helps women to focus on 
those that could be changed. Infection with high-risk or oncogenic HPV types is the 
primary cause of pre-cancerous and cancerous cervical lesions. The majority of cervical 
cancer cases are caused by HPV16 and 18. High-risk types, particularly HPV16, have 
been discovered to be extremely common in human populations. Zhang et al stated 
(2020:722) that the infection is commonly transmitted through sexual contact, resulting 
in squamous intraepithelial lesions. Due to immunological intervention, the majority of 
lesions disappear after 6-12 months. However, a small percentage of these lesions 
remain and can cause cancer. 
 
In Central and South America, Murillo, Herrero, Sierra and Forman (2016:S121) found 
that persistent infection of the cervix with high-risk types of human papillomavirus (HPV) 




to individuals‟ sexual behaviour. Immaturity status and low production of mucus of the 
cervix also favour the presence of HPV in women. 
 
Several risk factors increase the chance of developing cervical cancer, although some 
women with these risks do not develop the disease (American Cancer Society 2020:2). 
At the same time, women without any of these risk factors rarely develop cervical 
cancer. When a woman develops cervical cancer or pre-cancerous changes, it might 
not be possible to say that a particular risk factor was the cause and determining factor.  
 
The risk factors for acquiring HPV and cervical cancer include a weakened immune 
system; smoking; sexually-transmitted infection Chlamydia infection; long-term use of 
oral contraceptives; having children at a young age; having multiple sexual partners, 
and a family history of cervical cancer which are explained below (Dangou 2012:18; 
(Zhang et al 2020:722).  
 
2.7.1 Having a weakened immune system 
 
The human immunodeficiency virus (HIV) that causes Acquired Immune-deficiency 
Syndrome (AIDS) damages a woman‟s immune system and puts her at higher risk for 
HPV infections (WHO 2014a:139). The immune system is important in destroying 
cancer cells and slowing their growth and spread, and might explain why women with 
AIDS have a higher risk of cervical cancer. When a woman has HIV, her immune 
system is less able to fight off early cancer. In women with HIV, a cervical pre-cancer 
might develop into an invasive cancer faster than it would normally.  
 
Globally, about 6% of women with cervical cancer are living with HIV and just fewer 
than 5% of all cases of cervical cancer are attributable to HIV. Nevertheless, the 
proportions vary widely by region; 85 % of women with cervical cancer and HIV live in 
sub-Saharan Africa, underlining the major contribution of HIV to cervical cancer burden 
in the region (Stelzle, Tanaka, Lee Khalil, Baussano, Shah, McAllister, Gottlieb, Klug, 
Winkler & Bray 2020:e162). According to WHO (2020:11), women living with HIV are six 
times as likely to develop cervical cancer compared to women who are HIV negative 





In a study among HIV-positive women in southern Ethiopia, Gedefaw, Astatkie and 
Tessema (2013:4) found that 22.1% of the participants had precancerous cervical 
cancer. Women taking drugs to suppress their immune response, such as those being 
treated for an autoimmune condition or who have had an organ transplant, are also at 
risk for cervical cancer (WHO 2014a:42). A study done by Begoihn et al (2019:6) 
identified known HIV-infection was associated with an almost 1.5-fold risk of diagnosis 
at a more advanced stage compared to those patients with a negative or unknown HIV-
status (95% CI 1.05–2.1 p = 0.025). 
 
2.7.2 Smoking cigarettes  
 
Women who smoke are more likely to get cervical cancer, implying that tobacco use is a 
contributing cause. Furthermore, tobacco use has an impact on both adaptive and 
innate immunological responses to HPV (Aguayo, Muñoz, Perez-Dominguez, Carrillo-
Beltrán, Oliva, Calaf, Blanco & Nuñez-Acurio 2020:2201). Those who smoke are about 
twice as likely as non-smokers to get cervical cancer. Tobacco by-products have been 
found in the cervical mucus of women who smoke. Researchers believe that these 
substances damage the DNA of cervix cells and may contribute to the development of 
cervical cancer. Smoking also makes the immune system less effective in fighting HPV 
infections (American Cancer Society 2020:3). In an urban community of Kweara state, 
Nigeria, Durowade, Osagbemi, Salaudeen, Musa, Akande, Babatunde, Raji (2012:213) 
found tobacco smoking a risk factor for cervical cancer. Teka et al (2019:4) identified 
that in south Ethiopia women who had history of smoking were almost four times more 
likely to have pre-cervical cancer compared to those who had no history of smoking 
(AOR [95% CI]) = 3.7 [1.4-9.9]). 
 
2.7.3 Having sexually-transmitted infection 
 
Chlamydia is a relatively common type of bacteria that can infect the reproductive 
system. It is spread by sexual contact. Chlamydia infection can cause pelvic 
inflammation, leading to infertility. Some studies have seen a higher risk of cervical 
cancer in women whose blood tests and cervical mucus showed evidence of past or 
current Chlamydia infection.  Women who are infected with Chlamydia often have no 
symptoms. In fact, they may not know that they are infected at all unless they are tested 





In a case control study done in Indea by Kashyap, Krishnan, Kaur and Ghai (2019:310) 
among 75 women diagnosed cervical cancer 18 participants had a history of Sexually 
Transmitted Disease (STD).  
 
2.7.4 Long-term use of oral contraceptives (birth control pills) 
 
Long-term use of oral contraceptives (OCs) increases the risk of cancer of the cervix. 
The risk of cervical cancer increases the longer a woman takes OCs, but decreases 
after the use of OCs is stopped, and returns to normal about 10 years after stopping. A 
woman and her doctor should discuss whether the benefits of using OCs outweigh the 
potential risks (WHO 2014a:40). Long-term use of oral contraceptives has been 
associated with cervical cancer risk In Ethiopia, women with long term use of oral 
contraceptives were associated with an increased risk of cervical cancer compared to 
women who do not use oral contraceptives (Kassa 2018:4). 
 
2.7.5 Having children at a young age  
 
Women who were younger than 20 years old when they had their first full-term 
pregnancy are almost twice as likely to get cervical cancer later in life than women who 
became pregnant when they were 25 or older (America Cancer Society 2020:4).  
 
2.7.6 Having multiple sexual partners  
 
Moreover, many studies have also suggested that women with multiple sexual partners 
are at high risk for HPV acquisition and cervical cancer in their meta-analysis of 
epidemiological studies, Liu, Liu, Liu, Ye and Chen (2015:3899) found that having 
multiple sexual partners was a potential risk factor for cervical cancer. Study done by 
Teka et al (2019:4) identified that woman who had two or more than two life-time sexual 
partners were 2.2 times more likely to have pre cervical cancer compared to those who 





2.7.7 Having a family history of cervical cancer 
 
Cervical cancer may run in families. If a woman's mother or sister had cervical cancer, 
the chances of developing the disease are two to three times higher than if no one in 
the family had it. This familial tendency may be caused by an inherited condition that 
makes some women less able to fight off HPV infection than others (America Cancer 
Society 2020:5). In a study among women aged 18-49 years in Njiru Sub-County, 
Nairobi, Kenya, Mungai, Kikuvi, Wanzala and Mutai (2016:88) found that being sexually 
active from a young age, giving birth to many children, and early age at first birth were 
also risks for acquiring cervical cancer. Al-Madani et al (2019:449) identified that family 
history of cancer (AOR, 4.216; 95% CI, and 1.433-12.400) was risk for cervical cancer.  
 
2.7.8 Early age at first sexual intercourse 
 
Sexual behaviour was associated with an increased risk of HPV 16/18 infection. Early 
sexual intercourse can be a risk factor for cervical cancer in young women. Women who 
begin to have sexual intercourse before the age of 16 is more vulnerable to HPV 
infection because during puberty because during puberty the cervix undergoes cellular 
changes at the transformation zone that are known as ectopy. During ectopy, the 
cervical cells may not only be more susceptible to HPV infection, but they may also be 
more prone to persistent HPV infection and to more lasting damage from an infection. 
Women who engaged in sexual intercourse at a younger age tended to have a higher 
risk of harbouring HPV 16/18 infection (Itarat, Kietpeerakool, Jampathong, 
Chumworathayi, Kleebkaow, Aue-Aungkul & Nhokaew 2019:490)  
 
A significant association was found among women who had their first sexual intercourse 
prior to 16 years of age and HPV infection (OR 4.41; 95 %CI: 1.20- 19.33) ( Ribeiro, 
Costa, Alves, Villa, Saddi, dos Santos Carneiro, Zeferino, & Rabelo-Santos, 2015:3) 
Study done in Southern Ethiopia showed women who had first sexual intercourse at 
less than eighteen years were 6.6 times more likely to have pre-cervical cancer 
compared to those who had first intercourse at eighteen or above years (AOR [95% CI]) 





2.8 PREVENTION OF CERVICAL CANCER  
 
Cervical cancer prevention and control programmes are developed and designed to 
decrease cervical cancer incidence, morbidity and mortality. WHO (2014a:8) indicated 
that most women who die from cervical cancer, particularly in developing countries, are 
in the prime of their lives. They may be raising children or caring for their families and 
contributing to the social and economic lives of their community. A woman‟s death is 
both a personal disaster and a sad and unnecessary loss to her family and her 
community, with enormous consequences for the welfare of both. These deaths are 
unnecessary because there is compelling indication that cervical cancer is one of the 
most preventable and treatable forms of cancer if it is detected early and managed 
effectively. The WHO (2014a:45) recommends that comprehensive programmes should 
include primary, secondary and tertiary prevention activities and access to palliative 
care. 
 
2.8.1 Primary prevention 
 
Primary prevention consists of those preventive measures aimed at a healthy 
population or individual who is susceptible to a given disease. The purpose of primary 
prevention is to prevent an illness or injury from occurring. Common activities consist of 
activities that limit risk exposure or enhance the resistance of individuals at risk (Kisling 
& Das 2019). This would determine the women‟s awareness and knowledge of reducing 
the risk of cervical cancer.  
 
2.8.1.1 Reducing exposure to risk factors associated with HPV infection 
 
Primary prevention is essentially based on a healthy lifestyle and vaccination against 
HPV. Cervical cancer belongs to the group of cancers that are preventable and 
treatable by vaccination of HPV and early screening diagnoses. healthy sexuality 
education for boys and girls, tailored as appropriate to age and culture, essential 
messages which include delay of sexual initiation, and reduction of high-risk sexual 
behaviours; condom promotion or provision for those who are sexually active; male 
circumcision where relevant and appropriate aimed to reduce the risk of HPV 
transmission (WHO 2014a:53). Preventing HPV infection will prevent cervical cancer. 




other STIs. In a study among Zimbabwean women on anti-retroviral therapy (ART), 
Pomerai, Muchekez and Nyachowe (2012:495) found that although condoms 
significantly reduce the risk of HIV infection, there was no evidence that they reduced 
the risk of HPV infection.  
 
2.8.1.2 HPV vaccine  
 
Vaccination against HPV is the most effective way to prevent cervical cancer. In 
developing countries where women's healthcare facilities are minimal or extremely 
limited, the benefits of such a vaccine will be especially important. New vaccines 
against the Human papillomavirus (HPV) help to prevent cervical cancer further (WHO 
2013:2). 
 
According to the WHO (2013:4), 70% of cervical cancers worldwide are caused by only 
two HPV types (16 and 18). Two vaccines against HPV are licensed in most countries 
because both vaccines prevent 95% of HPV infections caused by HPV types 16 and 18, 
and may have some cross-protection against other less common HPV types which 
cause cervical cancer. The most effective population to target for HPV vaccination is 
young, adolescent girls. However, effective, affordable and equitable delivery strategies 
to reach girls 9-13 years of age three times during a 6-month period are required. 
Immuno-compromised individuals, including those who are living with HIV and females 
aged 15 years and older should also receive the vaccine and need three doses (WHO 
2014a:108).  
 
Despite the HPV vaccine‟s proven safety, efficacy and cost-effectiveness there exists a 
significant lag in its introduction in low- and middle-income countries (Wigle, Coast & 
Watson 2013:3812). Until a protective vaccine is widely available and accessible, 
primary prevention must focus on reducing the behaviours and risks that increase 
people‟s risk of becoming infected. Risk reduction counselling on the risk factors should 
be incorporated into all levels of the healthcare system, especially those dealing with 
young people, and should inform adolescents about practices designed to minimise the 






2.8.2 Secondary prevention  
 
Secondary prevention of cervical cancer focuses on identifying and treating women with 
precancerous (WHO 2020:28). The goal of secondary prevention intervention is to 
decrease the incidence and prevalence of cervical cancer and associated mortality, by 
discontinuing progress from pre-cancer to invasive cancer. Interventions include 
counselling and information sharing, and screening for all women aged 30-49 years (or 
ages determined by national standards) to identify precancerous lesions, which are 
usually asymptomatic; treatment of identified (WHO 2014a:53). 
 
2.8.2.1 Cervical cancer screening  
 
Cervical cancer prevention programmes aim to screen the largest possible proportion of 
women. Cervical cancer screening refers to the systematic application of a test to 
identify cervical abnormalities in an asymptomatic population (WHO 2013:6). Early 
detection, by screening all women in the target age group, followed by treatment of 
detected precancerous lesions can prevent the majority of cervical cancers. Cervical 
cancer screening should be performed at least once for every woman in the target age 
group 30-49 years where most benefit can be achieved. Cervical cancer screening, at 
least once, is recommended for every woman in the target age group, but this may be 
extended to women younger than age 30 if there is evidence of a high risk. For cervical 
cancer prevention to be effective, women with positive screening test results must 
receive effective treatment (WHO 2014a:131).  
 
Women who are already infected with HPV should be screened to determine whether 
they have early, easily treatable precancerous lesions. If lesions are found, they should 
be treated before they progress to cancer. Although the Pap smear is the most well-
established method of screening women for precancerous lesions, other approaches to 
screening women at risk for cervical cancer include visual screening, HPV tests and 
cytology screening (WHO 2013:7). With the aim of eliminating cervical cancer globally, 
cervical cancer screening, is becoming more important in overall prevention and control, 
in addition to HPV vaccination, particularly for those treatments that have shown to be 





2.8.2.2 Cytology-based screening  
 
For decades, the Papanicolaou (Pap) smear has been used throughout the world to 
identify precancerous cervical lesions for treatment and follow-up. Cytology-based 
screening has been shown to be effective when implemented as part of national 
programmes with high coverage and in settings where resources exist for patient follow-
up, additional diagnostic tests such as colposcopy and pathology, and disease 
management. However, in low- and middle-income countries cytology-based 
programmes have been challenging to implement, even where they have been 
implemented screening coverage is low (WHO 2020:28). In developed countries, 
routine Pap smear screening has contributed to a 70-80% reduction of cervical cancer. 
However, a single cervical cytology result is relatively insensitive for the detection of 
cervical pre-cancer and cancer (Ahmed 2016:6) 
 
Cytology-based screening involves taking a sample of cells from the entire 
transformation zone, and can use either conventional Pap smear or liquid-based 
cytology (LBC). With conventional cytology, a sample of cells is smeared on a glass 
slide, and preserved by a fixative agent. For LBC, instead of smearing the sample onto 
a slide, it is placed into a container of preservative solution and sent to the laboratory for 
microscopic examination (WHO 2014a:146).  
. 
Cervical cancer screening should not start before 30 years of age. Screening women 
between the ages of 30 and 49 years, even once, would reduce deaths from cervical 
cancer. Cervical cancer screening is recommended for every woman in this target age 
group, but this may be extended to younger ages if there is evidence of a high risk, such 
as HIV prevalence (WHO 2014a:138). 
 
2.8.2.3 Visual inspection with acetic acid (VIA) 
 
Visual inspection with acetic acid (VIA) is a method for detecting early cell changes that 
are visible when using a speculum to inspect the cervix with the naked eye after 
applying diluted solution (3-5%) acetic acid for nearly 1-2 minutes. After the use of the 
acetic acid, epithelial changes become aceto-white, which indicates that these have 
immature squamous metaplasia; that is, cervix infection with HPV and true cervical 




does not require laboratory staff training except the training and supervision of primary 
care providers. The results are immediately available, allowing treatment during a single 
visit and thus reducing loss to patient follow-up, and promoting a “screen and treat” 
mechanism that entails diagnosis and treatment at a single visit. The sensitivity of VIA is 
equivalent to or better than that of a Pap smear, although its specificity is lower (WHO 
2014a:148). 
 
2.8.2.4 Visual inspection with Lugol’s Iodine (VILI) 
 
The first method for cervical cancer screening was visual inspection of the cervix after 
application of Lugol‟s iodine (VILI), originally known as the Schiller test, and was 
introduced by Schiller in the 1930s. It involves naked eye examination of the cervix to 
identify mustard yellow lesions in the cervix immediately after application of Lugol‟s 
iodine. A positive result is based on the appearance of a definite mustard yellow area on 
the cervical os or on a cervical growth. The test cannot be repeated for several hours as 
iodine stains and changes persist for a long time (Denny 2012:71). Schiller‟s test has 
poor specificity and was almost completely replaced with cervical cytology. Current 
cervical cancer screening includes a combination of cervical cytology and HPV testing. 
Limited specificity notwithstanding, visual inspection of the cervix has re-emerged as a 
screening tool for low-resource settings because it is economical and provides 
immediate results. Visual inspection can be done with acetic acid (VIA) or Lugol‟s iodine 
(VILI) (Denny 2012:72). A cross sectional study done in India, identified that sensitivity 
for VIA and VILI was 89.5 and 100 per cent, respectively, while the specificity for VIA 
and VILI and was 91.2, 93.3 and 99.1 per cent, respectively (Ghosh, Gandhi, Kochhar, 
Zutshi & Batra 2012:265).  
 
2.8.2.5 HPV testing  
 
HPV testing established that cervical neoplasia is caused by persistent infection with 
certain oncogenic types of HPV. This knowledge led to the evaluation of HPV testing as 
a screening tool. The hybrid capture assay (HCA) is currently the most widely used. 
Other HPV DNA testing formats based on polymerase chain reaction permit identifying 
infection with individual oncogenic types. One advantage of HPV DNA testing is that it is 




are at increased risk for developing cervical disease, HPV DNA testing can identify 
women who already have the disease (Ahmed 2016:6). 
 
HPV testing is incorporated into cervical cancer screening programmes as a primary 
screening test in high resource settings (WHO 2014a:129). A population-based 
randomised trial indicated that using HPV DNA testing as the primary screening 
followed by cytological triage and repeat HPV DNA testing of women with normal 
cytology who were HPV DNA positive after at least one year was a feasible strategy for 
incorporating HPV testing in primary cervical cancer screening, because it improved 
sensitivity and maintained a high positive predictive value, thus minimising unnecessary 
referrals. However, HPV DNA testing is expensive and presents similar challenges as 
cytology screening in low-resource areas (Ahmed 2016:7).  
 
2.8.2.6 Treatment options for cervical pre-cancer 
 
Treatment aims to destroy or remove areas of the cervix identified as pre-cancerous 
lesion. Treatment methods may be ablative (destroying abnormal tissues by burning or 
freezing) or excision (surgically removing abnormal tissues). With ablative methods, no 
tissue specimen is obtained for further confirmatory histopathological examination 
(WHO 2014a:155). Cryotherapy or loop electrosurgical excision (LEEP) can provide 
effective and adequate treatment for the majority of women who are positive for cervical 
pre-cancer (WHO 2014a:131). 
 
The screen-and-treat approach was developed to reduce loss to follow-up, and this 
strategy was increasingly adopted worldwide (WHO 2013:5). Instead of screening and 
diagnosis by the standard sequence of cytology, colposcopy, biopsy, and histological 
confirmation of CIN, an alternative method is to use a screen-and-treat approach in 
which the treatment decision is based on a screening test and treatment is provided 
soon or, ideally, immediately after a positive screening test. Even for women who have 
received an HPV vaccination, it is important to continue screening and treatment when 
they reach the target age (WHO 2013:8). Each treatment method, namely Cryotherapy, 
Loop Electrosurgical Excision Procedure (LEEP) and Cold Knife Conisation (CKC), has 






Other forms of therapy, such as laser excision or ablation, are not as widely available. A 
hysterectomy is rarely an appropriate means to treat pre-cancer. Unless there are other 
compelling reasons to remove the uterus, a hysterectomy should not be performed for 
pre-cancer (WHO 2014a:155). 
 
2.8.3 Tertiary prevention of cervical cancer  
 
The annual number of new cases of cervical cancer has been projected to increase 
from 570 000 to 700 000 between 2018 and 2030 throughout the world that need 
treatment (WHO 2020:7). Invasive cervical cancer is treated by surgery and/or 
radiotherapy. Chemotherapy can complement the treatment regime in late stages. In 
many countries there is insufficient capacity to provide these services or the existing 
services are not accessible and affordable to the majority of affected women Palliative 
care which is tertiary prevention is provided to patients when the disease has already 
reached an incurable stage (Pomerai et al 2012:496). 
 
2.9 DIAGNOSIS  
 
A diagnostic or confirmatory test is a medical test performed to aid in the diagnosis or 
detection of a disease. Since not all women with positive results on cervical screening 
tests have pre-cancer, a subsequent diagnostic test is sometimes used for confirmation 
of pre-cancer or cancer (WHO 2014a:136). Colposcopy, biopsy and endo cervical 
curettage (ECC) are the most commonly used diagnostic tests. 
 
2.10 TREATMENT OF CERVICAL CANCER  
 
Globally, an estimated 570 000 new cases of cervical cancer are diagnosed annually 
that need treatment (WHO 2020:7). Treatment of cervical cancer is dependent on the 
stage of the disease, age and medical state of the patient, tumour characteristics, 
patient preferences, and resources within the health sector of each country. Cervical 
cancer treatment options include surgery, radiotherapy and chemotherapy, and these 
may be used in combination (WHO 2014a:165).  
 
A systematic review of cervical cancer prevention and treatment in public health 




or not available at all (Finocchario-Kessler, Wexler, Maloba, Mabachi, Ndikum-Moffor & 
Bukusi 2016:29). Consequently, palliative care with symptom control and support may 
be the most likely option for severely late-stage cervical cancer or for women with less 
advanced disease, but who cannot afford or access treatment. In many African 
countries, only 24% to 67% of those diagnosed with cervical cancer receive some form 
of treatment (either radiotherapy or hysterectomy). Table 2.1 lists treatment options with 
respect to stage of cervical cancer.  
 
Table 2.1 Treatment options with respect to stage of cervical cancer  
 
(Adopted from WHO 2014a:375) (Annexure 10) 
 
2.11 FACTORS INFLUENCING TO CERVICAL CANCER SCREENING  
 
Several factors contribute to poor screening, but may be summarised in three 
categories: (1) lack of knowledge and misinformation about cervical cancer; (2) 
psychosocial beliefs about cervical cancer and perceived barriers to screening, and (3) 
structural barriers to healthcare access. These factors are explained in the Health Belief 
Stage of cancer Treatment 
Stage 1 Cancer strictly confined to the cervix  
Stage IA Invasive cancer identified only 
microscopically 
Simple hysterectomy 
Stage IB Clinical lesions (lesions that can be seen 
without a microscope) confined to cervix 
 
Stage II Cancer extends beyond cervix, but not 
extended onto pelvic wall 
 
Stage IIA Cancer spread to upper part of vagina, but 
no obvious parametrial involvement 
Radical hysterectomy with pelvic 
node dissection or external beam and 
intra-cavity radiotherapy 
IIB Obvious parametrial involvement 
 
Stage III Extended onto the pelvic wall or to the lower 
third of the vagina 
 
Stage IIIA No extension onto the pelvic wall, but 
involvement of lower third of vagina 
 




Stage IV Extended beyond true pelvis or clinically 
involved mucosa of bladder or rectum 





Model (HBM) that describes individuals‟ health-related behaviours, particularly in regard 
to the uptake of health services. 
 
2.12 HEALTH BELIEF MODEL AND CERVICAL CANCER SCREENING 
BEHAVIOUR 
 
The health belief model (HBM) is a conceptual framework that describes a person‟s 
health behaviour as an expression of health beliefs. The model was designed to predict 
a person‟s health behaviour, including the use of health services, and to justify 
intervention to alter maladaptive health behaviour. Components of the model include the 
person‟s own perception of susceptibility to a disease or condition, the likelihood of 
contracting it, the person‟s perception of the severity of the consequences of contracting 
it, the perceived benefits of care and barriers to preventive behaviour, and the internal 
or external stimuli that result in appropriate health behaviour by the person (Mosby’s 
Medical and Nursing Dictionary 1988:512). (Detailed explanation of the model see 
chapter 1). 
 
 Perceived susceptibility  
 
As explained in chapter 1, Individuals who believe they have risk factors for developing 
cervical cancer and perceived susceptibility to an illness are more likely to take action to 
prevent a negative health outcome. In Kisumu, Kenya, Morema et al (2014:335) found 
that women who were not aware of susceptibility to cervical cancer had a higher 
likelihood of not being screened. In Mekelle Zone, Northern Ethiopia, Bayu, Berhe, 
Mulat and Alemu (2015:2) found that perceived susceptibility to cervical cancer was a 
significant predictor of cervical cancer screening service uptake. A study in Arba Minch 
Town, Southern Ethiopia, found that 41.4% of the participants utilised the cervical 
cancer screening service due to their perceived susceptibility to the disease (Gebru, 
Gerbaba & Dirar 2016:297). The study done in Jimma town, south-west Ethiopia 
revealed that perceived susceptibility for cervical cancer was a factor that affect cervical 
cancer screening utilizationshowing that women who had high perceived susceptibility 
were more likely to undergo screening when compared with low perceived susceptibility 





 Perceived severity  
 
Perceived severity of cervical cancer refers to women‟s feelings about the medical harm 
(death, disability or pain) or social damage (effects on work, family and social life) in 
developing cervical cancer or not utilising cervical cancer screening/treatment. In their 
study in Arba Minch town, Southern Ethiopia, Gebru et al (2016:297) found that 30.3% 
of the participants perceived the severity of cervical cancer and accepted screening for 
cervical cancer. Further, more than one-third of women perceived the seriousness of 
the disease in the study done in Saudi (Aldohaian, Alshammari & Arafah 2019:8). 
According to Annan, Asante and Kugbey (2019:4), increased perceived seriousness 
significantly predicted increased cervical cancer screening behaviours (b = .04, p < .05)  
 
 Perceived benefit  
 
Individuals who believe they are susceptible to a disease and that it is severe will take 
health action if they also perceive the action as potentially beneficial by reducing the 
threat (Tavafian 2012:5). Gebru et al (2016:297) found that 48.2% of the participants 
perceived the benefit of screening by detecting pre-cancerous cells, which gave them a 
sense of decreasing risk. In Njiru Sub-County, Nairobi, Kenya, Mungai et al (2016:88) 
reported that the majority of the participants perceived screening as highly effective in 
the prevention of cervical cancer.  
 
 Perceived barriers 
 
Perceived barriers refer to the cost of taking action and individuals must believe the cost 
is outweighed by the benefits (Tavafian 2012:6). In a study in Mekelle Zone, North 
Ethiopia, the participants believed the benefits outweighed the perceived barriers or 
cost of action, which was a predictor of cervical cancer screening uptake (Bayu et al 
2015:5). In Saudi 27% of the participants perceived barriers to obtaining a cervical 
cancer screening test (Aldohaian et al 2019:8). 
 
 Modifying variables 
 
Modifying variables can affect health-related behaviours indirectly either by mediating or 




benefits, and barriers (Glanz, Rimer & Viswanath 2015:75). Thus, socio-demographic 
factors may indirectly impact individuals‟ behaviour of cervical cancer screening by 
influencing their perception of susceptibility to the disease, severity of the disease and 
benefits of screening.  
 
Several studies found that participants were aware or had heard of cervical cancer, but 
had limited knowledge of the causes, risk factors and prevention of the disease (Mwaka, 
Orach, Were, Lyratzopoulos, Wabinga & Roland 2015:859; Mungai et al 2016:88; 
Aswathy, Quereshi, Kurian & Leelamoni 2012:207; Getahun, Mazengia, Abuhay & 
Birhanu 2013:4; Interis, Anakwenze, Aung & Jolly 2016:56).  
 
The study done in Bugiri and Mayuge districts in eastern Uganda, Ndejjo, Mukama, 
Musabyimana and Musoke (2016:6) found that the independent predictors of cervical 
cancer screening were: being recommended by a health worker, knowing where 
screening services were offered, and knowing someone who had ever been screened. 
 
According to Weng, Jiang, Haji, Nondo, and Zhou (2020:3) the married/cohabiting group 
showed higher acceptance than the divorced/widowed group (60.58% vs 48.97%, P = 
0.000). (60.58% vs 48.97%, P = 0.000)  
 
 Cues to action 
 
Readiness to action (perceived susceptibility and perceived benefits) is prompted by 
other factors or cues to initiate action (Glanz & Rimer 2008:49). According to Ndejjo et 
al (2016:6) one of cue to action was being recommended by a health worker.  
 
The HBM holds that a cue or trigger is necessary for timely involvement in health-
promoting behaviours. Readiness to action (perceived susceptibility and perceived 
benefits) is prompted by other factors or cues to initiate action (Glanz & Rimer 2008:49). 
Cues to action are events, or environmental events such as media publicity that move 
people to change their behaviour (Tavafian 2012:7). Thus, women would be more likely 
to take preventive action of cervical cancer screening if they were encouraged or 
reminded by family members, friends, mass media or heath care service providers. 
According to Ndejjo et al (2016:6) one of cue to action was being recommended by a 




Lack of specialized training in cervical cancer care and its management reported as a 
barrier by the health managers and a health worker that means the knowledge and 




This chapter discussed the literature review undertaken for the study. Chapter 3 










Chapter 2 discussed the literature review conducted for the study. This chapter 
discusses the research design and methodology of the study.  
 
Polit and Beck (2017:271) describe research methodology as the “steps, procedures 
and strategies taken to investigate the problem being studied and to analyse the 
collected data”. Research methods are “the techniques researchers use to structure a 
study and to gather and analyse information relevant to the research question” (Polit & 
Beck 2017:271). The methodology included the study setting, population, sample, and 
data collection and analysis.  
 
3.2 RESEARCH DESIGN  
 
A research design is the overall plan for addressing a research question, including the 
specifications for enhancing the integrity of the study (Polit & Beck 2014:741). Brink et 
al (2018:92) describe a research design as “a set of logical steps taken by the 
researcher to answer the research question”. A research design is an overall plan for 
identifying and selecting participants, collecting the data pertaining to the research 
questions, analysing the data and writing the report on the findings (Creswell & Creswell 
2018:43).  
 
There are three types of research design, namely qualitative, quantitative, and mixed 
methods research designs to be different types of inquiry within these different 
approaches and the choice of research design depends on the nature of the research 





3.3 MIXED METHOD RESEARCH APPROACHES   
 
Mixed method research design combines qualitative and quantitative approaches to 
complement each other to provide comprehensive data. Mixed method states that 
researchers collect and analyse both qualitative and quantitative data in a sequential 
and/or simultaneous and rigorous manner which integrates the two forms of data 
(Creswell 2014:32). The researcher considered a mixed methods design appropriate for 
the study as the combination of qualitative and quantitative data which would provide a 
deeper understanding of the research problem. 
 
The mixed approach designs classified as explanatory, exploratory sequential, and 
convergent parallel mixed method approaches. In this study, the researcher used a 
convergent parallel mixed methods approach, collecting quantitative and qualitative 
data (Creswell 2014:43). Quantitative data was collected from clients and qualitative 
data from health care providers Using the two methods provided different perspectives 
and allowed the researcher to explore the complex issues deeply (Creswell & Creswell 
2018:44).  
 
3.3.1 Convergent parallel mixed methods approach 
 
The convergence of mixed methods strategy collects both quantitative and qualitative 
data simultaneously and then analyses the results concurrently to see whether the 
findings validate or disprove each other (Creswell 2013:44). Convergent of parallel 
integrated approach is the design of the blended techniques in which the researcher 
assembles quantitative and qualitative data to provide a detailed evaluation of the 
research issue (Creswell 2014:43). Accordingly, convergent parallel mixed approaches 
were used in this study. The researcher collected quantitative and qualitative data 
simultaneously and incorporated both sets of data into the interpretation of the overall 
results. The quantitative data was statistically analysed to establish clear predictors, and 
then triangulated with the qualitative data to be used in the development of the 
guidelines. The researcher then developed the guidelines to improve utilisation of 






3.3.2  Rationale for conducting the concurrent parallel mixed method 
 
In concurrent/convergent parallel mixed methods research strategies, qualitative and 
quantitative data are collected, as the name indicates, at the same time or in parallel. 
This design involves a single study containing qualitative and quantitative data 
collection which is conducted at the same time.  
 
3.3.3  Purpose of concurrent parallel mixed method  
 
The purpose of convergent parallel design mixed methods is to provide a 
comprehensive analysis of cervical cancer screening utilisation by converging or 
merging quantitative and qualitative data.  
 
3.3.4  Comparative cross-sectional study  
 
A comparative cross-sectional study compares the prevalence of outcomes of interest, 
such as health, disease, risk factors, disability or death (Ahmad, Marwat & Khan 
2013:243). It is a type of non-experimental quantitative research in which the researcher 
compares two or more groups in terms of a cause (Creswell 2013:41). 
 
The researcher conducted an institutional based comparative study, in six selected 
health centres with two groups of patients, namely screened and not screened, to 
identify and compare the knowledge, awareness and perceptions of utilisation of 
cervical screening among women attending maternal health services at the selected 
health centres. The influencing factors for cervical cancer screening were compared 
and analysed between participants who were screened and participants who were not 
screened. The purpose was to explore the participants‟ exposure to cervical cancer 
screening and assess the determinant factors for women in Addis Ababa who attend 





3.4  QUANTITATIVE AND QUALITATIVE STRANDS: PHASE 1 
 
3.4.1  Purpose 
 
The purpose of the study was to investigate factors that determine cervical cancer 
screening among women in Addis Ababa, Ethiopia.   
 
3.4.1.1  Objectives  
 
 Identify the determining factors of screening practice for cervical cancer among 
women in Addis Ababa, Ethiopia. 
 Explore and describe health professionals‟ perceptions of cervical cancer screening 
utilisation among eligible women in Addis Ababa, Ethiopia. 
 
3.4.1.2  Research questions   
 
 What are determining factors related to screening for cervical cancer among women 
in Addis Ababa, Ethiopia? 
 What are health professionals‟ perceptions of cervical cancer screening utilisation 
among eligible women in Addis Ababa, Ethiopia? 
 
3.4.2  Research setting 
 
A setting refers to the “physical site or location used to conduct a study and in which 
data collection takes place” (Polit & Beck 2017:274). The study was conducted in Addis 
Ababa, the capital city of Ethiopia. Ethiopia is the oldest independent and second most 
populous country in Africa. Ethiopia is located at 3 degrees and 14.8 degrees latitude, 
33 degrees and 48 degrees longitude in the eastern part of Africa between the Equator 
and the Tropic of Cancer. It is bordered on the Northeast by Eritrea and Djibouti, on the 
East and Southeast by Somalia, on the south by Kenya, and on the West and 
Northwest by Sudan known as the Horn of Africa (Central Statistical Agency [CSA] of 






Figure 3.1  Map of Ethiopia, Addis Ababa 
(Masters, Tefera, Wagner & Boulton 2018:1-8) 
 
Figure 3.1 presents Map of Ethiopia, Addis Ababa. Addis Ababa is the largest city in 
Ethiopia, with an estimated population of 3,194,000 and an annual growth rate of 3% 
(Central Statistic Agency 2015:16). The city is administratively divided into 10 sub-cities, 
116 Woredas (lower administrative units), and 99 kebeles (villages), with a total of 42 
hospitals, 98 health centres, 359 clinics and 35 health posts in the city, including the 
private sector (Population Census Commission 2008:1). At the time of the study, 14 
public health centres in Addis Ababa were providing cervical cancer screening free of 
charge. The study was conducted at six (6) selected public health centres, namely Kolfe 
Keranio, Arada, Kolfe Woreda 9, Semen, Kotebe, and Yeka Woreda 1 health centres. 
These health centres were selected because they are governmental/public health 
centres and had started cervical cancer screening free of charge two years before the 
study period. The quantitative and qualitative data collection was done at the selected 





3.4.3 Population sampling and sample methods 
 
3.4.3.1 Population  
 
A population is “the entire aggregate of cases in which a researcher is interested” (Polit 
& Beck 2017:273). A study population comprises the entire aggregate of cases in which 
a researcher is interested (Creswell 2013:50). Walliman (2018:144) also defined study 
population as a collective term consisting of the total quantity of things which are the 
subject of the study. It can consist of objects, organisation, people or events to be 
studied. The researcher used two populations, namely clients and health care providers. 
In the quantitative phase, the population consisted of all the patients attending maternal 
health services in the selected health centres who met the inclusion criteria. In the 
qualitative phase, the population consisted of the health care workers providing the 
services. 
 
The population for quantitative research included all women who came to the selected 
health centres for antenatal, family planning, immunisation and postnatal service who 
visited the selected health centres in Addis Ababa city administration public health 
centres. 
 
For the quantitative part, women who came for maternal health service during the data 
collection period and who fulfilled the following inclusion criteria were included in the 
study. 
 
 Attend maternal health services and agree to participate voluntarily. 
 Be aged 18 years or older. 
 Have been residents of Addis Ababa for at least one year. 
 
Women with poor health conditions and/or a history of the disease (carcinoma of the 
cervix) were excluded from the study. 
 
For the qualitative study the population consisted of nurses, midwives and health 





 Be nurses, midwives or health officers working at the selected health centres. 
 Have served in the maternal health service units in the health centres for at least 
one year. 
 
3.4.3.2 Sample and Sampling Method  
 
The researcher performed sampling for each of the quantitative and qualitative phases 
of the study. Sampling refers to the practice of choosing incidents in the sample to 
represent the whole population (Polit & Beck 2017:275). A sample is a population 
subset. Individual units of the sample and population are referred to as elements. 
Elements may be in any shape, such as human beings and events. The researcher 
deals with samples rather than with the whole population.  Sample refers to a subset of 
a population (individuals, elements or objects) or a group selected to act as 
representative of the population as a whole. The representative samples have all the 
characteristics of the population (Polit & Beck 2017:275). 
 
Sampling is the selection of a number of study units from a population of interest (Alvi 
2016:11). Sampling refers to the practice of selecting a portion of the population in order 
to describe and analyse the characteristics of the phenomenon under study (Polit & 
Beck 2017:275). 
 
3.4.4  Sample size determination for quantitative and qualitative 
 
3.4.4.1 Sample size determination for quantitative phase of the study 
 
The sample size of the study is an important consideration in the design of many 
medical studies. In a comparative research study, the means or proportions of some 
characteristic in two or more comparison groups are measured. A statistical test is then 
used to assess whether or not there is a substantial difference between the means or 
proportions found in the comparison groups (Eng 2003:309). 
 
Since this study was a comparative study, the researcher used the following formula 
for the sample size n: 
 





Where Zα/2 is the critical value of the Normal distribution at α/2 (e.g. for a confidence 
level of 95%, α is 0.05 and the critical value is 1.96). 
 
Zβ is the critical value of the Normal distribution at β (e.g. for a power of 80%, β is 0.2 
and the critical value is 0.84) and p1 and p2 are the expected sample proportions of 
the two groups (Charan & Biswas2013:121) 
 
By using two proportion sample size calculation online calculator for the above 
formula, using the normal distribution at α/2 for a confidence level of 95%, for a power 
of 80%, ratio of sample size of group 2 to group 1 is 1.5.  
 
p1=56% assuming there is 12 difference p2=44% then the expected sample proportions 
becomes group 1 (screened)=226 and group 2 (not yet screened)=339 total sample 
became to 565. 
 
Taking into account the 10% of 565 non-responses which is 56, this added to 565+56 









First, Stratified sampling was used on the assumption that women come to different 
unit/service of maternal health in the health centres, namely antenatal care; 
immunisation; family planning and postnatal unit. The calculated sample size was 
allocated to each health centre in proportion to the sample size as shown in Figure 3.2. 
Stratified random sampling allows the random selection of subjects from two or more 
strata of the population independently (Hoffmann, Bennett & Del Mar 2013:31). 
Secondly, systematic random sampling was used to select respondent from each 
randomly selected health centre and came up with a desired sample size of 621. Then: 
Proportional allocation of sample size was made to each health centre units as shown in 
Table 3.1 based on records from the health centre and taking the average number of 
women who visited each unit for each department by using the following formula: 
 
nj=n /N* Nj  
nj is sample size of the jth stratum   
Nj is population size of the jth stratum  
n=n1 + n2 + ...+ nk is the total sample size  
N=N1 + N2 + ...+ Nk is the total population size 
 
Then this number was allocated proportionally according to flow of women to each 
health centre taken from the previous year‟s performance 
 
Table 3.1 Number of maternal health care clients in the selected health centres 
and sample interviewed for qualitative data 
 
Health Centres  
Population at maternal 
health units 
Sample interviewed/surveyed 
Group 1 Group 2 Total 
Kolfe Woreda 9 9,628 40 60 100 
Arada  10,576 45 66 111 
Semen  10,212 43 64 107 
Yaka Woreda 1 8,898 37 56 93 
Kolfe Keranio 10,941 46 68 114 
Kotebe  9,482 38 58 96 
Total  59,737 249 372 621 
 
Table 3.1 presents the number of maternal health care clients in the selected health 





3.4.4.2 Sample size determination for qualitative phase of the study 
 
Purposive sampling was used to pick the participants in the sample. Purposive sampling 
involves the selection of information-rich subjects which enhance the credibility of the 
study (Joubert & Ehrlich 2007:101). In this study the study population for qualitative 
research included the head of every unit of maternal health services in each health 
centre. A total of 18 health professionals, namely 8 nurses, 6 midwives, and 4 health 
officers, who were working at antenatal, family planning, immunisation and postnatal 
service unit, participated in the study. The selection process involeved using the 
inclusion critera those who are voluntairs and who are the heads of the units were 
selected. The researcher performed interviews until no new information was obtained 
and thus data saturation was reached.  
 
3.4.5 Inclusion and exclusion criteria: quantitative and qualitative  
 
Inclusion criteria are the key characteristics of the target population that the researchers 
will use to answer their research question. Demographic, clinical, and geographic 
factors are commonly used to determine eligibility. In contrast exclusion criteria are 
characteristics of potential study participants who meet the inclusion criteria but have 
special features that may interfere with the study's success or increase their risk of an 
unfavourable outcome. Characteristics of eligible individuals that make them highly 
likely to be lost to follow-up, miss scheduled appointments to collect data, provide 
inaccurate data, have comorbidities that could bias the study's results, or increase their 
risk of adverse events are common exclusion criteria (Patino and Ferreira 2018:84). 
 
For the quantitative, women who came for maternal health service during the data 
collection period and who fulfilled the following inclusion criteria were included in the 
study. 
 
 Attend maternal health services and agree to participate voluntarily. 
 Be aged 18 years or older. 





Women with poor health conditions and/or a history of the disease (carcinoma of the 
cervix) were excluded from the study. 
 
For the qualitative study the population consisted of nurses, midwives and health 
officers in the health centres. To be included in the study, the respondents had to: 
 
 Be nurses, midwives or health officers working at the selected health centres. 
 Have served in the maternal health service units in the health centres for at least 
one year. 
 
3.4.6 Data collection instruments 
 
3.4.6.1 Data collection of the quantitative phase of the study 
 
Data collection is the precise, systematic gathering of information relevant to the 
research purpose or objectives of the study (Burns & Grove 2009:52; Polit & Beck 
2017:276). Data is collected from the respondents by means of a data-collection 
instrument so that it is objective and systematic (Polit & Beck 2017:276; LoBiondo-
Wood & Haber 2006:319).  
 
 
Figure 3.3  Data collectors, principal investigator and supervisor at Semen Health 
Centre 
 
Figure 3.3 shows the data collector supervisor (left), researcher (middle), the two with 





The researcher selected and trained data collectors who had completed a Bachelor‟s 
degree in Health Studies and who has experience in research assisstance. Data has 
been collected by 12 data collectors two in each health centre and supervised by the 
researcher and a data collector supervisor. The data was collected from the 
respondents at the selected health centres that provide antenatal care, family planning, 
immunisation, and post-natal care from December one, to thirty, 2018 (from 1-
30/12/2018). The quantitative data was collected by 12 research assistants, using a 
questionnaire. The researcher conducted a two-day training programme with the 
research assistants and supervisors having informed them of the purpose of the study 




The Oxford Advanced Learner’s Dictionary (2010:1650) defines variable as “(noun) a 
situation, number or quantity that can vary or be varied”. Creswell (2013:84) describes a 
variable as a characteristic of a person, object, or observable fact, which can take on 
different values. These may be in the form of numbers or non-numerical characteristics. 
Variables are classified as independent or dependent. Independent variables influence 
outcome measures. Dependent variables are influenced by the independent variables. 
Dependent variables may be what a researcher is trying to predict and are the result of 
the influence of independent variables. Dependent variables are also referred to as 
criteria, outcomes, and effect-and-response variables. 
 
In this study, the main outcome (dependent) variable of interest was the respondents‟ 
history of having been screening at least one in their lifetime. Predictor variables of 
interest included socio-demographic and fertility health-related background, awareness 
and knowledge of cervical cancer, prevention and cervical cancer screening, risk 
behaviours and perceptions (perceived susceptibility, perceived seriousness, perceived 
barriers, perceived benefits, and cues to action) of cervical cancer and screening. 
 
3.4.6.2 Data collection of the qualitative phase of the study 
 
The researcher selected key informant interviews to collect qualitative data in order to 




cancer screening. Key informant interviews provide first-hand information on research 
topics (Mack et al 2011:3).  
 
 Key informant interview is described as an exchange of information between a 
researcher and a respondent; health professionals to make reasonable data by 
encouraging them freely discuss their lives to generate facts about their thoughts, 
views, values, attitudes, and beliefs regarding their private experience related to cervical 
cancer screening (Saldaña 2011:32). 
 
In this study, data was collected in face-to-face key informant interviews, using a semi- 
structured interview guide.  Semi- structured questions were used to probe the persons 
to grant responses. The researcher collected the qualitative data in interviews from 
health professional participants at the selected health centres, using a semi-structured 
interview guide. Field notes were taken and interviews were recorded with an audio 
tape recorder at the permission of the respondents. The audio records and the field 
notes were fully transcribed and analysed as soon as possible following the interviews. 
This helped the researcher to make necessary adjustments for the subsequent 
interview. 
 
The researcher translated the Amharic transcripts into English verbatim. The 
researcher‟s colleague who fluently speaks both English and Amharic checked the 
consistency between the Amharic transcripts and its English version. The participation 
of the researcher in the translation process helps to familiarise with the emerging 
concepts and themes. 
 
3.4.7  Data-collection instrument 
 
Data is collected from the respondents by means of a data-collection instrument (Polit & 
Beck 2017:278). In this study, the researcher developed two data-collection 
instruments: a survey-type questionnaire for quantitative data from the clients, and 





3.4.7.1 Data-collection instrument for quantitative data 
 
A quantitative study is a formal, objective and systematic process to describe 
relationships and examine cause-and-effect interaction among variables (Burns & 
Grove 2011:747). In quantitative studies, researchers use structured data-collection 
instruments and statistical data analysis (Polit & Beck 2012:16). A survey design 
instrument describes a population‟s trends, attitudes and opinions (Creswell & Creswell 
2018:147). In this study the data collectors collected quantitative data by completing the 
questionnaires with the clients‟ participants. 
 
A questionnaire is a written list of questions to be answered by participants in a study 
(Kumar 2011:138). Participants read or hear the questions, interpret what is expected 
and then give the answers.  
 
In this study, the researcher developed a questionnaire based on the literature review 
and the HBM (Abraham & Sheeran 2015:31). The questionnaire was prepared in 
English and translated to the local Amharic language so that the participants could 
answer the questions in a language that they understood. The answers were translated 
back into English. The questionnaire consisted of four sections as follows: 
 
 Section I Participants‟ socio demographic and health profile 
 Section II Awareness and knowledge of cancer and cervical cancer  
 Section III Practice of cervical cancer screening  
 Section IV Perception of cervical cancer and screening  
− Perceived susceptibility 
− Perceived seriousness/severity 
− Perceived benefits 
− Perceived barriers 
− Cues to action 
 
Knowledge level measured were adapted and modified from Bloom‟s cut of points 
Aschalew and Dube (2019:2) as follows:  
 




 60-79%: moderate knowledge 
 less than 60%: poor knowledge  
 
For the knowledge part of the questions, any two correct answerers were scored 2, one 
correct answer was scored 1 and 0 for wrong and don‟t know answers. 
 
A 5-point Likert scale was used in the sections on perceived susceptibility. The Likert 
scale is used to indicate how often people agree or disagree with given statements 
(McLeod 2019:1). 5-Point Likert scale is a type of psychometric response scale in which 
responders specify their level of agreement to a statement typically in five points: (1) 
Strongly disagree; (2) Disagree; (3) Neither agree not disagree; (4) Agree; (5) Strongly 
agree (Preedy & Watson 2010:4288).  
 
3.4.8 Pilot study  
 
A pre-test or pilot study is a trial run to determine whether the instrument is clearly 
worded and free from major biases and whether it solicits the desired information (Brink 
et al 2018:94). It provides an opportunity to try out the technique or instructions that will 
be used with an instrument, especially if the instrument has not been used with a 
specific population, as in the case of this study. Kumar (2011:158) adds that the 
pretesting of the data-collection instrument should be carried out under actual field 
conditions on a group of individuals similar to the study population.  
 
The purpose is to identify problems that the potential respondents might have in 
understanding or interpreting any questions as well as to estimate the time needed to fill 
out the questionnaire. Pre-testing the instrument allows researchers to critically examine 
the questions and their meaning, and identify whether different respondents interpret a 
question differently (Kumar 2011:158). According to LoBiondo-Wood and Haber 
(2014:305), pre-testing identifies problems in the design and sequencing of questions, 
and determines the instrument‟s reliability and validity. Accordingly, in order to ensure 
that the questions measured what they were intended to measure, the questionnaire 
was tested in a pre-test on 30 participants who were not involved in the main study. 




Modification of the questionnaire was performed according to the results of the pilot 
study. Women who participated in the pilot study were excluded from the main study.   
 
3.4.9  Data collection quantitative and qualitative research 
 
3.4.9.1 Quantitative data collection process  
 
For the quantitative data collection process twelve data collectors with BSc in health 
studies were responsible for gathering quantitative data. Approximately 621 women who 
came to randomly selected health centres for antenatal, family planning, immunisation 
and postnatal services and who met the inclusion criteria. Six data supervisors and 12 
data collectors took part in the quantitative study. The researcher conducted a two-day 
training programme with the research assistants, having informed them of the purpose 
of the study and the ethical considerations, inclusion and exclusion criteria and data 
collection processThe supervisors were in charge of monitoring and addressing the 
problems of research assistants in the data collection process. The supervisors 
coordinated the required logistics for data collection prior to the date of data collection. 
The data collectors were directed to their project areas and to the people who led them 
on the field. From the first day on, the supervisors went around and instructed the 
research assistants to comply with the Data Collection Guidelines to ensure the 
accuracy of the data and to provide additional technical assistance over the phone. At 
the end of the day, supervisors checked the completeness and accuracy of the 
completed data collection instruments. They also discussed the enumerator and took 
the field notes of the day's achievements and the challenges they encountered. 
 
3.4.9.2 Qualitative data collection process 
 
For the qualitative data collection process key informants‟ interview with health care 
providers were used. The researcher and two other research assistants with qualitative 
data collection experience have collected the data.  
 
For the qualitative data collection, semi-structured questions were used to probe for 
people to give answers. A field note was taken and interviews were conducted with an 







Figure 3.4  A data collector completing a questionnaire with a participant at Kolfe 
Woreda 9 Health Centre 
 
3.5 VALIDITY AND RELIABILITY: MEASURES TO ENSURE TRUSTWORTHI-
NESS 
 
Validity and Reliability in research refer especially to measurements in the data used to 
answer the question of research, and the key question for identifying the reliability and 
validity of data is the instrument that measures the study variables (Burns et al 
2013:389). In this study, the researcher developed the quantitative and qualitative data-
collection instruments based on models and the literature review.  
 
3.5.1  Validity  
 
Validity refers to the degree to which an instrument accurately measures what it is 
intended to measure (Polit & Beck 2017:582). Validity determines whether the research 
instrument truly measures that which it was intended to measure or how truthful the 
research results are. According to Kumar (2011:168), validity is the process of 
establishing the appropriateness, quality and accuracy of the procedures which a 
researcher adopted for finding answers to the research questions. Validity can apply to 




conclusions drawn, the statistical procedures applied, or the measurement procedures 
used. In terms of measurement procedures, therefore, validity is the ability of an 
instrument to measure what it is designed to measure (Smith 1991:106).  
 
3.5.1.1 Types of validity in quantitative research 
 
In this study, the researcher ensured internal, external, and content and face validity. 
 
Internal validity  
 
Internal validity is concerned with the congruence of the research findings with the 
reality. It deals with the degree to which the researcher observes and measures what is 
supposed to be measured (Zohrabi 2013:258). In this study, to boost the internal validity 
of the research data and instruments, the researcher used triangulation of the data and 
findings. Moreover, the researcher gave for two experienced researchers to review and 




External validity is the extent to which the findings can be generalised to other groups 
and settings (Heale & Twycross 2015:66). The findings of this study could be 
generalised to most areas of Addis Ababa city with similar demographic and socio-
economic status. The findings should also be important to other regions of Ethiopia.  
 
Content and face validity 
 
Content validity refers to whether the items or questions measure what the instrument is 
supposed to measure (Polit & Beck 2017:458). Content validity refers to the extent to 
which the instrument represents the factors of the study (Heale & Twycross 2015:66). 
Each aspect should be equally represented in the questions or items. 
 
Face validity reveals the logical link between the questions and the objectives of the 
study. Face validity basically verifies that the instrument gives the appearance of 






The researcher conducted a pre-test to ensure instrument validity and measure the 
effectiveness of the data collection instrument. Pretesting is the process of evaluating 
the questionnaire and survey procedures in advance to assess whether they will cause 
problems for respondents and interviewers and whether the survey will meet its 
intended objectives (Presser, Couper, Lessler, Martin, Rothgeb & Singer 2004:109). 
Presser et al (2004:109) add that the purpose of pretesting includes determining 
whether: 
 
 The instrument will elicit responses required to achieve the research objectives. 
 The content of the instrument is relevant and adequate. 
 The wording of questions is clear and suited to the understanding of the 
respondents. 
 The question structure and sequencing is consistent. 
 
In this study, the researcher administered the quantitative questionnaire to 30 
participants who were not involved in the main study. The researcher modified the 
content, question structure and sequencing based on the pre-test findings. The findings 
from the pre-test were not included in the statistics of the main study.  All necessary 
adjustments on the interview questions and on the overall approach of the questions 
were corrected as deemed important. 
 
3.5.1.2 Trustworthiness/rigour in qualitative research 
 
Trustworthiness refers to the confidence that qualitative researchers have in their data, 
using the strategies of credibility, dependability, conformability, and transferability (Polit 




Credibility refers to the believability of the results from the participants‟ perspective.  
Accordingly, the researcher ensured that the results reflected the participants‟ 







Dependability refers to the achievement of similar results if the study were conducted 
again (Kumar 2011:184). Triangulation ensured the dependability and transferability of 
the study findings. Transferability refers to the degree to which the results of qualitative 
research can be generalised or transferred to other contexts or settings (Kumar 
2011:184). In this study triangulation was introduced as a technique to incorporate 
qualitative and quantitative advantages and to enhance the quality of the assessment 




Conformability reduces researcher bias (Polit & Beck 2017:723). Conformability refers 
to the degree to which the results could be confirmed by other independent reviewers 
(Polit & Beck 2017:724; Kumar 2011:184. The interview transcriptions and audio 




Transferability is the degree to which the findings can be transferred to have 
applicability in different settings or organisations (Polit & Beck 2012:585; Kumar 





Reliability refers to “the degree of consistency or dependability with which the 
instrument measures the attribute it is designed to measure. The instrument is reliable; 
the results will be the same each time the test is repeated” (Polit & Beck 2017:194). 
According to Kumar (2011:168), reliability is the level to which the research tool yields 
the same results on repeated applications. Therefore, reliability is the degree of 
accuracy or precision in the measurements made by a research instrument.  
 
According to Kumar (2011:169), reliability can be affected by the physical setting, the 




interview. Reliability of a study can be determined using internal and external 
consistency methods. 
 
External consistency compares findings from two independent processes of data 
collection with each other as a means of verifying the reliability of the measure. 
 
Internal consistency determines that items or questions measuring the same 
phenomenon, if they are reliable indicators, should produce similar results irrespective 
of their number in an instrument.  
 
According to Heale and Twofold (2015:67), Cronbach‟s α is the most commonly used 
test to determine the internal consistency of an instrument. In this test, the average of all 
correlations in every combination of split-halves is determined. Instruments with 
questions that have more than two responses can be used in this test. The Cronbach‟s 
α result is a number between 0 and 1. The alpha of 0.7 in Cronbach‟s α is considered 
acceptable (Burns & Grove 2005:374). In this study Cronbach„s alpha calculation was 
found to be 0.795, which indicated a high level of internal consistency (Table 3.2). 
 
Table 3.2 Reliability statistics of Cronbach’s Alpha result  
 
Cronbach's Alpha 
Cronbach's Alpha based on standardised 
items 
N of Items 
.795 .792 8 
 
3.6 RESPONDENTS AND PARTICIPANTS QUALITATIVE AND QUANTITATIVE 
RESEARCH 
 
In quantitative research survey respondent is appropriately referred to as a 
"respondent" because that is exactly the role they play in the research process. They're 
answering the researcher's questions, which are usually structured and closed-ended. 
Similarly, the qualitative research participant is appropriately referred to as a 
"participant" because their role extends beyond simply answering a series of questions 
to include participation in the research on different levels. The participant explains on 
the interviewer‟s/moderator‟s questions, changes the topic if need be to convey an idea, 
takes part in a social relationship with the interviewer/moderator, engages with other 




and, in some instances, is asked to aid in the analysis. For all of these reasons (and 
more), it is research participants, not respondents, who provide qualitative data (Roller 
and Lavrakas 2016:16.) 
 
3.6.1 Ethical consideration 
 
Research that is carried out with human participants requires careful consideration of 
ethical issues that may also occur at some point during the duration of the study. While 
there are no acknowledged harms related to this research, the researcher shall observe 
and be guided through moral principles. Ethics research is linked to the morality of 
research from the beginning to the completion and publication of results (Babbie 
2008:66). Trust in research results in trust in the integrity of researchers and the 
reliability of their scientific work. Science must remain reliable; researchers must follow 
basic moral principles (Rivera & Borasky 2009: 6). The researcher obtained permission 
to conduct the study and upheld the principles of autonomy, anonymity and 




The researcher obtained approval and permission to conduct the study from the Ethics 
and Research Committee of the Department of Health Studies at the University of South 
Africa (see Annexure A). Written permission was also obtained from the Regional State 
Health and Ethical Administration Office of Addis Ababa for the study to be conducted at 
the selected health centres (see Annexures B and C).  
 
 Informed consent 
 
Informed consent protects individuals‟ right to autonomy because participants knowingly 
and voluntarily consent to participate (Fouka & Mantzorou 2011:4). In this study, the 
participants were informed of the purpose of the study, their role in the study, and the 
approximate time required for completing the questionnaire. The participants were 
assured of confidentiality and anonymity because their names would not be filled in on 
the questionnaires. Moreover, for the qualitative part the data collectors informed the 




questions, and they could withdraw from the study at any time should they wish to do 
so.  
 
The researcher collected qualitative data from the health professional participants after 
explaining the purpose of the study, arranging the time and place convenient for their 
interviews.   
 
Informed consent was obtained from all the participants (see Annexure F).  
 
 Anonymity and confidentiality 
 
The participants were assured of anonymity and confidentiality. No names were 
provided on the questionnaires. All the questionnaires were numbered and no 
information given could be traced to any participant. Confidentiality and anonymity is 
closely connected to respect for the human dignity. Sharing information about a 
respondent with others for purposes other than research is unethical (Akaranga & 
Makau 2016:6).   
 
 Beneficence  
 
The principle of beneficence requires researchers to do good and above all do no harm. 
Beneficence imposes a duty on researchers to minimise harm to study participants and 
maximise benefits (Polit & Beck 2017:139).  
 
The participants were not exposed to any discomfort and were told that they would not 
necessarily benefit from participating in the research, but that their involvement would 
enable health care professionals to take a better approach to the cervical cancer 
screening programme (Fouka & Mantzorou 2011:5).  
 
 Justice 
Justice requires a fair and equal distribution of the benefits and risks of participating in a 
research study. According to this principle, all research participants were treated fairly. 




Since this was not an intervention or experimental study, there was no anticipated major 
risk to the participants in this study. 
  
In this specific research, the researcher ensured that the rights of the participants are 
treated fairly/equally through the application of a systematic random sampling technique 
to select the study participants and purposive sampling technique for qualitative study. 
The researcher also applied the same types of assessment tools and methods for all 
participants. 
 
3.7 DATA ANALYSIS QUANTITATIVE AND QUALITATIVE RESEARCH 
 
Analysis of quantitative data is a methodological way in which the researcher transforms 
data collected into numerical data (Burns & Grove 2011:290). 
 
3.7.1  Data processing and analysis for quantitative study 
 
Data entry and analysis for quantitative part was done using Statistical Package for 
Social Sciences (SPSS) version 23 program. The results from the data analysis and 
interpretation were presented in the form of frequency tables, percentages, graphs and 
diagrams correlation analysis was also determined. Chi-square (X2) was used to 
explore the significance and relationships between the variables in this study. The level 
of statistical significance was set at p-value <0.05 with 95% confidence interval. The 
level of statistical significance was set at p-value <0.05 with 95% confidence interval 
(detail part presented in Chapter 4). 
 
3.7.2 Data processing and analysis for qualitative study 
 
Qualitative research is interpretative and involves researchers in a close relationship 
with the participants (Creswell & Creswell 2018:183). Qualitative data analysis 
commences with data collection, and involves specific to general steps (Creswell & 
Creswell 2018:183). The researcher organised and prepared the data. First, the 
researcher transcribed the interviews verbatim and compared the transcriptions with the 
recordings. The researcher read all the transcriptions carefully to get an overall picture 




Creswell 2018:196). Coding is a process of organising data by bracketing chunks and 
writing a word representing a category in the margin.  
 
The researcher identified topics and themes that emerged from the data in the 
transcriptions. Topics that related to each other were grouped together and themes 
identified. The researcher wrote topics next to appropriate segments of text, checking to 
see whether new themes emerged. The topics were turned into categories by finding 
descriptive wording, final abbreviations for categories, and arranging them 
alphabetically. Codes were formulated for each theme developed. The researcher used 
the computer software program ATLAS ti to code the data.   
 
3.8 SCIENTIFIC INTEGRITY OF THE RESEARCH 
 
To maintain scientific integrity and eliminate the possibility of scientific misconduct and 
plagiarism, the researcher followed the steps mentioned in Rivera and Borasky 
(2009:61). Hence, the researcher preserved primary data and documentation during the 
study. When citing ideas, words, processes, findings and results obtained by other 
authors, a clear reference was made to the respective sources. Important results which 
were contrary to the researchers‟ results and conclusions were cited and discussed. 
Besides, the limitation of the research methods was recognised and properly 
documented and reported in chapter 7. 
 
The initial review of the research protocol was received from the Health Studies 
Research Ethics Committee (HSREC) of the UNISA Department of Health Studies 
(REC-012714-039) (NHERC). After reviewing the informed consent documents and 
data collection tools, the committee approved the protocol in addition to the research 
protocol (see Annexure A). Rivera and Borasky (2009:61) suggest that researchers are 
responsible for ensuring that no individual will be involved in the study prior to obtaining 
informed consent. The guideline of the council for international organizations of medical 
sciences (CIOMS) also states that the researcher has a duty to inform prospective 
subjects of all the information necessary for adequate informed consent. In particular, 
the researcher had an obligation to protect the confidentiality of the study participants 
(Rivera & Borasky 2009:61). In this study, the researcher was honest to accomplish the 
integrity of the research by adhering to study procedures, and by being transparent in 





3.9 BRIEF DEVELOPMENT OF GUIDELINES: PHASE 2 
 
The guidelines were developed to enhance cervical cancer screening service utilization 
among women in Ethiopia. The guidelines provided recommendations addressing the 
themes, categories and sub-categories identified by the study. The guidelines were 
developed based on the findings from the interview conducted with women to assess 
the views and experiences on cervical cancer screening and findings from the interview 
conducted with health care professionals to assess the perception and experiences on 
clients‟ utilisation to cervical screening. The guidelines can be utilised by policy makers, 
health service managers, and health service providers at different levels of the health 
system. 
 
3.10 BRIEF VALIDATION OF GUIDELINES: PHASE 3 
 
The draft guidelines were reviewed by senior public health experts to make sure that the 
recommendations are feasible and in line with the country‟s context. Criteria consist of 
issues on Clarity and presentation, Specificity, Reliability, Effectiveness, Validity, 
Achievability: Relevance: Applicability (OECD 2021:36) was distributed to experts to 
evaluate the draft guidelines. Then, the guidleliens were finalised incorporating the 




This chapter described the research design and methodology, study population, sample 
size, data collection and data analysis of the study. Chapter 4 discusses the quantitative 














Chapter 3 described the research design and methodology of the study. This chapter 
discusses the quantitative data analysis and interpretation. The purpose of the study 
was to develop guidelines to improve the utilisation of cervical cancer screening by 
women in Ethiopia. In order to do so, the aim was to determine the factors that impacted 
the uptake of cervical cancer screening among women in Addis Ababa, including socio-
demographic and socio-economic circumstances and perceptions that facilitated or 
prevented screening. 
 
The quantitative data was obtained from patient participants (screened and not 
screened) at the selected health centres.  
 
4.2 PRESENTATION AND DISCUSSION OF QUANTITATIVE FINDINGS 
 
Burns and Grove (2011:535) describe data analysis as the technique used to reduce, 
organise and give meaning to data. It is the process of gathering, modelling, and 
analysing data in order to extract insights that can be used to make decisions. 
Depending on the research type and the goal of the analysis, there are various methods 
and techniques for performing analysis (Durcevic 2020:1).  
 
Quantitative data analysis is the statistical manipulation of numerical data for the 
purpose of describing phenomena or making inferences about how phenomena are 
related (Polit & Beck 2010:565). In this study, a face-to-face survey using a structured 
questionnaire was used to gather quantitative data. A total of 609 respondents took part 
in the study. 
 
The questionnaire had a covering page explaining the purpose of the study, data 
collection, the right to anonymity and confidentiality and to leave the study at any time 




informed consent. The questionnaire consisted of four sections. Section A covered the 
respondents‟ socio-demographic profile and health background; section B covered their 
awareness and knowledge of cervical cancer; section C covered their practice of 
cervical cancer screening, and section D covered their perceptions of cervical cancer 
and screening. 
 
The quantitative data was analysed using the SPSS version 23 for Windows program. 
All the variables were entered numerically on an SPSS spread sheet. Descriptive 
statistics such as frequencies and percentages and inferential statistics such as chi 
square test and independent sample t-tests; and spearman rank correlation were 
presented. The chi-square test for independence, also called Pearson's chi-square test 
or the chi-square test of association, is used to discover if there is a relationship 
between two categorical variables. Independent sample t-tests were made to see if 
there is a significant difference in average rating of a variable between two groups. The 
level of statistical significance was set at 𝑝-value <0.05. Control for potential 
confounders such as age and socioeconomic class of respondents was done by placing 
our respondents in different categories. The adjusted odds ratio and 95% confidence 
interval were obtained to determine factors that were significantly associated with 
uptake of cervical cancer screening programs among our respondents 
 
4.2.1 Respondents’ demographic information  
 
Table 4.1 Selected health centres and number of respondents 
 
Health centre Frequency % 
Kolfe Woreda 9 Health Centre 100 16.4 
Arada Health Centre 107 17.6 
Semen Health Centre 103 16.9 
Yeka Woreda 1 Health Centre 91 14.9 
Kolfe Keranio Health Centre 112 18.4 
Kotebe Health Centre 96 15.8 
Total 609 100.0 
 
Table 4.1 presents the number of respondents from each of the selected health centres. 
A total of 609 patient respondents participated in the study. The respondents were 
selected at each of the six participating health centres. Of the respondents, 16.4% 




Health Centre; 16.9% (n=103) were from Semen Health Centre; 14.9% (n=91) were 
from Yeka Woreda1 Health Centre; 18.4% (n=112) were from Kolfe Keranio Health 
Centre, and 15.8% (n=96) were from Kotebe Health Centre. The respondents were 
composed of 233 screened and 376 not screened women.  
 
4.2.2 Respondents’ socio-demographic profile and screening status  
 
Table 4.2 presents the respondents‟ socio-demographic data covered their age, marital 
status, educational level, occupation, ethnic group and monthly income.  
 








Age in years  
18-24 years 7 (3%) 88 (23.4%) 
25-34 years 140 (60.1%) 227 (60.3%) 
35-44years 84 (36%) 57 (15.2%) 
Above 44 years 2 (0.9%) 4 (1.1%) 
Total  233 (100%) 376 (100%) 
Marital status  
Single  42 (18%) 109 (29%) 
Married 149 (64%) 233 (62%) 
Divorced/separated 32 (13.7%) 28 (7.4%) 
Widowed 10 (4.3%) 6 (1.6%) 
Total 233 (100%) 376 (100%) 
Educational level  
 
No education  22 (9.4%) 28 (7.4%) 
Primary  81 (34.8%) 154 (41%) 
Secondary  50 (21.5%) 96 (25.5%) 
College and above  80 (34.3%) 98 (26.1%) 
Total  233 (100%) 376 (100%) 
Occupation  
Housewife 65 (27.9%) 112 (29.8%) 
Government employee 95 (40.8%) 102 (27.1%) 
Private employee 62 (26.6%) 126 (33.5%) 
Daily labourer 11 (4.7%) 36 (9.6%) 
Total  233 (100%) 376 (100%) 
Ethnic group  
Amhara 85 (36.5%) 144 (38.3%) 
Oromo 42 (18%) 98 (26.1%) 
Tigrie 40 (17.2%) 36 (9.6%) 
Southern Nations 66 (28.3) 97 (25.7%) 
Other 0 *1 (0.3%) 
Total  233 (100%) 376 (100%) 
Monthly income  <400 birr 23 (9.9%) 25 (6.6%) 
401-999 birr 44 (18.9%) 67 (17.8%) 
1000 and above 102 (43.8%) 177 (47.1%) 
Not known 64 (27.4) 107 (28.5%) 





 Respondents’ age  
 
The mean age of the respondents was 30 ± 5.7 years. Of the screened respondents, 
60.1% (n=140) were 25-34 years old; 36% (n=84) were 35-44; 3% (n=7) were 18-24, 
and 0.9% (n=2) were over 44 years old. Of the not screened respondents, 60.4% 
(n=227) were 25-34 years old; 23.4% (n=88) were 18-24; 15.1% (n=57) 35-44, and 
1.9% (n=4) were over 44 years old.   
 
 Marital status  
  
Of the screened respondents, 64% (n=149) were married; 18% (n=42) were not 
married, 13.7% (n=32) were divorced/separated, and 4.3% (n=10) were widowed.  Of 
the not screened respondents, 62% (n=233) were married; 29% (n=109) were not 
married; 7.4% (n=28) were divorced/separated, and 1.6% (n=6) were widowed. 
 
 Educational level  
 
About 9.4% (n=22) of screened and 7.4% (n=28) of not screened respondents had no 
education. Of the screened respondents, 34.8% (n=81) were attended primary 
education, 21.5% (n=50) attended secondary education and 34.3% (n=80) attended 
College and above educational level. Of not screened respondents, 41% (n=154) were 
found at primary level of education, 25.5% (n=96) attended secondary education and 
26.1% (N=98) attended College and above educational level. 
 
 Occupation  
 
Of the screened respondents, 27.9% (n=65) were housewives; 40.8% (n=95) were 
government employees; 26.6% (n=62) were private employees; and 4.8% (n=11) were 
daily labourers. Of the respondents who were not screened, 29.8% (n=112) were 
housewives; 27.1% (n=102) were government employees, 33.5% (n=126) were private 





 Ethnic group  
 
Of the screened respondents, 36.5% (n=85) were Amhara; 28.3% (n=66) were 
Southern Nations; 18% (n=42) were Oromo, and 17.2% (n=40) were Tigrie. Of the 
respondents who were not screened, 38.3% (n=144) were Amhara; 26.1% (n=98) were 
Oromo; 26.1% (n=98) were Southern nations; 9.6% (n=36) were Tigrie, and 0.3% (n=1) 
was Afar (Table 4.2). 
 
 Monthly income 
 
Of the screened respondents, 9.9% (n=23) reported as they earned <400 birr; 18.9% 
(n=44) earned between 401-999 birr and 43.8% (n=102) reported as they earned 1000 
birr and more per month, while 27.4% (n=64) did not know their monthly income. Of the 
respondents who was not been screened, 6.6% (n=25) reported as they earned <400 
birr; 17.8% (n=67) earned between 401-999 birr, 47.1% (n=177) earned 1000 birr and 
more per month; and 28.5% (n=107) did not know their monthly income.  
 
4.2.3 Respondents’ reproductive health information  
 
The respondents‟ reproductive health data covered contraceptive use, type of 
contraceptive methods, number of children, age at menarche and first sexual 








Figure 4.1  Respondents’ use of contraceptives and screening status 
 
 Use of contraceptive methods 
 
Figure 4.1 presents the respondents‟ use of contraceptives and screening status. Of the 
screened respondents, 88.9% (n=207) used contraceptives; 9.4% (n=22) did not use 
contraceptives, and 1.7% (n=4) did not answer the question. Of the not screened 
respondents, 73.7% (n=277) used contraceptives; 23.7% (n=89) did not use 
contraceptives, and 2.6% (n=10) did not answer the question.  
 








Age of woman at first 
pregnancy  
 
<15 years 16 (6.9%) 15 (4%) 
15-18 years 84 (36%) 113 (30%) 
>18 years 115 (49.4%) 186 (49.5%) 
No response 18 (7.7%) 62 (16.5%) 
Total 233 (100%) 376 00%) 
 
Table 4.3 indicates the respondents‟ age at first pregnancy and their screening status of 
respondents. Of the screened respondents, 49.4% (n=115) were over 18 years old at 
their first pregnancy; 36% (n=84) were between 15 and 18 years old, and 6.9% (n=16) 
were age below 15 years old. Of the not screened respondents, 49.5% (n=186) were 
over 18 years old at their first pregnancy; 30% (n=113) were between 15 and 18 years 





Table 4.4 Respondents’ reproductive health information and screening status 
 
Factors 





What was your age at menarche? 
<14 years 85 (36.5%) 127 (33.8%) 
14-15 years 113 (48.5%) 203 (54) 
>15 years 26 (11.2%) 25 (6.6%) 
No response 9 (3.8%) 21 (5.6%) 
Total 233 (100%) 376 (%) 
Age of woman at first intercourse 
<15 years 23 (9.9%) 33 (8.8%) 
15-18 years 85 (36.5%) 145 (38.6%) 
>18 years 113 (48.5%) 158 (42%) 
No response 12 (5.1%) 40 (10.6%) 
Total 233 (100) 376 (100) 
Have you had any miscarriages? 
Yes 64 (27.5%) 76 (20.2%) 
No 150 (64.4%) 262 (69.7%) 
No response 19 (8.1%) 38 (10.1) 
Total 233 (100%) 376 (100%) 
Have you been using birth control 
contraceptives 
Yes  207(88.9%) 277(73.7%) 
No  22(9.4%) 89(23.7%) 
No response 4(1.7%) 10(2.6%) 
Type of contraceptive used 
Hormonal 
contraceptives  
152 (73.5% 229(82.7%) 
Barrier methods 46(22.2%) 30(10.8%) 
Mixed methods 9(4.3%) 14(5.1%) 
No response - 4(1.4%) 
Total  207 (100) 277 (100) 
Number of children 
None 21 (9.1%) 122 (32.4%) 
One 40 (17.2%) 98 (26.1%) 
Two to four 136 (58.3%) 125 (33.2%) 
Above four 33 (14.1%) 28 (7.5%) 
No response 3 (1.3%) 3 (0.8) 
Total 233 (100) 376 (100) 
Do you have more than one sexual 
partner?  
Yes 94 (40.3%) 107 (28.5%) 
No 132 (56.7%) 251 (66.7%) 
No response 7 (3%) 18 (4.8%) 
Total 233 (%) 376 (100%) 
 
Table 4.4 indicates respondents‟ reproductive health information and screening status. 
Th description presented as follows. 
 
 Age at menarche and first sexual intercourse 
 
Of the screened respondents, 48.5% (n=113) reported that they had menarche at the 
age of 14-15 years; 36.5% (n=85) had menarche before the age of 14, and 11.2% 
(n=26) had menarche after 15 years of age. Of the not screened respondents, 33.8% 




years of age; 6.6% (n=25) had menarche after 15 years of age, and 5.6% (n=21) did not 
answer the question. 
 
Of the screened respondents, 48.5% (n=113) started sexual intercourse after the age of 
18 years; 36.5% (n=85) started at 15-18 years old; 9.9% (n=23) started before the age 
of 15, and 5.1% (n=12) did not answer the question. Of the not screened respondents, 
42% (n=158) started sexual intercourse after the age of 18 years; 38.6% (n=145) 
started at 15-18 years old; 8.8% (n=33) started before the age of 15, and 5.1% (n=12) 
did not answer the question  
 
 Type of contraceptives used  
 
Regarding type of contraceptives, of the screened respondents, 72% (n=152) used 
hormonal contraceptives; 21.8% (n=46) used barrier methods, and 4.3% (n=9) used 
mixed methods. Of the not screened respondents, 79.7% (n=229) used hormonal 
contraceptives; 10.5% (n=30) used barrier methods, and 4.9% (n=14) used mixed 
methods (Table 4.4). 
 
 Number of children 
 
Of the screened respondents, 58.3% (n=136) had two to four children; 17.2% (n=40) 
had one child; 14.1% (n=33) had more than four children, and 9.1% (n=21) had no 
children. Of the not screened respondents, 33.2% (n=125) had two to four children; 
32.4% (n=122) had no children; 26.1% (n=98) had one child, and 7.5% (n=28) had 
more than four children (Table 4.4). 
 
 Having more than one sexual partner  
 
Regarding their number of sexual partners, of the screened respondents, 40.3% (n=94) 
said they had more than one sexual partner; 56.7 (n=132) said they had no more than 
one sexual partner and 3% (n=7) did not answer the question. Of the not screened 
respondents, 66.7% (n=251) said they had more than one sexual partner; 28.5% 






 Having any miscarriages  
 
The respondents were asked if they had had any miscarriages. Of the screened 
respondents, 27.5% (n=64) reported that they had miscarriage; 64.4% (n=150) reported 
that they had no miscarriage and 8.1% (n=19) did not answer the question. Of the not 
screened respondents, 20.2% (n=76) reported that they had miscarriage; 69.7% 
(n=262) reported that they had no miscarriage and 10.1% (n=38) did not answer the 
question. 
 
4.2.4 Respondents’ awareness of cervical cancer  
 
 
Figure 4.2  Distribution of not screened respondents who had heard about 
cervical cancer 
 
Concerning awareness about cervical cancer respondents were asked if they heard of 
about cervical cancer, causes, prevention, risk factors, screening and treatment. The 
response to each question was „yes‟ or „no‟.  
 
Figure 4.2 presents the distribution of not screened respondents who had heard about 
cervical cancer. Of those not screened respondents 92% (n=345) reported that they 
heard about cervical cancer and 8  (31) reported that they had not heard. 
 
Of screened respondents, 53.7% (n=173) were aware of causes of cervical cancer and  
20.9% (n=60) were not aware of causes of cervical cancer; 75.1% (n=175) were aware 




for cervical cancer; 179 (76.8%) were aware of methods of cervical cancer preventions 
and 54 (23.2%) were not aware of methods of cervical cancer preventions; all of them 
were aware of where to get test for cervical cancer; 73.8% (n=172) were aware of 
whether cervical cancer treatable or not and 26.2% (n=61 ) were not aware of whether 
cervical cancer treatable or not;  35.2% (n=82) were knew person with cervical cancer 
and 151 (64.8%)were not knew any  person with cervical cancer. 
 








Do you know the causes of cervical 
cancer?  
Yes  173 (53.7%) 149 (39.7%) 
No 60 (20.9%) 226 (60.3%) 
Total 233 (38.3%) 375 (61.7%) 
Do you know the risk factors for 
cervical cancer? 
Yes 175 (75.1%) 132 (35.1%) 
No 58 (24.9%) 244 (64.9%) 
Total 233 (100%) 376 (100%) 
Do you know any methods of cervical 
cancer prevention?  
Yes 179 (76.8%) 125 (33.3%) 
No 54 (23.2%) 250 (66.7%) 
Total 233 (100%) 375 (100%) 
Have you ever heard of cervical cancer 
screening? 
Yes 233 (100%) 200 (72.5%) 
No (0%) 175 (27.5%) 
Total 233 (100%) 375 (100%) 
Do you know where to get test for 
cervical cancer? 
Yes 233 (100%) 133 (35.5%) 
No  (0%) 242 (64.5%) 
Total 233 (100%) 375 (100%) 
Is cervical cancer treatable? 
Yes 172 (73.8%) 158 (42%) 
No 61 (26.2%) 218 (58%) 
Total 233 (100%) 376 (100%) 
Do you know any person with cervical 
cancer? 
Yes 82 (35.2%) 75 (27.2%) 
No 151 (64.8%) 301 (72.8%) 
Total  233 (100%) 376 (100%) 
 
Table 4.5 shows respondents‟ awareness of cervical cancer and screening status. The 
causes, risks factors, method of prevention, ever heard of cervical cancer creening, 
whether cervical cancer is treatable and know any person with cervical cancer 
presented. Of not screened respondents 39.7% (n=149) were aware of the causes of 
cervical cancer and 60.3% (n=226) were not aware of the causes of cancer cervical 
cancer; 35.1% (n=132) were aware of risk factors for cervical cancer and 64.9% 
(n=244) were not aware of risk of cervical cancer; 33.3% (n=125)  were aware of 




methods of cervical cancer prevention; 72.5% (n=200) were aware of cervical cancer 
screening 27.5% (n=175) were not aware of cervical cancer screening; 42% (n=158)  
aware of whether cervical cancer treatable or not and 58% (218) were not whether 
cervical cancer treatable or not; 27.2% (n=75) knew person with cervical cancer and 
72.8% (n=301) didn‟t know any person with cervical cancer. 
 
4.2.5 Respondents’ knowledge of cervical cancer  
 
The respondents‟ knowledge of cervical cancer covered the part of the body affected; 
signs and symptoms of cervical cancer; transmission, prevention, stages and treatment 
options; screening frequency and results, and risk factors for cervical cancer. 
 




Figure 4.3  Respondents’ knowledge on part of the body affected by cervical 
cancer, and screening status 
 
Figure 4.3 presents respondents‟ knowledge on part of the body affected by cervical 
cancer, and screening status. Of the screened respondents, 92.3% (n=215) answered 
that the main part of body affected by cervical cancer is the cervix; 2.1% (n=5) 
answered the brain, and 5.6% (n=13) didn‟t know which parts of the body is affected by 




part of body affected by cervical cancer is the cervix, and 12.8% (n=44) answered the 
brain and18 (5.2%) did not know which part of the body was affected by the disease.  
 
4.2.5.2 Respondents’ knowledge of cervical cancer signs and symptoms, and 
screening status 
 












Pain during intercourse 32 (14.2%)  35 (10.1%) 
Post coital bleeding 28 (12.4%)  41 (11.9%) 
Irregular vaginal bleeding 21 (9.3%) 18 (5.2%) 
Weight loss 15 (6.7%) 56 (16.2%) 
Foul smell vaginal discharge 20 (8.9%) 104 (30.1%) 
Two of the above 67 (29.9%) 42 (12.2%) 
Three of the above  28 (12.4%) 28 (8.1%) 
All of the above 11 (4.9%) 18 (5.2%) 
I don‟t know 3 (1.3%) 3 (1%) 
 
Table 4.6 indicates the respondents‟ knowledge of signs and symptoms of cervical 
cancer and screening status. Of the screened respondents, 14.2% (n=32) answered 
pain during intercourse was a sign and symptom of cervical cancer; 12.4% (n=28) 
answered post-coital bleeding; 9.3% (n=21) answered irregular vaginal bleeding; 6.7% 
(n=15) answered weight loss, and 8.9% (n=20) answered foul smell of vaginal 
discharge was a sign and symptom of cervical cancer; while 29.9% (n=67) said two of 
the above; 12.4% (n=28) said three of the above, and 11 (4.9%) said all of the above 
were signs and symptoms of cervical cancer. Of the not screened respondents, 10.1% 
(n=35) answered pain during intercourse; 11.9% (n=41) answered post coital bleeding; 
16.2% (n=56) answered weight loss, and 30.1% (n=104) answered foul smell of vaginal 
discharge was a sign and symptom of cervical cancer; while 12.2% (n=42) said two of 
the above; 8.1% (n=28) said three of the above, and 5.2% (n=18) said all of the above 





4.2.5.3 Respondents’ knowledge of cervical cancer transmission, prevention, 
treatment options and regarding the stage at which cervical cancer can 
be cured 
 
Table 4.7 Respondents’ knowledge of cervical cancer transmission, prevention 










The virus is 
transmitted 
through  




17 (7.3%) 19 (5.5%) 
Blood transfusion 15 (6.5%) 12 (3.5%) 
I don't know 39 (16.8%) 154 (44.6%) 
Total 232 (100%) 345 (100%) 




of the cervix? 
Avoid multiple sexual 
partners 
32 (13.7%) 35 (10.1%) 
101.3 0.000** 
Avoid early sexual 
intercourse 
34 (14.6%) 10 (3%) 
Quit smoking 5 (2.2%) 28 (8.1%) 
Vaccination of HPV 10 (4.3%) 27 (7.8%) 
Regular medical check-up 
for screening  
25 (10.7%) 62 (18%) 
Two or more of the above 126 (53.2%) 112 (32.4%) 
I don't know 3 (1.3%) 71 (20.6%) 
Total 232 (100%) 345 (100%) 




Radiation  46 (20.1%) 54 (15.7%) 
17,1 0.004** 
Surgery  36 (15.7%) 53 (15.4%) 
Chemotherapy  41 (17.9%) 35 (10.1%) 
Two or more of the above 39 (17%) 72 (20.9%) 
Other 4 (1.7%) 24 (7%) 
I don' know 63 (27.5%) 107 (31%) 
Total 229 (100%) 345 (100%) 
Stage when 
cervical 
cancer can be 
cured 
Early  165 (70.8%) 192 (55.6%) 
53.07 0.000** 
Cannot be cured 28 (12.1%) 15 (4.3%) 
Any time  15 (6.4%) 13 (3.7%) 
I don't know 25 (10.7%) 125 (36.2%) 
Total 233 (100%) 345 (100%) 
** Highly significant p<0.001, p<.001 
 
Table 4.7 presentes the respondents‟ knowledge of cervical cancer transmission, 
prevention and treatment options, stages and screening status. Regarding knowledge of 
cervical cancer transmission, of the screened respondents, 69.4% (n=161) said by 
sexual intercourse; 7.3% (n=17) said by maternal-foetal transmission; 6.5% (n=15) said 




46.4% (n=160) sexual intercourse, 5.5% (n=19) maternal-foetal transmission, 3.5% 
(n=12) blood transfusion, and 44.6% (n=154) did not know. 
 
Regarding how to prevent getting cervical cancer, of the screened respondents, 13.7% 
(n=32) said avoid multiple sexual partners; 14.6% (n=34) said avoid early sexual 
intercourse; 2.2% (n=5) said quit smoking; 4.3% (n=10) said by HPV vaccination; 10.7% 
(n=25) said by regular medical check-up for screening, and 53.2% (n=126) said two or 
more of the above. Of the not screened respondents, 10.1% (n=35) said avoid multiple 
sexual partners; 3% (n=10) said avoid early sexual intercourse; 8.1% (n=28) said quit 
smoking; 27 (7.8%) said by HPV vaccination, 18% (n=62) said by regular medical 
check-up, and 32.4% (n=112) said by two or more of the above. 
 
Regarding treatment modality of cervical cancer, of the screened respondents, 20.1% 
(n=46) said radiation; 15.7% (n=36) said surgery; 17.9% (n=41) said chemotherapy; 
17% (n=39) said two or more of the above; 1.7% (n=4) said other but did not specify, 
and 27.5% (n=63) did not know. Of the not screened respondents, 15.7% (n=54) said 
radiation; 15.4% (n=53) said surgery; 10.1% (n=35) said chemotherapy; 20.9% (n=72) 
said two or more of the above; 7% (n=24) said other but did not specify, and 31% 
(n=107) did not know. 
 
Regarding the stage at which cervical cancer can be cured, of the screened 
respondents, 70.8% (n=165) said early; 12.1% (n=28) said it cannot be cured; 6.4% 
(n=15) said at any time, and 10.7% (n=25) did not know. Of the not screened 
respondents, 55.6% (n=192) said early; 4.3% (n=15) said it cannot be cured; 3.7% 





4.2.5.4 Respondents’ knowledge about cervical cancer screening period and 
result interpretation and screening status 
 
Table 4.8 Respondents’ knowledge of cervical cancer screening period and 


















Annually  51 (22%) 109 (31.6%) 107.1 0.000 
Every 2-3 years 65 (28%) 54 (15.7%) 
Every 5 years 97 (41.8%) 38 (11%) 
I don't know 20 (8.6%) 143 (41.4%) 
Total 232 (100%) 345 (100%) 





Precancerous cells 121 (51.9%) 96 (27.8%) 122.4 0.000 
Cervical cancer 70 (30.1%) 67 (23.1%) 
Sexually transmitted 
infection 
27 (11.6%) 21 (6.0%) 
I do not know 15 (6.4%) 161 (46.7%) 
Total 233 (100%) 345 (100%) 
 
Figure 4.8 indicates the respondents‟ knowledge of cervical cancer screening period 
and result interpretation and screening status, 41.8% (n=97) of the screened 
respondents said screening should be done every 5 years; 28% (n=65) said every 2-3 
years; 22% (n=51) said annually, and 8.6% (n=20) they did not know. Of the not 
screened respondents, 41.1% (n=143) said they did not know; 31.6% (n=109) said 
annually; 15.7% (n=54) said every 2-3 years, and 11% (n=38) said every 5 years. 
 
Regarding the meaning of an abnormal screening test result, of the screened 
respondents, 51% (n=121) said it indicated precancerous cells; 30.1% (n=70) said 
cervical cancer; 11.6% (n=27) said sexually transmitted infection, and 6.4% (n=15) said 
they did not know. Of the not screened respondents, 46.7% (n=161) did not know; 
27.8% (n=96) said precancerous cells; 23.1% (n=67) said cervical cancer, and 6% 





4.2.5.5 Respondents’ knowledge of cervical cancer risk factors  
 













Having multiple sexual 
partners 
Yes  205 (88%) 249 (72.2%) 
45.1 <0.001 No  24 (10.3%) 24 (7%) 
I don‟t know 4 (1.7%) 72 (20.8%) 
Having sex at an early age 
Yes  184 (79%) 197 (84.5%) 
40.38 <0.001 No  31 (13.3%) 49 (14.2%) 
I don‟t know 18 (7.7%) 99 (28.7%) 
Smoking cigarettes 
Yes  146 (62.7%) 169 (49%) 
20.1 <0.001 No  54 (23.2%) 72 (20.9%) 
I don‟t know 33 (14.1%) 104 (30.1%) 
Use of contraceptives 
Yes  102 (43.8%)  64 (27.5%) 
44.1 <0.001 No  83 (35.6%) 164 (79.4%) 
I don‟t know 48 (20.6%) 117 (50.2%) 
Having sexually transmitted 
infection 
Yes  154 (66.1%) 184 (53.3%) 
40.49 <0.001 No  57 (24.5%) 52 (15.1%) 
I don‟t know 22 (9.4%) 109 (31.6%) 
Acquiring human 
papillomavirus infection 
Yes  140 (60.1%) 128 (37.1%) 
40.23 <0.001 No  36 (15.4%) 43 (12.5%) 
I don‟t know 57 (24.5%) 174 (50.4%) 
Family history of cervical 
cancer 
Yes  134 (57.5%) 133(38.55%) 
20.56 <0.001 No  35 (15%) 67 (19.4%) 
I don‟t know 64 (27.5%) 145 (42%) 
Having a weakened immune 
system 
Yes  145 (62.2%) 146 (42.3%) 
27.6 <0.001 No  39 (16.7%) 58 (16.8%) 
I don‟t know 49 (21%) 141 (40.9%) 
* Highly significant P-value <0.001 
 
Table 4.9 indicates the respondents‟ knowledge of risk factors, and screening status.Of 
the screened respondents, 88% (n=205) said having multiple sexual partners was a risk 
factor for cervical cancer; 10.3% (n=24) said having multiple sexual partners was not a 
risk factor, and 1.7% (n=4) did not know. Of the not screened respondents, 72.2% 
(n=249) said having multiple sexual partners was a risk factor; 7% (n=24) said it was 
not, and 20.8% (n=72) did not know. Of the screened respondents, 79% (n=184) said 
having sexual intercourse at an early age was a risk factor; 13.3% (n=31) said it was 
not, and 7.7% (n=18) did not know. Of the not screened respondents, 84.5% (n=197) 




Of the screened respondents, 62.7% (n=146) said smoking cigarettes was a risk factor; 
23.2% (n=54) said it was not, and 14.1% (n=33) did not know. Of the not screened 
respondents, 49% (n=169) said it was a risk factor; 20.9% (n=72) said it was not, and 
30.1% (n=104) did not know. Of the screened respondents, 43.8% (n=102) said use of 
contraceptives was a risk factor; 35.6% (n=83) said it was not, and 20.6% (n=48) did not 
know. Of the not screened respondents, 27.5% (n=64) said use of contraceptives was a 
risk factor; 79.4% (n=164) said it was not, and 50.2% (n=117) did not know.  
 
4.2.6 Respondents’ practice of cervical cancer screening  
 
 
Figure 4.4  Respondents’ practice of cervical cancer screening 
 
Figure 4.4 indicates that of the screened respondents, 77% (n=179) had been screened 
in the past two years; 14% (n=33) had been screened three and above years before, 





4.2.7 Respondents’ perceptions of susceptibility to cervical cancer  
 



















I worry about 
getting cervical 
cancer   
27 (12%) 67 (29.5%) 22 (9.7%) 54 (23.7%) 57 (25.1%) 227 (100%) 
I worry about 
getting human 
papilloma virus, 
the virus which 
causes cervical 
cancer  
23 (9.9%) 73 (31.4%) 31 (13.4%) 63 (27.2%) 42 (18.1%) 232 (100%) 
It is beyond my 
personal control, 
because all 
women have an 
equal chance of 
developing 
cervical cancer  
41 (17.6%) 54 (23.3%) 47 (20.3%) 51 (22%) 39 (16.8%) 232 (100%) 
My chances of 
getting cervical 
cancer are high  
36 (15.5%) 76 (32.7%) 50 (21.6%) 42 (18.1%) 28 (12.1%) 232 (100%) 
My chances of 
contracting 
human papilloma 
virus are low    
5 (2.1%) 75 (32.2%) 39 (16.7%) 58 (25%) 56 (24%) 233 (100%) 
I have the ability 
to avoid cervical 
cancer   
11 (4.7%) 44 (18.9%) 27 (11.6%) 88 (37.8%) 63 (27%) 233 (100%) 
I have the ability 
to avoid HPV 
infection   
3 (1.4%) 49 (21%) 17 (7.3%) 98 (42%) 66 (28.3%) 233 (100%) 
 
The participants were asked about their perceptions to cervical cancer susceptibility. 
Table 4.10 indicates the screened respondents‟ percieved susceptibility to cervical 
cancer.  
 
Of the screened respondents,  
 
25.1% (n=57) strongly agreed; 23.7% (n=54) agreed; 9.7% (n=22) were neutral; 29.5% 






18.1% (n=42) strongly agreed; 27.2% (n=63) agreed; 13.4% (n=31) were neutral; 31.4% 
(n=73) strongly disagreed, and 9.9% (n=23) disagreed that they worried about getting 
HPV. 
 
16.8% (n=39) strongly agreed; 22% (n=51) agreed; 20.3% (n=47) were neutral; 23.3% 
(n=54) strongly disagreed, and 17.6% (n=41) disagreed that it was beyond their control 
to prevent developing of cervical cancer. 
 
28.3% (n=66) strongly agreed; 42% (n=98) agreed; 7.3% (n=17) were neutral; 21% 
(n=49) strongly disagreed, and 1.4% (n=3) disagreed that their chances of getting 
cervical cancer were high. 
 
24% (n=56) strongly agreed; 25% (n=58) agreed; 16.7% (n=39) were neutral; 32.2% 
(n=75) strongly disagreed, and 2.1% (n=5) disagreed that their chances of contracting 
HPV were low. 
 
27% (n=63) strongly agreed; 37.8% (n=88) agreed; 11.6% (n=27) were neutral; 18.9% 
(n=44) strongly disagreed, and 4.7% (n=11) disagreed that they had the ability to avoid 
cervical cancer. 
 
28.3% (n=66) strongly agreed; 42% (n=98) agreed; 7.3% (n=17) were neutral; 21% 
(n=49) strongly disagreed, and 1.4% (n=3) disagreed that they had the ability to avoid 
HPV infection. 
 




















I worry about 
getting cervical 
cancer 1 
56 (16.5%) 133 (39.1%) 35 (10.3%) 55 (16.2%) 61 (17.9%) 340 (100%) 
I worry about 
getting human 
papilloma virus, the 
virus which causes 
cervical cancer  
57 (16.6%) 135 (39.2%) 41 (11.9%) 63 (18.3%) 48 (14%) 344 (100%) 
It is beyond my 
personal control, 
because all women 

























My chances of 
getting cervical 
cancer are high  
60 (17.5%) 138 (40.4%) 50 (14.6%) 53 (15.5%) 41 (12%) 342 (100%) 
My chances of 
contracting human 
papilloma virus are 
low 
31 (9%) 105 (30.5%) 73 (21.2%) 83 (24.2%) 52 (15.1%) 344 (100%) 
I have the ability to 
avoid cervical 
cancer 
20 (5.8%) 87 (25.3%) 43 (12.5%) 119 (34.6%) 75 (21.8%) 344 (100%) 
I have the ability to 
avoid HPV 
infection 
19 (5.5%) 83 (24.3%) 45 (13.2%) 123 (36%) 72 21%) 342(100%) 
 
Table 4.11 presents the not screened respondents‟ perceptions about their susceptibility 
to cervical cancer. Of the not screened respondents, 17.9% (n=61) strongly agreed; 
16.2% (n=55) agreed; 10.3% (n=35) were neutral; 39.1% (n=133) disagreed, and 16.5% 
(n=56) strongly disagreed that they worried about getting cervical cancer. 
 
Of not not screened respondents,  
 
14% (n=48) strongly agreed; 18.3% (n=63) agreed; 11.9% (n=41) were neutral; 39.2% 
(n=135) strongly disagreed, and 16.6% (n=57) disagreed that they worried about getting 
HPV. 
 
18.1% (n=62) strongly agreed; 20.4% (n=70) agreed; 12.6% (n=43) were neutral; 35.7% 
(n=122) strongly disagreed, and 13.2% (n=45) disagreed that it was beyond their control 
to prevent developing cervical cancer. 
 
12% (n=41) strongly agreed; 15.5% (n=53) agreed; 14.6% (n=50) were neutral; 40.4% 
(n=138) strongly disagreed, and 17.5% (n=60) disagreed that disagreed that their 
chances of getting cervical cancer were high. 
 
15.1% (n=52) strongly agreed; 24.2% (n=83) agreed; 21.2% (n=73) were neutral; 30.5% 
(n=105) strongly disagreed, and 9% (n=31) disagreed that their chances of contracting 





21.8% (n=75) strongly agreed; 34.6% (n=119) agreed; 12.5% (n=43) were neutral; 
25.3% (n=87) strongly disagreed, and 5.8% (n=20) disagreed that they had the ability to 
avoid cervical cancer. 
 
72.2% (n=66) strongly agreed; 36% (n=123) agreed; 13.2% (n=45) were neutral; 24.3% 
(n=83) strongly disagreed, and 5.5% (n=19) disagreed that they had the ability to avoid 
HPV infection. 
 
4.2.7.1 Respondents’ perceived severity seriousness of cervical cancer 
 
Table 4.12 Respondents’ perceptions of seriousness/severity of cervical 




Screened Not screened 
I will not screen for cervical cancer because of fear of the result No (%) No (%) 
True 48 (20.8%) 89 (25.9%) 
False 171 (74%) 192 (56.0%) 
I don't know 12 (5.2%) 62 (18.1%) 
Total 231 (100%) 343 (100%) 
There is very little that one can do about cervical cancer   
True 112 (48.3) 108 (28.9%) 
False 99 (42.7%) 155 (41.4%) 
I don't know 21 (9.0%) 111 (29.7%) 
Total 232 (100%) 374 (100%) 
I would rather screen for cervical cancer   
True 169 (72.8%) 221 (59.2%) 
False 49 (21.1%) 88 (23.6%) 
I don't know 14 (6.0%) 64 (17.2%) 
Total 232 (100%) 373 (100%) 
All women who develop cervical cancer must have their uteruses 
removed 
  
True 44 (19.0%) 79 (23.0%) 
False 140 (60.6%) 138 (40.1%) 
I don't know 47 (20.4%) 127 (36.9%) 
Total 231 (100%) 344 (100%) 
Early detection can increase survival chances   
True 163 (70.3%) 198 (57.6%) 
False 44 (18.9%) 63 (18.3%) 
I don't know 25 (10.8%) 83 (24.1%) 
Total 232 (100%) 344 (100%) 
Loss of cervix or uterus through surgery would affect my 
sexuality 
  
True 99 (42.3%) 153 (44.5%) 
False 77 (33%) 100 (29.1%) 
I don't know 57 (24.7%) 91 (26.4%) 
Total 233 (100%) 344 (100%) 
Among the diseases I can imagine getting cervical cancer is 







Screened Not screened 
True 162 (69.5%) 203 (59.3%) 
False 61 (26.2%) 72 (21.1%) 
I don't know 10 (4.3%) 67 (19.6%) 
Total 233 (100%) 342 (100%) 
Cervical cancer is a life-threatening disease   
True 150 (65.5%) 213 (62.4%) 
False 62 (27.1%) 66 (19.4%) 
I don't know 17 (7.4%) 62 (18%) 
Total 229 (100%) 341 (100%) 
Cervical cancer would threaten my relationship with my 
husband/partner 
  
True 148 (63.5%) 215 (62.5%) 
False 60 (25.8%) 53 (15.4%) 
I don't know 25 (10.7%) 76 (22.1%) 
Total 233 (100%) 344 (100%) 
Most women who develop cervical cancer will die from it.   
True 87 (37.3%) 126 (36.6%) 
False 83 (35.6%) 89 (25.9%) 
I don't know 63 (27.0%) 129 (37.5%) 
Total 233 (100%) 344 (100%) 
My whole life would change if I had cervical cancer   
True 105 (45.1%) 146 (42.6%) 
False 99 (42.5%) 112 (32.6%) 
I don't know 29 (12.4%) 85 (24.8%) 
Total 233 (100%) 343 (100%) 
 
Regarding their perceived seriousness of cervical cancer, the respondents were 
required to answer True or False to statements. Table 4.12 shows respondents‟ 
perceptions about seriousness/severity of cervical cancer, and screening status 
 
Of the screened respondents,  
 
20.8% (n=48) said „true‟ and 74% (n=171) said „false‟ for „I will not screen for cervical 
cancer because of fear of the result‟;  48.3% (n=112) said „true‟ and 42.7% (n=99) said 
„false‟ for „There is very little that one can do about cervical cancer‟;  72.8% (n=169) 
said „true‟ and 21.1% (=49) said false for „I would rather screen for cervical cancer‟;  
19% (n=44) said „true‟ and 60.6% (n=140) said „false‟ for „All women who develop 
cervical cancer must have their uteruses removed‟. 
 
70.3% (n=163) said „true‟ and 18.9% (n=44) said „false‟ for „Early detection can increase 
survival chances‟;  42.3% (n=99) said „true‟ and 33% (n=77) said „false‟ for „Loss of 
cervix or uterus through surgery would affect my sexuality‟; 69% (n=162) said „true‟ and 
26.2% (n=61) said „false‟ for „Among the diseases I can imagine getting cervical cancer 




„Cervical cancer is a life threatening disease‟; 63.5% (n=148) said „true‟ and 25.8% 
(n=60) said „false‟ for „Cervical cancer would threaten my relationship with my 
husband/partner‟; 37.3% (n=87) said „true‟ and 35.6% (n=83) said „false‟ for „Most 
women who develop cervical cancer will die from it‟; 45.1% (n=105) said „true‟ and 
42.5% (n=99%) said „false‟ for „My whole life would change if I had cervical cancer‟. 
 
Of the not screened respondents, 25.9% (n=89) said „true‟ and 56% (n=192) said „false‟ 
to „I will not screen for cervical cancer because of fear of the result‟. 28.9% (n=108) said 
„true‟ and 41.4% (n=155) said „false‟ for „There is very little that one can do about 
cervical cancer.‟ 59.2% (n=221) said „true‟ and 23.6% (n=88) said „false‟ for „I would 
rather screen for cervical cancer‟. 23% (n=79) said „true‟ and 40.1% (n=138) said „false‟ 
for „All women who develop cervical cancer must have their uteruses removed‟. 57.6% 
(n=198) said „true‟ and 18.3% (n=63) said „false‟ for „Early detection can increase 
survival chances‟. 44.5% (n=153) said „true‟ and 29.1% (n=100) said „false‟ for „Loss of 
cervix or uterus through surgery would affect my sexuality‟.  59.3% (n=203) said „true‟ 
and 21.1% (n=72) said false for „Among the diseases I can imagine getting cervical 
cancer is among the most serious‟. 62.4% (n=213) said „true‟ and 19.4% (n=66) said 
„false‟ for „Cervical cancer is a life-threatening disease‟. 62.5% (n=215) said „true‟ and 
15.4% (n=53) said „false‟ for „Cervical cancer would threaten my relationship with my 
husband/partner‟. 36.6% (n=126) said „true‟ and 25.9% (n=89) said „false‟ for „Most 
women who develop cervical cancer will die from it‟. 42.6% (n=146) said „true‟ and 
32.6% (n=112) said „false‟ for „My whole life would change if I had cervical cancer‟.  
 
4.2.7.2 Respondents’ perceived benefits of cervical cancer screening 
 
Table 4.13 Respondents’ perceived benefits of cervical cancer screening  
 
Question 





Cervical cancer can be diagnosed at an early stage     
Yes 212 91.0 251 73.0 
No 8 3.4 30 8.7 
I don‟t know 13 5.6 63 18.3 
Total 233 100.0 344 100.0 
Cervical cancer screening would save lives if detected 
at an early stage 
    
Yes 193 83.2 221 64.2 
No 29 12.5 54 15.7 
I don‟t know 10 4.3 69 20.1 










Cervical cancer is often curable with early detection 
and proper medical treatment 
    
Yes 201 86.6 230 66.9 
No 16 6.9 31 9.0 
I don‟t know 15 6.5 83 24.1 
Total 232 100.0 344 100.0 
Regular cervical cancer screening decreases the risk 
of cancer 
    
Yes 199 85.8 221 64.4 
No 24 10.3 37 10.8 
I don‟t know 9 3.9 85 24.8 
Total 232 100.0 343 100.0 
 
The respondents were required to answer „yes‟ or „no‟ to statements on the perceived 
benefits of cervical cancer screening. Table 4.13 depicts respondents‟ perceived 
benefits of cervical cancer screening. Of the screened respondents, 91% (n=212) said 
„yes‟ and 3.4% (n=8) said „no‟ to „Cervical cancer can be diagnosed at an early stage‟, 
and 5.6% (n=13) did not know; 83.2% (n=193) said „yes‟ and 12.5% (n=29) said „no‟ to 
„cervical cancer screening would save lives if detected at an early stage‟, and 4.3% 
(n=10) did not know; 86.6% (n=201) said „yes‟ and6.9% (n=16) said „no‟ to „cervical 
cancer is often curable with early detection and proper medical treatment‟, and 6.5% 
(n=15) did not know.; 85.8% (n=199) said „yes‟ and 10.3% (n=24) said „no‟ to „regular 
cervical cancer screening decreases the risk of cervical cancer‟, and 3.9% (n=9) did not 
know. 
 
Of the not screened respondents, 73% (n=251) said „yes‟ and 8.7% (n=30) said „no‟ to 
„cervical cancer can be diagnosed at an early stage‟, and 18.3% (n=63) did not know; 
64.2% (n=221) said „yes‟ and 15.7% (n=54) said „no‟ to „cervical cancer screening would 
save life if detected at an early stage‟, and 20.1% (n=69) did not know; 66.9% (n=230) 
said „yes‟ and 9% (n=31) said „no‟ to „cervical cancer is often curable with early 
detection and proper medical treatment‟, and 24.1% (n=83) did not know; 64.4% 
(n=221) said „yes‟ and 10.8% (n=37) said „no‟ to „regular cervical cancer screening 





4.2.7.3 Respondents’ perceived barriers to cervical cancer screening 
 
Table 4.14 Respondents’ perceived barriers to cervical cancer screening 
 
Question 
Screening status  
Screened 
Not 
screened I don't want to be seen in a cervical cancer screening clinic by my 
friends. 
True  120 (51.9%) 167 (48.6%) 
False 105 (45.5%) 127 (36.9%) 
I don't know 6 (2.6%) 50 (14.5%) 
Total 231 (100%) 344 (100%) 
Cervical cancer screening test is humiliating.   
True  56 (33.1%) 69 (28.8%) 
False 88 (52.1%) 104 (43.3%) 
I don't know 25 (14.8%) 67 (27.9%) 
Total 169 (100%) 240 (100%) 
I have no time for doing a test.   
True  46 (19.7%) 56 (16.49%) 
False 175 (75.1%) 225 (66%) 
I don't know 12 (5.2%) 60 (17.6%) 
Total 233 (100%) 341 (100%) 
I am not aware of any test.   
True  46 (19.9%) 113 (33.1%) 
False 171 (74%) 162 (47.5%) 
I don't know 14 (6.1%) 66 (19.4%) 
Total 231 (100%) 341 (100%) 
I do not know where the test is done.   
True  53 (22.8%) 117 (34.4%) 
False 170 (73.3%) 164 (48.2%) 
I don't know 9 (3.9%) 59 (17.4%) 
Total 232 (100%) 340 (100%) 
I don’t know how much it costs.   
True  85 (36.8%) 172 (50.4%) 
False 131 (56.7%) 93 (27.3%) 
I don't know 15 (6.5%) 76 (22.3%) 
Total 231 (100%) 341 (100%) 
I am still too young for the test.   
True  44 (18.9%) 63 (18.5%) 
False 179 (76.8%) 234 (68.6%) 
I don't know 10 (4.3%) 44 (12.9%) 
Total 233 (100%) 341 (100%) 
My partner is uncomfortable about my having cervical cancer 
screening test 
  
True  51 (22.1%) 53 (15.6%) 
False 162 (70.1%) 235 (69.1%) 
I don't know 18 (7.8%) 52 (15.3%) 
Total 231 (100%) 340 (100%) 
Cervical cancer screening test is painful and unpleasant   
True  74 (31.9%) 182 (31.8%) 
False 150 (64.7%) 274 (47.8%) 
I don't know 8 (3.4%) 117 (20.4%) 
Total  232 (100%) 341 (100.%) 
I don’t have a risk of getting cervical cancer therefore I don’t want 
to be screened. 
  
True  34 (14.6%) 59 (17.4%) 
False 187 (80.3%) 223 (65.8%) 
I don't know 12 (5.2%) 57 (16.8%) 





Table 4.14 shows the respondents‟ response on perceived barriers to cervical cancer 
screening. Of the screened respondents;  51.9% (n=120) said „true‟ and 45.5% (n=105) 
said „false‟ to “I don‟t want to be seen in a cervical cancer screening clinic by my 
friends”, and 6(2.6%) did not know; 33.1% (n=56) said „true‟ and 88% (n=52.1) said 
„false‟ to “Cervical cancer screening test is humiliating”, and 14.8% (n=25) did not know; 
19.7% (n=46) said „true‟ and 75.1% (n=175) said „false‟ to “I have no time for doing a 
test”, and 5.2% (n=12) did not know; 19.9% (n=46) said „true‟ and 74% (n=171) said 
„false‟ to “I am not aware of any test”, and 6.1% (n=14) did not know; 22.8% (n=53) said 
„true‟ and 73.3% (n=170) said „false‟ to “I do not know where the test is done”, and 3.9% 
(n=9) did not know; 36.8% (n=85) said „true‟ and 56.7% (n=131) said „false‟ to “I don‟t 
know how much cost required”, and 6.5% (n=15) did not know;18.9% (n=44) said „true‟ 
and 76.8% (n=179) said „false‟ to “I am still too young for the test”, and 4.3% (n=10) did 
not know; 22.1% (n=51) said „true‟ and 70.1% (n=162) said „false‟ to “My partner is 
uncomfortable about my having the test and 7.8% (n=18) did not know;31.9% (n=74) 
said „true‟ and 64.7% (n=150) said „false‟ to “Cervical cancer testing is painful and 
unpleasant” and 3.4% (n=8) did not know;14.6% (n=34) said „true‟ and 80.3% (n=187) 
said „false‟ to “I don‟t have a risk of developing cervical cancer, therefore I don‟t want to 
be screened”, and 5.2% (n=12) did not know. 
 
Of not screened respondents, 48.8% (n=167) said „true‟ and 127% (n=36.9) said „false‟ 
to “I don‟t want to be seen in a cervical cancer screening clinic by my friends”, and 
14.5% (n=50) did not know; 28.8% (n=69) said „true‟ and 43.3% (n=104) said „false‟‟ to 
“Cervical cancer screening is humiliating”, and 27.9% (n=67) did not know;  16.4% 
(n=56) said „true‟ and 66% (n=225) said „false‟‟ to “I have no time for doing a test”, and 
17.6% (n=60) did not know; 50.4% (n=172) said „true‟ and 27.3% (n=93) said „false‟‟ to 
“I am not aware of any test”, and 22.3% (n=76) did not know;  34.4% (n=117) said „true‟ 
and 48.2% (n=164) said „false‟‟ to “I do not know where the test is done”, and 17.4% 
(n=59) did not know; 50.4% (n=172) said „true‟ and 27.3% (n=93) said „false‟‟ to “I don‟t 
know how much it costs”, and 22.3% (n=76) “Don‟t know how much cost requested” 
18.5% (n=63) said „true‟ and 68.6% (n=234) said „false‟‟ to “I am still too young for the 
test”, and 12.9% (n=44) did not know; 15.6% (n=53) said „true‟ and 69.1% (n=235) said 
„false‟‟ to “My partner is uncomfortable about my having cervical cancer screening test”, 
and 15.3% (n=52) did not know; 31.8% (n=182) said „true‟ and 47.8% (n=274) said 
„false‟‟ to “Cervical cancer screening test is painful and unpleasant” and 20.4% 




have a risk of getting cervical cancer, therefore I don‟t want to be screened”, and 16.8% 
(n=57) did not know.   
 
4.2.8 Respondents’ cues to action  
 
The HBM holds that a cue or trigger is necessary for timely involvement in health-
promoting behaviours. Readiness to action (perceived susceptibility and perceived 
benefits) is prompted by other factors or cues to initiate action (Glanz & Rimer 2008:49). 
This section covered the respondents‟ sources of information on cervical cancer 
screening services which cued their action, namely health care providers, media, friends 
or neighbours, and school. 
 
4.2.8.1 Respondents’ sources of information  
 
 
Figure 4.5  Respondents’ sources of information on cervical cancer screening  
 
Figure 4.5 indicates the respondents‟ source of information on cervical cancer 
screening. Of the screened respondents, 63.8% (n=164) indicated health care 
providers, 21.4% (n=55) indicated the media, 10.1% (n=26) indicated 
friends/neighbours and 4.7% (n=12) indicated tutors/school as their main sources of 
information. Of the not screened respondents, 50.2% (n=182) indicated health care 
providers, 27.4% (n=99) indicated the media, 16% (n=58) indicated friends/neighbours 
and 6.4% (n=23) indicated tutors/school. Majority 60% (n=346) of respondents of both 




by the media 24.9% (n=154) as well as (13.6%; n=84) indicated friends and (5.6%; 
n=35) indicated neighbours and school as sources of information. 
 
4.2.8.2 Best methods for providing information about cervical cancer and 
screening  
 
Table 4.15 Respondents’ best methods for providing information about cervical 
cancer and screening 
 
Method Frequency % 
Campaign advertisement on television 107 17.8 
Campaign advertisement on radio 36 6 
Health talks by health care providers 229 38.1 
Health talks by community leaders 40 6.7 
Media and health care providers 175 29.1 
All of the above 14 2.3 
Total 601 100% 
 
Table 4.15 indicates that best methods for providing information about cervical cancer 
and screening identified by respondents. The main sources of information indicated as 
best methods for providing information about cervical cancer for  both screened and not 
screened respondents were health talks by health care providers (38.1%; n=229); 
media and health care providers (29.1%; n=175), and campaign advertisement on TV 
(17.8%; n=107). Other sources of information were health talks by community leaders 
(6.7%; n=40); campaign advertisement on radio (6%; n=36), and 2.3% (n=14) 
respondents said “all of the above” sources. 
 
4.2.9 Factors affecting respondents’ screening practice for cervical cancer  
 
4.2.9.1 Association between respondents’ socio-demographic characteristics 
and knowledge of cervical cancer 
 
Associations of the respondents‟ socio-demographic characteristics, reproductive health 
information and their knowledge of cervical cancer were calculated statistically, using 






Table 4.16 Association between respondents’ screening status and socio-
demographic characteristics  
 
Factor Classification 







Age group  
<35 years 
No  147 315 
33.618 <0.001* 
% 31.8% 68.2% 
>35 years 
No 86 61 




No 149 233 
0.241 0.623 
% 39.0% 61.0% 
unmarried 
No. 84 143 
% 37.0% 63.0% 
Education 
level (N=609) 
No education  
No. 22 28 
1.018 0.272 
% 9.4% 7.4% 
Primary school 
No. 81 154 
% 34.8% 41% 
Secondary and 
above 
No. 130 194 





No. 65 112 
0.249 0.618 
% 36.7% 63.3% 
Gov/private 
employee 
No. 168 264 




Less than 1000 
birr 
No. 67 92 
1.371 0.242 
% 42.1% 57.9% 
1000 birr and 
above 
No. 166 284 
% 36.9% 63.1% 
*Highly significant association p<0.001 
 
Table 4.16 indicates cross-tabulation of SPSS output of screening status by 
respondents‟ socio-demographic characteristics. There was a significant association of 
age category (X2=33.618 at p-value <0.001) and screening status. In this study 
indicates that older rather than younger respondents were screened. Other socio 
demographic was not characteristics did not indicate association with screening status 





4.2.9.2 Association between respondents’ screening status and  reproductive 
health information  
 
Table 4.17 Association between respondents’ screening status and 
reproductive health information 
 




Screened Not screened 
What was your age 
of menarche 
<14 years 85 (36.5%) 127 (33.8%) 
5.5 0.139 
14-15 years 113 (48.5%) 203 (54) 
>15 years 26 (11.2%) 25 (6.6%) 
No response 9 (3.8%) 21 (5.6%) 
Total 233 (100%) 376 (100%) 
Age of first 
intercourse 
<15 years 23 (9.9%) 33 (8.8%) 
6.8 0.079 
15-18 years 85 (36.5%) 145 (38.6%) 
>18 years 113 (48.5%) 158 (42%) 
No response 12 (5.1%) 40 (10.6%) 
Total  233 (100) 376 (100) 
Age of first 
pregnancy 
<15 years 16 (6.9%) 15 (4%) 
12.4 0.006** 
15-18 years 84 (36%) 113 (30%) 
>18 years 115 (49.4%) 186 (49.5%) 
No response 18 (7.7%) 62 (16.5%) 
Total 233 (100%) 376 (100%) 
Have you had any 
miscarriage 
Yes  64 (27.5%) 76 (20.2%) 
4.5 0.107 
No  150 (64.4%) 262 (69.7%) 
No response 19 (8.1%) 38 (10.1) 
Total 233 (100%) 376 (100%) 
Have you been 
using birth control 
contraceptives 
Yes  207 (88.9%)  277 (73.7%) 
20.7 <0.001** 
No  22 (9.4%) 89 (23.7%) 
No response 4 (1.7%) 10 (2.6%) 
Total 233 (100%) 376 (100%) 




152 (73.5% 229 (82.7%) 
14.3 0.003* 
Barrier methods 46 (22.2%) 30 (10.8%) 
Mixed methods 9 (4.3%) 14 (5.1%) 
No response - 4 (1.4%) 
Total  207 (100) 277 (100) 
Number of children 
None  21 (9.1%) 122 (32.4%) 
66.7 <0.001** 
One  40 (17.2%) 98 (26.1%) 
Two to four 136 (58.3%) 125 (33.2%) 
Above four 33 (14.1%) 28 (7.5%) 
No response 3 (1.3%) 3 (0.8) 
Total 233 (100) 376 (100) 
**Highly significant p< 001, **Highly significant p< 0.01, significant p<0.05 
 
As Table 4.17 indicates of the screened respondents, 49.4% (n=115) were over 18 
years old at their first pregnancy; 36% (n=84) were between 15 and 18 years old, and 
6.9% (n=16) were age below 15 years old. Of the not screened respondents, 49.5% 
(n=186) were over 18 years old at their first pregnancy; 30% (n=113) were between 15 




there is significant association between the age first pregnancy and screening status of 
the respondents X2=12.40.at p-value <0.01. 
 
The chi-square test, with X2value=20.7 and p-value <0.001, found that the respondents‟ 
screening status and their use of contraceptives were significantly associated.  Of the 
screened respondents, 88.8% (n=207) used contraceptives; 9.4% (n=22) did not, and 
1.7% (n=4) did not answer the question. Of the not screened respondents, 73.7% 
(n=277) used contraceptives, 23.7% (n=89) did not, and 2.7% (n=10) did not answer the 
question. 
 
Concerning the type contraceptives use of respondents, 73.5% (n=152) of screened 
respondents and 82.7% (n=229) not screened respondents were used hormonal 
contraceptives; 22.2% (n=46) of screened respondents and 10.8% (n=30) of not 
screened respondents used Barrier Methods of contraceptives; 4.3% (n=9) of screened 
respondents and 5.1% (n=14) of not screened respondents were used mixed method of 
contraceptives.The type of contraceptives that respondents used revealed highly 
significant association with the screening status of the respondents X2=14.3, p-
value=0.003, where 73.5% (n=152).  
 
Of the screened respondents 58.3% (n=136) have two to four children and 33.2% 
(n=125) of not screened respondents have two to four children; 17.2% (n=40) of 
screened respondents and 26.1% (n=98) of not screened respondents have one child; 
14.1% (n=33), of screened respondents and 9.1% (n=21) of not screened respondents 
have above four children; 9.1% (n=21) of screened respondents and 32.4% (n=122) of 
not screened respondents had no child. The number the respondents had revealed 
highly significant association in Pearson chi-square test X2=66.7 and p-value<0.001. 
The study indicated that respondents with two to four children were more found 













Good and moderate 
knowledge of cervical 
cancer  
N (%) 




Screened  126 (54.1%) 107 (45.9%) 
51.649 <0.001 
Not screened  95 (25.3%) 281 (74.7%) 
 
By assessing the responses of each knowledge questions about cervical cancer, 
symptoms, prevention, cervical screening tests; treatment options, the researcher 
graded the knowledge of women as poor or moderately good. Then a chi-square test of 
association between respondents‟ knowledge and their screening status was 
performed. The result indicated in the table 4.18 verified a significant difference 
between screened and not-screened women knowledge about cervical cancer 
screening. The data verified 54.1% (n=126) of screened respondents and 25.3% (n=95) 
of not-screened respondents have good to moderately knowledge level about cervical 
cancer; while 25.3% (n=95) of screened respondents and 74.7% (n=281) of not 
screened respondents have poor knowledge level about cervical cancer This implies 
that screened women were found to be more knowledgeable about cervical cancer than 
not-screened women. (X2=51.649, p-value=0.001).   
 
4.2.9.3 Association between respondents’ perceptions and screening status 
 





Table 4.19 Respondents’ screening status and perceived susceptibility to 
cervical cancer 
 
The respondents‟ perceptions of their susceptibility to cervical cancer were assessed 
using a 5-point Likert scale and their perceptions compared using independent sample 
T-tests. Table 4.19 indicates repondents‟ screening status and perceived susceptibility 
to cervical cancer  
 
Regarding their worry about getting cervical cancer, the screened respondents‟ average 
agreement level was M=3.21 and the not-screened respondents‟ average was M=2.80. 
The t-test result with t=3.420 and p-value=0.001 <0.05 indicated that the two groups 
differed significantly in their agreement with the statement. The screened respondents 
were relatively more worried than the not screened respondents.  
 







T-test for equality of means 
Mean 
difference 
T-value Df P-value 
I worry about 
getting cervical 
cancer 
Screened 227 3.21 1.407 
.407 3.420 565 .001 Not 
Screened 
340 2.80 1.377 
I worry about 
getting human 
papilloma virus 
Screened 232 3.12 1.304 
.382 3.432 574 .001 Not 
Screened 
344 2.74 1.316 
I believe that I am 
at risk of 
developing 
cervical cancer 
Screened 232 2.81 1.295 
.122 1.115 570 .265 Not 
Screened 
340 2.69 1.279 
It is beyond my 
personal control, 
because all 
women have an 
equal chance of 
developing 
cervical cancer 
Screened 232 2.97 1.356 
.022 .195 572 .845 Not 
Screened 
342 2.95 1.347 
My chances of 
getting cervical 
cancer are high 
Screened 232 2.78 1.254 
.144 1.341 572 .181 Not 
Screened 
342 2.64 1.271 
My chances of 
contracting 
human papilloma 
virus are low 
Screened 233 3.36 1.221 
.307 2.947 575 .003 Not 
Screened 
344 3.06 1.230 
I have the ability 
to avoid cervical 
cancer 
Screened 233 3.75 1.121 
.338 3.341 575 .001 Not 
Screened 
344 3.41 1.240 
I have the ability 
to avoid HPV 
infection 
Screened 233 3.64 1.200 
.208 2.023 573 .044 Not 
screened 




Regarding their worry about getting HPV, the screened respondents‟ rating was M=3.21 
and the not-screened respondents‟ rating was M=2.74. The t-test result (t-value=3.432, 
p-value=0.001<0.01) indicated a relatively higher level of worry by the screened 
respondents than the not screened respondents.  
 
Regarding their belief that they were at risk of developing cervical cancer, there was no 
significant difference between the screened respondents (M=2.81) and the not 
screened respondents (M=2.69) (with t-value=1.115, p-value=0.265 >0.05).  
 
Regarding the statement that cervical cancer was beyond their personal control, there 
was no significant difference between the screened respondents (M=2.97) and the not 
screened respondents (M=2.95) (with t-value=1.115, p-value=0.265 >0.05).  
 
Regarding the statement that their chances of getting cervical cancer were high, both 
groups of respondents had a similar low level of agreement (t-value=1.341, p-
value=0.181 >0.05). There was no significant difference between the screened 
respondents (M=2.78) and the not screened respondents (M=2.64). Regarding their 
chances of contracting HPV being low, the screened respondents‟ rating was M=3.36 
and the not screened respondents‟ rating was M=3.06 (with t-value=2.947, p-
value=.003). Regarding their ability to avoid cervical cancer, the screened respondents‟ 
rating was M=3.75 and the not screened respondents‟ rating was M=3.41 (with t-
value=3.341, p-value=.001). Regarding their ability to avoid HPV, the screened 
respondents‟ rating was M=3.64 and the not screened respondents‟ rating was M=3.43 
(with t-value=2.023, p-value=.044). 
 
4.3  DISCUSSION OF QUANTITATIVE FINDINGS 
 
The researcher used the Health Belief Model (HBM) as the conceptual framework. The 
HBM is based on people‟s beliefs about whether or not they are susceptible to a 
disease or condition and how their perceptions of the benefits of trying to avoid it 
influence their readiness to act (National Cancer Institute (NCI) 2005:13). Health 
behaviour is based on perceived threat of disease (Rosenstock et al 1988:177). In 
terms of the HBM, people's beliefs about health problems, perceived benefits of action 
and barriers to action, and cues to action explain engagement (lack of engagement) in 




activate health-promoting behaviour (Abraham & Sheeran 2015:101). This section 
compares the screened and not screened respondents‟ results in terms of the HBM 
constructs. 
 
4.3.1 Comparison of HBM constructs between screened and not screened 
respondents 
 
 Modifying factors  
 
Individual characteristics, including demographic, psychological and structural variables, 
can affect perceptions of seriousness/severity, susceptibility, benefits, and barriers of 
health-related behaviours (Rosenstock 1974:328-335). Demographic variables include 
age, sex, ethnicity, and education; psychosocial variables include personality, social 
class, and peer and reference group pressure; structural variables include knowledge 
about a given disease and prior contact with the disease. These modifying variables can 
affect health-related behaviours indirectly either by mediating or moderating the key 
HBM constructs by affecting perceived seriousness, susceptibility, benefits, and barriers 
(Glanz et al 2015:75).  
 
Respondents’ age  
 
As indicated in Table 4.16, of the total respondents 31.8% (n=147) of the screened 
respondents and 68.2% (n=315) of not screened respondents were age less than 35 
years old while 58.5% (n=86) of screened respondents and 41.5% (n=61) of not 
screened were age=>35 years. The age characteristics of respondents specified that 
there was highly significant association of their age category (X2=33.618 at level of p-
value <0.001). The result implies that women in the higher age category were screened 
women. That is, the higher the age of woman the higher that respondent got screened 
for cervical cancer. This finding was concurrent to the study done in India where 
respondents whose age was 30 years and above were likely to have practice of 
screening for cervical cancer (Bansal, Pakhare, Kapoor, Mehrotra & Kokane 2015:327) 
and Arbaminch, Southern Ethiopia where mothers whose age >30 years were more 
likely have screen for cervical cancer (Gebru et al 2016:3). This could be age advanced 
women were most likely visit the health facility for different type of reproductive health 





Marital status  
 
This study showed that of the total respondents 39% (n=149) of screened respondents 
and 61% (n=233) of not screened respondents were married; 37% (n=84) of screened 
respondents and 63% (n=143) of not screened respondents were unmarried. There was 
no significant difference of marital status on screened status. The finding was similar to 
study done at but differ to study done in Kumasi Metropolis of Ghana (p=0.040) and 
Zanzibar, Tanzania (60.58% vs 48.97%, P=0.000) where married participants were 
more utilised cervical cancer screening test than the unmarried group (Kokuro 2017:51; 




As Table 4.16 indicated of the total respondents 9.4% (n=22) of screened respondent 
7.4% (n=28) of not screened respondents were reported that they had no education; 
34.8% (n=81) of screened respondents and 41% (n=154) of not screened respondents 
reported that they were at primary level of education and 40.1% (n=130) of screened 
and 59.9% (n=194) of not screened respondents were secondary and above level of 
education. However, 59.9% of not screed respondents were secondary and above level 
of education, in this study there was no significant association between educational 




Relating the occupation category of respondents 36.7% (n=65) of screened 
respondents and 63.3% (n=112) of not screened respondents identified housewife and 
38.9% (n=168) of screened participants and 61.1% (n=264) not screened participants 
identified employed. The Pearson chi-square test indicated that respondents‟ 
occupation category and screening status were not significantly associated. Both the 
housewives and employed respondents have similar probability of being screened and 
not. However, other study indicated that participants who had undergone cervical 







Regarding income category of the respondents 42.1% (n=67) of screened respondents 
and 57.9% (n=92i) of not screened respondents were reported below 1000 birr income 
while 36.9% (n=166) of screened respondents and 63.1% (n=284) of not screened 
respondents reported 1000 birr and above Birr. Hence the income category of the 
respondents was not associated with the screening status. 
 
Age of first pregnancy  
 
As Table 4.17 indicates of the screened respondents, 49.4% (n=115) were over 18 
years old at their first pregnancy; 36% (n=84) were between 15 and 18 years old, and 
6.9% (n=16) were age below 15 years old. Of the not screened respondents, 49.5% 
(n=186) were over 18 years old at their first pregnancy; 30% (n=113) were between 15 
and 18 years old, and 4% (n=15) were below 15 years old. The study identified that 
there is significant association between the age first pregnancy and screening status of 
the respondents X2=12.4.at p-value <0.01. Majority of screened respondents was above 
18 years old at their first pregnancy. As compared to the not screened women  
 
The chi-square test, with X2value=20.7 and p-value <0.001, found that the respondents‟ 
screening status and their use of contraceptives were significantly associated.  Of the 
screened respondents, 88.8% (n=207) used contraceptives; 9.4% (n=22) did not, and 
1.7% (n=4) did not answer the question. Of the not screened respondents, 73.7% 
(n=277) used contraceptives, 23.7% (n=89) did not, and 2.7% (n=10) did not answer. In 
this study screened respondents were used contraceptives more as compared to not 
screened respondents. 
 
Having two to four children of screened respondents revealed highly significant 
association in Pearson chi-square test. Of the screened respondents 58.3% (n=136) 
have two to four children and 33.2% (n=125) of not screened respondents have two to 
four children; 17.2% (n=40) of screened r3spndents and 26.1% (n=98) of not screened 
respondents have one child; 14.1% (n=33), of screened respondents and 9.1% (n=21) 
of not screened respondents have above four children; 9.1% (n=21) of screened 
respondents and 32.4% (n=122) of not screened respondents had no child. The number 




This indicates that majority (58.3%) of respondents with two to four children were more 
found screened as compared to not screened respondents. 
 
Awareness of cervical cancer cervical cancer, causes, prevention, risk factors, 
screening and treatment options 
 
Concerning awareness about cervical cancer respondents were asked if they had 
awareness on cervical cancer, causes, prevention, risk factors, screening and 
treatment. Of those not screened respondents 91.8% (n=345) reported that they heard 
about cervical cancer and 8.2 (n=31) reported that they were not heard. When 
compared to other studies, this finding was lower than the finding in North Uganda 
(Mawaka et al 2015:859) which was 99% of respondents were aware of cervical cancer 
and higher than studies done in Nairobi Kenya (Mungai et al 2016:88) 85% of 
respondents were aware of cervical cancer, Kerala India (Aswathy et al 2012:207) 
72,1%, North Ethiopia (Getahun et al 2013:4) 78.7% and Jamaica (Interis 2016:53) 65% 
of respondents had heard about cervical cancer. This difference might be due to 
difference in population, disease prevalence, information about cervical cancer 
screening and availability of cervical cancer screening services. 
 
Of screened respondents, 53.7% (n=173) were aware of causes of cervical cancer and  
20.9% (n=60) were not aware of causes of cervical cancer; 75.1% (n=175) were aware 
of the risk factors for cervical cancer and 24.9% (n=58 ) were not aware the risk factors 
for cervical cancer; 179 (76.8%) were aware of methods of cervical cancer preventions 
and 54 (23.2%) were not aware of methods of cervical cancer preventions; all of them 
were aware of where to get test for cervical cancer; 73.8% (n=172) were aware of 
whether cervical cancer treatable or not and 26.2% (n=61 ) were not aware of whether 
cervical cancer treatable or not; 35.2% (n=82) were knew person with cervical cancer 
and 151 (64.8%) were not knew any person with cervical cancer. 
 
Of not screened respondents 39.7% (n=149) were aware of the causes of cancer 
cervical and 60.3% (n=226) were not aware of the causes of cancer cervical cancer; 
35.1% (n=132) were aware of risk factors for cervical cancer and 64.9% (n=244) were 
not aware of risk of cervical cancer; 33.3% (n=125) were aware of methods of cervical 
cancer prevention and 66.7% (n=250 ) were not aware of any methods of cervical 




(n=175) were not aware of cervical cancer screening; 42% (n=158)  aware of whether 
cervical cancer treatable or not and 58% (218) were not whether cervical cancer 
treatable or not; 27.2% (n=75) knew person with cervical cancer and 72.8% (n=301) 
didn‟t know any person with cervical cancer. 
 
Respondents’ knowledge of cervical cancer 
 
To assess the knowledge of the respondents on cervical cancer, the respondents were 
asked to identify the part of the body affected by cervical cancer; signs and symptoms 
of cervical cancer; transmission, prevention and stages of cervical cancer; screening 
frequency and interpretation of the results; risk factors for cervical cancer and treatment 
options. 
 
Regarding knowledge of the part of the body affected by cervical cancer, of the 
screened respondents, 92.3% (n=215) answered that the main part of body affected by 
cervical cancer is the cervix; 2.1% (n=5) answered the brain, and 5.6% (n=13) didn‟t 
know which parts of the body is affected by cervical cancer. Of the not screened 
respondents, 82% (n=283) answered that the main part of body affected by cervical 
cancer is the cervix, and 12.8% (n=44) answered the brain and 18 (5.2%) did not know 
which part of the body was affected by the disease. The result indicates higher number 
of screened respondents knew the part of the body affected by cervical cancer then not 
screened.  
 
Regarding their knowledge of the symptoms and signs of cervical cancer, the study 
found no significant difference between the screened and not screened respondents 
(Table 4.6).  
 
Regarding transmission of cervical cancer, 69.4% of screened respondents and 46.4% 
of not-screened women identified that cervical cancer can easily transmitted by sexual 
intercourse; 154 (44.6%) of not screened respondents do not know how cervical cancer 
is transmitted The study found highly significant difference between the screened and 
not screened respondents‟ knowledge of transmission with X2=48.7, p< 0.001 .The 
screened respondents found more knowledgeable than not screened respondents on 





Regarding how to prevent getting cervical cancer, as indicated Table 4.7, 53.2% 
(n=126) identified two and more of prevention methods listed while only 32.4% (n=112) 
of not screened respondents identified two and more of prevention methods listed. The 
screened respondents found more knowledgeable than not screened respondents on 
transmission ways of cervical cancer. Pearson chi squared found highly significant 
difference between the screened and not screened respondents‟ knowledge of 
transmission with X2=101.3, p< 0.001.  
 
Regarding the stage at which cervical cancer can be cured, 70.8% (n=165) of the 
screened respondents said early and 55.6% (n=192) of the not screened respondents 
said early that the stage of cervical cancer to be cure; while 12.1% (n=28) of screened 
respondents and 4.3% (n=15) not screened respondents said it cannot be cured. The 
study identified that screened respondents were found more knowledgeable to identify 
the stage in which the cervical cancer can be cured than not screened respondents 
(X2=53.7, p-value <0.001).  
 
Regarding treatment modality of cervical cancer, 20.1% (n=46) of the screened 
respondents and 15.7% (n=54) the not screened respondents said radiation; 15.7% 
(n=36) of screened respondents and 15.4% (n=53) said surgery said surgery; 17.9% 
(n=41) of screened respondents 10.1% (n=35) not screened respondents said 
chemotherapy;17% (n=39) of respondents and 20.9% (n=72) identified two or more of 
the above modalities as treatment options for cervical cancer. Pearson chi squared 
found highly significant difference between the screened and not screened respondents‟ 
knowledge (X2=17.1, p-value <0.01) 
 
Regarding the meaning of an abnormal cervical cancer screening result, 51% (n=121) 
of the screened respondents, and 27.8% (n=96) of the not screened respondents said 
precancerous cells; 30.1% of screened respondent and (n=70 23.1% of not screened 
respondents said cervical cancer; 11.6% (n=27) of screened respondents and  6.(n=21) 
said sexually transmitted infection, and 6.4% (n=15) of screened respondents and 
46.7% (n=161) not screened respondents did not know the abnormal cervical cancer 
screening result. The results indicated highly significant difference in their knowledge of 






Regarding their knowledge of the screening period, majority of 41.8% (n=97) of the 
screened respondents said every 5 years while 11% (n=38) of not screened 
respondents said every 5 years; 28% (n=65) of screened respondents and 15.7% 
(n=54) of not screened said every 2-3 years. On other hand 8.6% (n=20) of screened 
respondent and 41.1% (n=143) of not screened respondents said they did not know; the 
results indicated highly significant difference in their knowledge of the meaning between 
the screened and not screened respondents, with X2=107.1 p-value <0.001. 
 
Regarding the respondents‟ knowledge of risk factors for cervical cancer, of the 
screened respondents, 88% (n=2015) stated having multiple sexual partners was a risk 
factor for cervical cancer; 10.3% (n=24) said having multiple sexual partners was not a 
risk factor, and 1.7% (n=4) did not know. Of the not screened respondents, 72.2% 
(n=249) said having multiple sexual partners was a risk factor; 7% (n=24) said it was 
not, and 20.8% (n=72) did not know. The finding was more of similar with the study 
done in Uganda where (88.3%) of participants recognised cervical cancer risk factors 
including multiple male sexual partners (Mwaka et al 2016:862). 
 
Of the screened respondents 79% (n=184) said having sexual intercourse at an early 
age was a risk factor; 13.3% (n=31) said it was not, and 7.7% (n=18) did not know. Of 
the not screened respondents, 84.5% (n=197) said it was a risk factor; 14.2% (n=49) 
said it was not, and 28.7% (n=99) did not know. The screened women tend to be more 
identified the risk of sexual intercourse at an early age than not screened. Study done in 
Kenya supports this finding (Mungai et al 2016:88). where being sexually active from a 
young age, identified by majority of respondent to be risks for acquiring cervical cancer. 
 
Of the screened respondents, 62.7% (n=146) said smoking cigarettes was a risk factor; 
23.2% (n=54) said it was not, and 14.1% (n=33) did not know; of the not screened 
respondents, 49% (n=169) said it was a risk factor; 20.9% (n=72) said it was not, and 
30.1% (n=104) did not know.  
 
Of the screened respondents, 43.8% (n=102) said use of contraceptives was a risk 
factor; 35.6% (n=83) said it was not, and 20.6% (n=48) did not know. Of the not 
screened respondents, 27.5% (n=64) said use of contraceptives was a risk factor; 
79.4% (n=164) said it was not, and 50.2% (n=117) did not know. Table 4.9 indicates the 




the use of contraceptives as one of risk factor for development of cervical cancer 
documents of WHO identified that long time use of contraceptives increases the risk of 
cervical cancer as indicated (WHO 2014a:40). 
 
Knowing about risk factors for cervical cancer helps women to focus on those that could 
be changed. Regarding knowledge of risk factors for acquiring cervical cancer stated on 
the above statements, the finding indicated that majority of the screened respondent 
identified the risk factors for cervical cancer more of than not screened respondents.  
 
By assessing the responses of each knowledge questions about cervical cancer the 
researcher graded the knowledge of women as poor or moderately good, the 
researcher graded the knowledge of respondents as good knowledge level for score of 
80-100%, Moderate knowledge level for score of 60-79% and Poor knowledge level for 
score less than 60%. Of the screened respondents 54.1% (n=126) have Good to 
moderately knowledge level about cervical cancer only 25.3% (n=95) of not-screened 
respondents have Good and moderately knowledge level about cervical cancer. On 
other hand 25.3% (n=95) of screened respondents and 74.7% (n=281) of not screened 
respondents have poor knowledge level about cervical cancer. The study found a 
significant gap between the screened and not-screened respondents‟ knowledge of 
cervical cancer (chi-value=51.649, p-value<0.001). This indicates having good 
knowledge of cervical cancer tends the respondent to be screen. Study done in Nigeria 
identified that Inadequate knowledge about cervical cancer was responsible for no 
uptake of cervical cancer screening among Nigerian women in a qualitative study in 
which none out of 82 of the participants ever screened (Nwobodo & Ba-Break 2015:16). 
 
 Perceived susceptibility to cervical cancer 
 
The respondents‟ perception of their susceptibility to cervical cancer was assessed 
using a 5-point Likert scale and 8 statements. The findings between the screened and 
not-screened respondents on their susceptibility were compared, using independent 
sample t-tests (Table 4.19). 
 
The screened respondents (M=3.21) were relatively more worried about getting cervical 
cancer than the not screened respondents (M=2.80). The t-test result with t=3.42 and p-




susceptibility. The screened respondents (M=3.36) were relatively more worried about 
getting HPV compared to the not screened respondents (M=3.06). The t-test result (t-
value=3.432, p-value=0.001) indicated a significant difference. The screened 
respondents‟ ability to avoid cervical cancer was rated M=3.75 compared to the not 
screened respondents‟ rating of M=3.41. The screened respondents‟ ability to avoid 
HPV infection was rated M=3.64 compared to the not screened respondents‟ rating of 
M=3.43.  
 
In this study the screened respondents rated more on statements related to perceived 
susceptibility, so screened respondents found more susceptible than not screened 
respondents. In Mekelle Zone, Northern Ethiopia, Bayu et al (2015:2) reported that 
perceived susceptibility to cervical cancer was a significant predictor of cervical cancer 
screening service uptake. In the study done by Gebru et al (2016:297) at Arba Minch 
town, Southern Ethiopia, it was found that a high perceived susceptibility prompted 
utilisation of cervical carcinoma screening service.  
 
 Perceived seriousness of cervical cancer  
 
Tavafian (2012:4) described perceived severity as the severity of a health problem 
which is assessed by the individual and the feeling about the seriousness of contracting 
an illness or of leaving it untreated. If women think that cervical cancer is a sever 
disease and believe that getting cervical cancer would have serious medical, social and 
economic consequences for them; it is more likely to obtain cervical cancer screening 
test. 
 
As shown on Table 4.12, 48.3% (n=112) of screened respondents said „true‟ and 42.7% 
(n=99) said „false‟ for „There is very little that one can do about cervical cancer‟ while 
28.9% (n=108) not screened respondent said „true‟ and 41.4% (n=155) said „false‟ for 
„There is very little that one can do about cervical cancer; 72.8% (n=169) of screened 
respondents said „true‟ and 21.1% (n=49) said false for „I would rather screen for 
cervical cancer‟. 59.2% (n=221) of not screened said „true‟ and 23.6% (n=88) said „false‟ 
for „I would rather screen for cervical cancer‟. 
 
Of screened respondents 42.3% (n=99) said „true‟ and 33% (n=77) said „false‟ for „Loss 




not screened respondent said „true‟ and 29.1% (n=100) said „false‟ for „Loss of cervix or 
uterus through surgery would affect my sexuality‟; 69% (n=162) of screened 
respondents said „true‟ and 26.2% (n=61) said „false‟ for „among the diseases I can 
imagine getting cervical cancer is among the most serious‟. While 59.3% (n=203) of not 
screened respondent said „true‟ and 21.1% (n=72) said false for „Among the diseases I 
can imagine getting cervical cancer is among the most serious‟; 65.5% (n=150) of 
screened respondents said „true‟ and 27.1% (n=62) said „false‟ for „Cervical cancer is a 
life-threatening disease‟. While 62.4% (n=213) of not screened respondents said „true‟ 
and 19.4% (n=66) said „false‟ for „Cervical cancer is a life-threatening disease‟; 63.5% 
(n=148) said „true‟ and 25.8% (n=60) said „false‟ for „Cervical cancer would threaten my 
relationship with my husband/partner‟. While 62.5% (n=215) of not screened said „true‟ 
and 15.4% (n=53) said „false‟ for „Cervical cancer would threaten my relationship with 
my husband/partner‟. In this study the above statements indicated that higher screened 
respondents perceived seriousness of cervical cancer which indicates screened women 
obtained screening test as a result of their perceived seriousness/severity. 
 
According to Glanz and Rimer (2008:45) individuals who perceive a given health 
problem as serious are more likely to engage in behaviours to prevent the health 
problem (2008:45). Similarly, 70.3% (n=163) of screened respondents said „true‟ and 
18.9% (n=44) said „false‟ for „Early detection can increase survival chances‟. While 
57.6% (n=198) of not screened said „true‟ and 18.3% (n=63) said „false‟ for „Early 
detection can increase survival chances‟.  
 
Of screened respondents 19% (n=44) said „true‟ and 60.6% (n=140) said „false‟ for „All 
women who develop cervical cancer must have their uteruses removed‟. 23% (n=79) of 
not screened said „true‟ and 40.1% (n=138) said „false‟ for „All women who develop 
cervical cancer must have their uteruses removed‟; 37.3% (n=87) said „true‟ and 35.6% 
(n=83) said „false‟ for „Most women who develop cervical cancer will die from it‟. While 
36.6% (n=126) of not screened said „true‟ and 25.9% (n=89) said „false‟ for „Most 
women who develop cervical cancer will die from it‟. 45.1% (n=105) said „true‟ and 
42.5% (n=99%) said „false‟ for „my whole life would change if I had cervical cancer‟. 
While 42.6% (n=146) of not screened respondents said „true‟ and 32.6% (n=112) said 
„false‟ for „My whole life would change if I had cervical cancer‟. Similar finding reported 




Gebru et al (2016:3) found that the participants‟ perceived seriousness of cervical 
cancer encouraged screening practice. 
 
 Perceived benefits of cervical cancer screening 
 
Perceived benefit refers to one‟s opinion of the efficacy of the advised action to reduce 
risk or seriousness or impact (Day et al 2010b:7). According to Glanz et al (2015:47), 
even if a person perceives personal susceptibility to a serious health condition, whether 
this perception leads to behavior change will be influenced by the person‟s belief 
regarding the perceived benefits of the various available actions for reducing the 
disease treat. 
 
In this study 91% (n=212) of the screened respondents, said „yes‟ and 3.4% (n=8) said 
„no‟ to the statement „Cervical cancer can be diagnosed at an early stage‟ and 5.6% 
(n=13) did not know; of the not screened respondents, 73% (n=251) said „yes‟ ,8.7% 
(n=30) said „no‟ and 18.3% (n=63) did not know to „cervical cancer can be diagnosed at 
an early stage‟; 83.2% (n=193) of the screened respondents said „yes‟ and 12.5% 
(n=29) said „no‟ and 4.3% (n=10) did not know to „cervical cancer screening would save 
lives if detected at an early stage‟; 64.2% (n=221) of not screened said „yes‟, 15.7% 
(n=54) said „no‟ and 20.1% (n=69) did not know to „cervical cancer screening would 
save life if detected at an early stage‟, 86.6% (n=201) of the screened respondents said 
„yes‟ and6.9% (n=16) said „no‟ and 6.5% (n=15) did not know to „cervical cancer is often 
curable with early detection and proper medical treatment‟; 66.9% (n=230) of the not 
screened said „yes‟ and 9% (n=31) said „no‟ and 24.1% (n=83) did not know to „cervical 
cancer is often curable with early detection and proper medical treatment‟.;85.8% 
(n=199) of the screened respondents said „yes‟ and 10.3% (n=24) said „no‟ to „regular 
cervical cancer screening decreases the risk of cervical cancer‟, and 3.9% (n=9) did not 
know. 64.4% (n=221) of not the screened respondents said „yes‟ and 10.8% (n=37) said 
„no‟ and 24.8% (n=85) did not know to „regular cervical cancer screening decreases the 
risk of cancer‟. 
 
This study indicated that relatively higher number (86.6%) of screened respondents 
perceived the benefit of cervical cancer screening while 67.1% not screened 
respondents perceived the benefit of cervical cancer. The findings indicated screened 




screened respondents. Hence the finding of this study was supported by the theory of 
Health belief model theory; Health-related behaviours are influenced by the perceived 
benefits of taking action (Glanz & Rimer 2008:45). In Nigeria Nwobodo and Ba-Break 
described (2015:16) described their findings women who believed that cervical cancer is 
preventable via screening were more likely to uptake screening. The findings of this 
study were found higher when compared to the study finding in Fasa, Iran where 73% of 
women obtained perceived benefits (Mehraban, Namdar & Naghizadeh 2018:2157). 
 
 Perceived barriers to cervical cancer screening 
 
Perceived barriers refer to individuals‟ evaluation of the difficulties to behaviour 
modification (Glanz & Rimer 2008:48). Perceived barriers refer to the cost of taking 
action and individuals must believe the cost is outweighed by the benefits (Tavafian 
2010:6). Thus, the joint action of susceptibility and severity offer the energy of power to 
take action and the perception of benefits gives an extended path of action (Glanz & 
Rimer 2008:45). 
 
In this study, regarding perceived barriers to cervical cancer screening, 51.9% (n=120) 
of the screened respondents said „true‟ and 45.5% (n=105) said „false‟ to “I don‟t want to 
be seen in a cervical cancer screening clinic by my friends” and 6(2.6%) did not know.. 
while 48.8% (n=167) of not screened respondents said „true‟ and 127% (n=36.9) said 
„false‟ to “I don‟t want to be seen in a cervical cancer screening clinic by my friends”, 
and 14.5% (n=50) did not know; 33.1% (n=56) of screened respondents said „true‟ and 
88% (n=52.1) said „false‟ to “Cervical cancer screening test is humiliating”, and 14.8% 
(n=25) did not know.  While 28.8% (n=69) of not screened respondents said „true‟ and 
43.3% (n=104) said „false‟ ‟to “Cervical cancer screening test is humiliating”.  19.7% 
(n=46) said „true‟ and 75.1% (n=175) said „false‟ to “I have no time for doing a test”, and 
5.2% (n=12) did not know; whereas 16.4% (n=56) of not screened respondents said 
„true‟ and 66% (n=225) said „false‟‟ to “I have no time for doing a test”, and 5.2% (n=12).  
 
Similarly, 19.9% (n=46) said „true‟ and 74% (n=171) said „false‟ to “I am not aware of 
any test”, and 6.1% (n=14) did not know. Whereas 50.4% (n=172) of not screened 
respondents said „true‟ and 27.3% (n=93) said „false‟‟ to “I am not aware of any test”, 
and 22.3% (n=76) did not know; 22.8% (n=53) of screened respondents said „true‟ and 




not know. Whereas 34.4% (n=117) of not screened respondents said „true‟ and 48.2% 
(n=164) said „false‟‟ to “I do not know where the test is done”, and 17.4% (n=59) did not 
know; 36.8% (n=85) of screened respondents said „true‟ and 56.7% (n=131) said „false‟ 
to “I don‟t know how much cost required”, and 6.5% (n=15) did not know. Whereas 
50.4% (n=172) of not screened respondents said „true‟ and 27.3% (n=93) said „false‟‟ to 
“I don‟t know how much it costs”, and 22.3% (n=76) “Don‟t know how much cost 
requested”  18.9% (n=44) of screened respondents said „true‟ and 76.8% (n=179) said 
„false‟ to “I am still too young for the test”, and 4.3% (n=10) did not know. While 18.5% 
(n=63) said „true‟ and 68.6% (n=234) said „false‟‟ to “I am still too young for the test”, 
and 12.9% (n=44) did not know. 22.1% (n=51) of screened respondents said „true‟ and 
70.1% (n=162) said „false‟ to “My partner is uncomfortable about my having the test and 
7.8% (n=18) did not know, while 15.6% (n=53) of not screened respondents said „true‟ 
and 69.1% (n=235) said „false‟‟ to “My partner is uncomfortable about my having 
cervical cancer screening test”, and 15.3% (n=52) did not know. 
 
Of screened respondents 31.9% (n=74) said „true‟ and 64.7% (n=150) said „false‟ to 
“Cervical cancer testing is painful and unpleasant” and 3.4% (n=8) did not know while 
31.8% (n=182) said „true‟ and 47.8% (n=274) said „false‟‟ to “Cervical cancer screening 
test is painful and unpleasant” and 20.4% (n=117). 14.6% (n=34) of screened 
respondents said „true‟ and 80.3% (n=187) said „false‟ to “I don‟t have a risk of 
developing cervical cancer, therefore I don‟t want to be screened”, and 5.2% (n=12) did 
not know while 17.4% (n=59) of not screened respondents said „true‟ and 65.8% 
(n=223) said „false‟ to “I don‟t have a risk of getting cervical cancer, therefore I don‟t 
want to be screened”, and 16.8% (n=57) did not know.   
 
In this study the extent of barrier felt by screened and not-screened women were not 
significantly differ except lack of knowledge about the screening, place where to perform 
the test, and the price of the test are somehow more to not-screened women which 
prevent them from cervical cancer screening. Cervical cancer screening programme 
with VIA is free of charge in Ethiopia at public health centres. However, lack of 
knowledge where to get the test and how much the test costs found to be a barrier 50% 
of not-screened respondents. This indicated that lack of awareness had hindered not-
screened women to the test of cervical cancer screening. The finding of the study is 
supported by a systematic review of 31 studies done by Devarapalli, Labani, Nagarjuna, 




cancer screening in Tamil Nadu, lack of awareness was one of the key barrier to access 
screening service. (Jayaraman, Khichi, Singh, Goel, Roy & Goyal 2016:768). Similarly 
lack of knowledge about cervical cancer and where screening services are offered, fear 
of pain, unpleasant side effects and positive result, were identified to impede cervical 
cancer screening uptake in Nigeria (Nwobodo and Ba-Break 2015:16).  
 
In this study 31.8% of respondents reported that cervical cancer screening test 
procedure found painful and unpleasant. However, this finding was also presented in 
qualitative study done by Armstrong, James and Dixon-Woods (2012:464) where most 
participants reported embarrassment and discomfort (sometimes severe) in exposing 
personal part of their body to the practitioner conducting the procedure, and felt the 
cervical screening procedure involved as painful, uncomfortable and personally 
threatening. 
 
 Cues to action  
 
The HBM holds that a cue or trigger is necessary for timely involvement in health-
promoting behaviours. Readiness to action (perceived susceptibility and perceived 
benefits) is prompted by other factors or cues to initiate action (Glanz & Rimer 2008:49). 
 
In this study 346 (55.9%) of women had obtained information on cervical cancer 
screening through health care providers which is concurrent to other study done in 
Eastern Ethiopia where the health institution mentioned as the main source of 
information (51.1%) for cervical cancer by the respondents (Muhye, Assefa, Mohammed 
& Dessie 2017:24) followed by media 31.3%. Regarding preferable choice of obtaining 
information about cervical cancer, 38.1% (n=229) of respondents reported that the 
preferred and best method of providing information about cervical cancer and screening 
to be health care providers, which is similar finding on study done by Nattembo (2018:3) 
where most the respondent intended to access cervical cancer information from a 
health professional based on the idea that they more knowledgeable and informed 
about cervical cancer issues. The second option was combination of media and health 
care provider 26.7% (n=175), followed by television 17.6% (n=107) and community 







This chapter discussed the quantitative data analysis and findings of the study. Chapter 










Chapter 4 discussed the quantitative data analysis and findings. This chapter presents 
the research findings on the in-depth interview conducted with health care providers on 
the experiences and views on cervical cancer service utilisation. The biographical data 
the health care workers are presented first. The emerged themes and categories are 
presented subsequently. 
 
5.2 DATA MANAGEMENT AND ANALYSIS 
 
To understand the research question, the study follows scientific research methods. In 
the process of data collection interview and discussion were successfully employed. At 
the beginning of the interview conducted the interviewer introduced the research topic, 
objective along with the contents of the informed consent document 
 
The process of data collection scheduled was key informant interviews with health care 
professionals working at maternal health service units in the health centers. All 
participants completed a consent form before the interview and the discussions takes 
place face to face using interview guid questionnaire and all the ethical process were 
followed, including introducing the objective of the study, grantee of anonymity and 
confidentiality (see Annexure H). 
 
The researcher used a convergent mixed methods approach to collect quantitative and 
qualitative data (Creswell 2014:43). Quantitative data was collected from clients 
attending mathernal health services and qualitative data from health care providers 
(Creswell & Creswell 2018:44). The researcher incorporated both sets of data into the 
interpretation of the overall results. The quantitative data was statistically analysed to 
establish clear predictors, and then triangulated with the qualitative data to be used in 




improve utilisation of cervical cancer screening based on the quantitative and qualitative 
findings.  
 
5.3 RESPONDENTS’ BIOGRAPHICAL PROFILE  
  
Table 5.1 Participants’ biographical profile 
 
No  Health Centre  Sex  Age  
Professional and 
educational level   
Years of 
service 
Position in the health 
centre 
1 
Kotebe  M  37 Health Officer, BSc 10 years 
FP provider + pre-cancer 
service provider 
2 
Kotebe  M  33 Health Officer, BSc 10 years 
FP provider and OR 
assistance  
3 Kotebe  F 30 Midwife, BSC  7 years  ANC and delivery service  
4 
Yeka woreda1  F 32 Midwife, BSc 5 years  
FP provider + pre-cancer 
service provider 
5 Yeka woreda1 F 28 Nurse, BSc 5 years ANC provider 
6 
Yeka woreda1 M 34 Nurse, BSc 7 years  
Delivery service + pre-
cancer service provider 
7 
Semen  F 34 Midwife, BSc  10 years  
Delivery and postnatal 
service provider 
8 
Semen  F 38 Nurse, BSc  10 years 
Pre-cancer service 
provider  
9 Semen  M 35 Nurse, BSc  10 years FP provider  
10 Woreda 9  F 37 Health Officer, BSc 10years FP coordinator 
11 Woreda 9  F  30 Nurse, BSc 7 years ANC coordinator 
12 
Woreda 9  M 32 Nurse, BSc  12 years  
FP + pre-cancer service 
provider  
13 Kolfe keranyo  F  33 Nurse, BSc  7 years  ANC provider  
14 
Kolfe keranyo F  30 Midwife, BSc 7 years  
Delivery and postnatal 
service provider 
15 
Kolfe keranyo  M 27 Midwife, BSc  5 years  
FP + pre-cancer service 
provider  
16 
Arada HC M 27 Midwife, BSc  5 years 
Midwifery, ANC, Abortion 
Care Unit  
17 Arada HC F 34 Nurse, BSc  12 years 
FP, pre-cancer service 
provider  
18 Arada HC F 30 Nurse, BSc  7 years  ANC coordinator  
 
Table 5.1 presents the respondents‟ biographical profile. The qualitative data was 
collected from 18 health professionals at the 6 selected health centres; that is, three 
respondents at each health centre. The participants consisted of health officers, 
midwives and nurses. Most of the respondents worked in the cervical cancer screening 
service delivery rooms on rotation. The respondents‟ biographical profile consisted of 






Of the participants, thirty-nine per cent (n=7) were males and 51% (n=11) were females. 
Regarding their profession, 16.7% (n=3) were health officers; 33.3% (n=6) were 
midwives, and 50% (n=9) were nurses. 
 
Regarding age of respondents, 16.7% (n=3) were 27-28 years old and 83.3% (n=15) 
were 30-38 years old. 
 
Regarding year of experience, 22.2% (n=4) had 5 years‟ experience; 33.3% (n=4) had 7 
years‟ experience; 33.3% (n=4) had 10 years‟ experience, and 11.1% (n=2) had 12 
years‟ experience.  
 
5.4 QUALITATIVE FINDINGS  
 
The researcher used the ten questions from the interview questionnaire as the themes 
and developed the sub-themes from the respondents‟ answers.  
 
Table 5.2 Themes and sub-themes  
 
Themes  Sub-themes  
1 Involvement in cervical cancer screening 
provision  
1.1 Assignment on rotation 
1.2 Involvement in/assignment to other 
services  
2 Health centre‟s available strategies/activities 
to prevent cervical cancer 
2.1 Availability of separate unit for the service 
2.2 Availability of trained health provider 
2.3 Presence of campaign session  
2.4 Presence of regular awareness and 
educational activities  
3 Women‟s response to having cervical cancer 
screening 
3.1 Accepting information offered   
4 Women‟s knowledge of the advantage of 
cervical cancer screening test 
4.1 Poor knowledge of cervical cancer 
screening  
4.2 Information bias/misinformation on cervical 
cancer screening 
5 Opinion about the perception of women of 
cervical cancer screening test? 
5.1 Perception of advantage /benefit of 
screening 
5.2 Perception of seriousness/risk of cervical 
cancer   
6 Women‟s reasons given to have cervical 
cancer screening 
6.1 Women‟s educational background  
6.2 Counselling service  
7 Women‟s reasons given not to have cervical 
cancer screening 
7.1 Low-level of knowledge about cervical 
cancer screening 
7.2 Fear of the procedure 
7.3 Permission from their spouses   
7.4 Fear of the results  
8 Challenges in cervical cancer screening 
service in the health centre 
8.1 Inadequate awareness and health 
education activities 




Themes  Sub-themes  
8.3 Lack of responsible person assigned to the 
service 
8.4 Health professionals‟ lack of commitment  
9 Suggestions to address the challenges 9.1 Assignment of responsible health provider 
and supply  
9.2 Appropriate work plan and data 
management 
9.3 Strengthening awareness and education 
activity 
9.4 Capacitating the health professional 
10 Suggestions to increase cervical cancer 
screening uptake 
10.1 Enhancing community awareness 
10.2 Strengthening of cervical cancer screening 
service 
10.3 Prompt action research to investigate 
existing problems 
 
Table 5.2 lists the themes and sub-themes.  The findings are discussed according to the 
themes and sub-themes. 
 
5.4.1 Theme 1: Involvement in cervical cancer screening provision  
 
This theme indicated the respondents‟ involvement in cervical cancer screening 
provision. The sub-themes were assignment on rotation, and involvement in/assignment 
to other services. 
 
5.4.1.1 Sub-theme 1.1 Assignment on rotation 
 
Some of the respondents were assigned to cervical cancer screening service, and 
worked in the pre-cancer screening service provision room; some had VIA training and 
were assigned to cervical cancer screening. Some respondents did patient counselling 
and did cervical cancer testing when on rotation. The respondents were not 
permanently assigned, but were assigned to other units and worked on rotation 
because of the shortage of health workers. According to respondents, 
 
I have been trained to and work in pre-cancer service provision room. (Participant 
8) 
 
I took the VIA training and I was assigned in cervical cancer screening service 





I have taken the training therefore I can do it, and I am counselling women who 
come for family planning service and I send them to the screening unit for the 
screening test. I am also assigned to the pre-cancer service provision room on 
rotation. (Participant 6)  
 
I have taken training therefore I can do it, and I am working on counselling and 
testing and provide the test for those interested to be tested, when I am assigned 
in the cervical cancer provision room during my rotation. (Participant 7) 
 
5.4.1.2 Sub-theme 1.2: Involvement in/assignment to other services 
 
Some of the respondents provided counselling and cervical cancer screening after FP 
service. According to a respondent, 
 
I have taken the training and I am working in the area, after provision of FP 
service and counselling for cervical cancer screening. If the women agree, I take 
the test. (Participant 2)  
 
In order to achieve successful cervical cancer screening provision and promote uptake, 
it is important that a qualified person should be responsible for the service. This would 
facilitate early detection and treatment service provision at the health centres. The 
respondents indicated that they were not permanently assigned, but worked on rotation 
because of staff shortages. 
 
In their study on the barriers to the delivery of cervical cancer screening and early 
treatment services in Malawi, Munthali, Ngwira and Taulo (2015:505) found that the 
health care providers who did the screening also provided antenatal and family planning 
services due to the shortage of staff.  
 
5.4.2 Theme 2: Available strategies/activities in the health centre for the 
prevention of cervical cancer 
 
Cervical cancer screening is the main strategy to prevent cervical cancer. In the 
selected health centres, the available strategies/activities for the prevention of cervical 
cancer were the availability of a separate unit for the service; availability of trained staff; 





5.4.2.1 Sub-theme 2.1: Availability of separate unit for the service 
 
Concerning the availability of separate unit for the service, the respondents indicated 
that there was a specific room for cervical cancer screening provision. According to 
respondents, 
 
In our health centre there is one separate room for this programme, as strategy 
counselling should be given in all rooms of OPD and MCH clinics where clients 
visit. (Participant 4) 
 
There is one separate room for the service and trained health workers were 
assigned for service provision. (Participant 13) 
 
5.4.2.2 Sub-theme 2.2: Availability of trained health staff 
 
The availability of trained staff was a strategy to promote cervical cancer prevention by 
screening provision. According to respondents,  
 
Trained health workers are assigned for service provision. (Participant 13) 
 
In our health centre, there is one separate room for this service, with a health 
officer and one nurse assigned regularly. (Participant 6) 
 
5.4.2.3 Sub-theme 2.3: Campaign sessions 
 
The respondents stated that campaign sessions to raise awareness of cervical cancer 
screening were provided as a strategy in their health centres. According to one 
respondent, 
 
Community awareness is given in campaign sessions. (Participant 12) 
 
5.4.2.4 Sub-theme 2.4: Regular awareness creation and education activities 
 
The respondents stated that regular awareness and educational activities were another 





Education is given in regular health education programmes. In addition, 
awareness creation activities are done in all service delivery rooms. (Participant 
7) 
 
In our health centre as strategy, awareness about the service is given in all 
rooms of OPD and MCH clinics where the clients visit, then the women were 
referred to the pre-cancer service provision unit. In addition, health education is 
also given at OPD level in the regular health education programme to all clients. 
(Participant 5) 
 
Some respondents stated that the awareness activities were not always strong or 
provided regularly. According to respondents, 
 
Even though it is not strong, sometimes awareness would be given related to the 
service in all units where the women get health service. (Participant 15) 
 
But I don‟t think, practically, the awareness creation activities are done properly.  
(Participant 1) 
 
5.4.3 Theme 3:  Women’s responses to having cervical cancer screening  
 
Theme 3 was women‟s response to having cervical cancer screening. The sub-theme 
was accepting information offer regarding cervical cancer screening test.  
 
5.4.3.1 Sub-theme 3.1: Accepting information offered  
 
The respondents stated that women generally appreciated the information offered on 
the advantage of screening. According to respondents, 
 
They have good response, if we give good counselling they accept. Nowadays 
the number of women who came the screening was increasing. (Participant 12)  
 
Most of the time the women would be counselled in all units, then they would 





I am working in the maternity delivery room. As far as the women I counselled 
understood and agreed to the screening programme, they promised me that they 
would return after delivery. (Participant 14) 
 
When we give good counselling, their response is good. Some of them accept 
the counselling and say okay, they want to think over it. (Participant 16)  
 
However, one respondent stated that many women seemed to agree but did not want to 
screen: 
 
Most women did not say no, if they were counselled properly, but there were 
women who did not practise it. They left and went away. Some women also 
rejected [screening] totally. (Participant 1) 
 
5.4.4 Theme 4: Women’s knowledge of advantage of cervical cancer screening  
 
Theme 4 was women‟s knowledge of the advantage of cervical cancer screening. The 
sub-themes were poor knowledge of cervical cancer screening, and information 
bias/misinformation on cervical cancer screening.  
 
5.4.4.1 Sub-theme 4.1: Poor knowledge of cervical cancer screening  
 
The respondents indicated that most women had a low level of knowledge of cervical 
cancer screening; many women had poor knowledge of the advantage of the screening 
test as preventing cervical cancer, and some women needed to talk to their husbands 
first. According to respondents, 
 
Most of them have low knowledge about the disease, cause, transmission, 
prevention and screening. (Participant 9) 
 
I can say that most of the women have low level of knowledge or they did not 
know about cervical cancer screening as preventive for cervical cancer. 
(Participant 11) 
 
I can say that most women had poor knowledge of the disease and about the 





Poor level of knowledge about screening; some also need consultation with their 
husbands. (Participant 15)  
 
A study in Nigeria found that inadequate knowledge about cervical cancer was one of 
the determinants of low cervical cancer screening uptake (Nwobodo & Ba-Break 
2015:16).  
 
5.4.4.2 Sub-theme 4.2: Information bias/misinformation on cervical cancer 
screening 
 
The respondents referred to women with poor knowledge of causes, risk factors, 
prevention and screening, and women with a lack of correct information or with 
misinformation about cervical cancer screening and thus did not perceive that they were 
at risk. According to a respondent, 
 
Most women have heard about cervical cancer and service, but they do not have 
correct information about the screening. They have misinformation from somewhere, 
and when we tried to tell them, they tried to accept but still need repeated awareness 
creation programmes. (Participant 5) 
 
5.4.5 Theme 5: Women’s perception of cervical cancer screening  
 
Theme 5 was women‟s perception of cervical cancer screening test. The sub-themes 
were perception of advantage/benefit of screening, and perception of seriousness of 
cervical cancer. 
 
5.4.5.1 Sub-theme 5.1: Perception of advantage/benefit of screening 
 
The respondents stated that the majority of women had little perception of the 
advantage or benefit of cervical cancer screening. According to respondents, 
 





The majority do not have good knowledge; the gap is not in their perception or 
attitude but in the knowledge. So, if a woman did not have adequate knowledge, 
she could not consider the screening test important. (Participant 16) 
 
Since most of the women have a knowledge gap, they also have a poor 
perception of the advantage of the screening test. Some also did not perceive 
that they could get the disease. They perceived the disease as something that 
came from God. (Participant 10) 
 
The respondents also indicated that women with higher educational levels and 
screened women showed a good perception of the advantage of cervical cancer 
screening. According to respondents, 
 
Some women, especially with a higher level of education, have a good 
knowledge of the advantage of this screening test and perceived the advantage 
of screening. (Participant 14) 
 
Of course, some women who had been screened understood and had a good 
perception that the problem is serious and considered themselves at risk. That is 
why they screened. (Participant 17) 
 
5.4.5.2 Sub-theme 5.2: Perception of seriousness/risk of cervical cancer 
 
The respondents indicated that some women did not perceive that cervical cancer is 
serious and so thought they were not at risk. According to respondents, 
 
They did not know that they could have a risk of having the disease therefore 
they did not take it as a serious problem to them, and did not perceive as it as a 
risk. (Participant 10) 
 
They think that the problem may not affect them, and do not perceive that they 
are at risk or that it is serious. (Participant 8) 
 
To me, there is a wide knowledge gap. They perceived that they might not be 





Most women did not have enough knowledge. They thought that they might not 
be affected by the disease, so they did not take the risk as serious. (Participant 7) 
 
As I said, most of them did not know about the advantage of screening, therefore, 
they did not perceive that they were at risk. (Participant 3) 
 
In their study among married women in Arba Minch Town, Southern Ethiopia, Gebru et 
al (2016:3) found that the participants‟ perceived seriousness of cervical cancer 
encouraged screening practice. 
 
5.4.6 Theme 6: Women’s reasons to have cervical cancer screening  
 
Theme 6 was reasons given by women to have cervical cancer screening. The sub-
themes were women‟s educational background, and counselling.  
 
5.4.6.1 Sub-theme 6.1: Women’s educational background  
 
The respondents indicated that women‟s educational background was a reason for 
them to have cervical cancer screening. Educated women were aware of the disease 
and screening. According to respondents, 
 
Women who have good knowledge about the problem and about the advantage 
of the screening were screened for cervical cancer, especially educated women 
can easily understand. (Participant 17) 
 
Educated women were also [the ones] who agreed to be screened because they 
get better information from school, from reading or the internet. (Participant 8)   
 
Some of them knew about the disease, especially those who were educated. 
They told me that they had read, or heard about the disease from media. 
(Participant 7) 
 
5.4.6.2 Sub-theme 6.2: Counselling service 
 
The respondents stated that the strength of counselling provided to the women was one 





It depends on the strength of the counselling. If they get adequate counselling 
and education, they will have cervical cancer screening. (Participant 2)  
 
If a woman has adequate and appropriate counselling and information on the 
disease, prevention and advantage of the screening, she could have screening. 
(Participant 3) 
 
5.4.7 Theme 7: Women’s reasons not to have cervical screening  
 
Theme 7 was reasons given by women not to have cervical screening. The sub-themes 
were low level of knowledge about cervical cancer screening; fear of the procedure; 
permission from their spouses, and fear of the results. 
 
5.4.7.1 Sub-theme 7.1: Low level of knowledge about cervical cancer screening  
 
The respondents stated that a low level of knowledge about cervical cancer screening 
was one of the reasons for women not to be screened.  According to respondents, 
 
I think women who did not have enough knowledge about cervical cancer were 
not screened. (Participant 8) 
 
I think the reason not to have screening is because they did not have adequate 
information about the advantage of the screening test. There is a knowledge gap. 
(Participants 1, 4) 
 
Low level of knowledge is the reason not to be screened. (Participant 10) 
 
Women with a poor level of knowledge or incorrect knowledge about the 
advantage of the screening did not want to screen. (Participant 14) 
 
5.4.7.2 Sub-theme 7.2: Fear of the procedure 
 
The respondents stated that fear of the procedure was another reason that some 





Some women are afraid the procedure. (Participant 6) 
 
Some women are afraid of the procedure; some are afraid to be seen by 
speculum, they perceive that it has discomfort. (Participant 7) 
 
Poor knowledge and fear of the procedure would be some women‟s reason not to 
be screened. (Participant 12) 
 
Also some women have a fear of the procedure. (Participant 17) 
 
Low level of awareness and fear of the procedure was the reason not to screen. 
(Participant 18) 
 
A study in Kenya on the challenges of cervical cancer screening found that many 
participants were not aware of the importance of screening; thought it would be painful, 
and were afraid of the screening results (Kei, M‟Ndegwa, Ndwiga & Masika 2016:293).  
 
5.4.7.3 Sub-theme 7.3: Permission from their spouse 
 
The respondents indicated that permission from their spouse was another reason for 
some women not to be screened. Some respondents stated that women said they 
needed to have permission from their husband or families for the screening. According 
to respondents, 
 
Some of them also want permission from their spouse. (Participant 4) 
 
When you counsel them, some women need consultation of their husbands. 
(Participant 13) 
 
Some of them want to talk to somebody from the family. (Participant 5) 
 
In Malawi, Munthali et al (2015:505) found that some women opted to go home first 





5.4.7.4 Sub-theme 7.4: Fear of the results 
 
The respondents stated that fear of the results was another reason for some women not 
to be screened. According to a respondent, 
 
The reason for women not to have cervical cancer screening is that most of them 
fear the procedure. Some women are afraid of the result; that if the result 
indicates there is cancer they don‟t want to hear it, so they don‟t want to be 
screened or they leave without hearing.  (Participant 9) 
 
5.4.8 Theme 8: Challenges in cervical cancer screening service in the health 
centres 
 
Theme 8 was the challenges in cervical cancer screening in the respondents‟ health 
centres. The sub-themes were inadequate awareness and health education activities; 
shortage of trained health professionals; lack of responsible person assigned to the 
service, and health professionals‟ lack of commitment. 
 
5.4.8.1 Sub-theme 8.1: Inadequate awareness and health education activities  
 
The respondents indicated that inadequate awareness and health education activities 
were one of the challenges in their health centres. The respondents maintained that 
even though awareness creation and education programmes were given in the health 
centres, the programmes were irregular, inadequate and not well organised, and 
counselling in maternal health services was weak. According to respondents, 
 
The great challenge is the information gap; the awareness creation activity is not 
strong. (Participant 7) 
 
In our health centre, the main challenge in cervical cancer screening service is 
that there is no strong awareness creation activity. We planned activities, but they 
were not practically applied. (Participant 5)  
 
In our health centre, the main challenge concerning cervical cancer screening 





The awareness creation activity is not well organised, and is not as strong as 
expected. In general, it is not given attention; it did not take as daily activities or 
responsibility of every health personnel member. (Participant 17) 
 
5.4.8.2 Sub-theme 8.2: Shortage of trained health professionals 
 
A shortage of trained health professionals was another challenge. Most of the 
respondents pointed out that there was a lack of health professionals who took the 
cervical cancer screening training. According to respondents, 
 
There is no adequately trained health professional in our health centre. 
(Participant 15)  
 
Inadequately trained health workers are another challenge. (Participant 4) 
 
There is no adequate training opportunity given for health professionals. Many 
more, providers should be trained. (Participant 10) 
 
In 2017, Tamirat, Getachew and Tesfaye (2017:100) found that a shortage of trained 
health professionals contributed to poor cervical cancer screening service provision, 
due to lack of knowledge, skills and training opportunities for staff.  
 
5.4.8.3 Sub-theme 8.3: Lack of responsible person assigned to the service 
 
The respondents stated that the lack of a responsible person assigned to the cervical 
cancer screening unit was another challenge. According to respondents, 
 
To me, the main challenge concerning cervical cancer screening service in our 
health centre is there is no responsible person or professional assigned for the 
service. I am a family planning service provider and also pre-cancer service 
provider. The majority of the health workers took the training in this health centre, 
but there is no responsible assigned person on screening service. (Participant 1) 
 
The main challenge concerning cervical cancer screening service is that there is 
no responsible person or professional assigned for the service. In our health 




were not assigned permanently there. If there is no responsible person on the 
screening room permanently, the service provision will be poor. (Participant 3) 
 
5.4.8.4 Sub-theme 8.4: Health professionals’ lack of commitment  
 
The respondents indicated that some health professionals‟ lack of commitment was one 
of the challenges to the cervical cancer screening service. According to respondents,   
 
The health providers‟ low commitment is seen in the awareness creation 
activities. (Participant 8) 
 
I observed low commitment of some of the staff; the health workers did not pay 
attention, and there are low trained persons. (Participant 16) 
 
5.4.9 Theme 9: Suggestions to address the challenges 
 
Theme 9 was the respondents‟ suggestions to address the challenges to the cervical 
cancer screening services. The sub-themes were assignment of responsible health care 
professional and supplies; appropriate work plan and data management; strengthening 
awareness and education programmes and activities, and capacitating the health care 
professionals.  
 
5.4.9.1 Sub-theme 9.1: Assignment of responsible health care professional and 
supplies  
 
The respondents indicated the need for the assignment of a cervical cancer screening 
professional and the necessary supplies. Most of the respondents emphasised that the 
responsible health professional should be available at all times in order to provide the 
service properly. They also stressed the importance of adequate supplies. According to 
respondents, 
 
There should be a responsible health professional assigned to the pre-cancer 
screening unit. This person should be available at all times, responsible for 
preparing the necessary equipment for the procedure, and have an appropriate 





Sometimes the room used to be closed. The room should never be closed; a 
responsible person should be assigned for this, and the number of trained health 
workers needs to be increased. (Participant 9) 
 
This person will plan and also be responsible to carry out the plan. (Participant 1)  
 
There should be responsible health professionals assigned to the service. 
(Participant 3) 
 
Tamirat et al (2017:100) found that a shortage of trained health professionals 
contributed to poor provision of cervical cancer screening service, due to lack of 
knowledge, skills and training opportunities for staff. In Malawi, Munthali et al 
(2015:505) found that the limited number of members of staff involved in the delivery of 
cervical cancer screening and early treatment services was a serious barrier to 
screening uptake.  
 
5.4.9.2 Sub-theme 9.2: Appropriate work plan and data management 
 
The respondents indicated the need for an appropriate work plan and data management 
to address the challenges. Some respondents stressed the necessity of an appropriate 
plan to equip and enable the health professionals responsible to organise and ensure 
effective service and performance. According to respondents, 
 
There must be standard plan and periodic performance report and evaluation. 
The service also should be strength with equipment, manpower and supply. 
(Participant 7) 
 
There is should be appropriate plan, there should be monitoring and evaluation 
system and data management. (Participant 2) 
 
5.4.9.3 Sub-theme 9.3: Strengthening awareness and education activity  
 
The respondents stated that awareness and education programmes and activities 
should be strengthened to promote and improve cervical cancer screening service. The 




counselling, monitoring and follow-up to strengthen the service. According to 
respondents, 
 
I think it needs to work aggressively; attention should be given to the awareness 
creation strategy, because most of the women‟s awareness is low. (Participant 1) 
 
We need commitment and well-organised awareness creation activities. All 
health workers must be trained, so that appropriate counselling can be done in all 
units. (Participant 4) 
 
Continuous and strong awareness creation should be done, and appropriate 
follow up of health extension workers is necessary. (Participant 6) 
 
We need strong awareness creation activities and good counselling service. 
(Participant 14) 
 
Commitment is important to apply the awareness creation strategy. Strong 
counselling is important at all units in the health centre. (Participant 18) 
 
Having regular health education programmes, assigning responsible persons, 
and proper counselling of women in all units can reduce the challenges. 
(Participant 17) 
 
5.4.9.4 Sub-theme 9.4: Capacitating the health professionals 
 
The respondents stressed the shortage of trained health service providers in cervical 
cancer screening service provision. The respondents suggested increasing training 
opportunities to as many health professionals and as regularly as possible to tackle the 
challenges. According to respondents, 
 
Giving training for all health care workers is important because if the one who 
trained is not available, it will be easy to assign another one, so the room will 
always be open for the service. (Participant 15) 
 
Additional training should also be given for all health workers. This will help to 





All health workers must be trained, so that appropriate counselling is done in all 
units. (Participant 5) 
 
Staff should be added; much more staff should be trained so that everybody can 
be assigned to give the service. (Participant 3) 
 
5.4.10 Theme 10: Suggestions to increase cervical cancer screening uptake 
 
Theme 10 was suggestions to increase cervical cancer screening uptake. The sub-
themes were enhancing community awareness; strengthening of cervical cancer 
screening service, and prompt action research to investigate existing problems. 
 
5.4.10.1 Sub-theme 10.1: Enhancing community awareness 
 
The respondents emphasised the need to increase and enhance community awareness 
by means of media awareness creation programmes, school health education 
programmes, and health extension workers‟ (HEWs) house-to-house visitation. 
According to respondents, 
 
Awareness creation programmes in the media to all people, School health 
education programmes in schools, health extension workers‟ house-to-house 
visiting and education should be expanded. Awareness raising programmes 
should be provided by different methods. (Participant 17) 
 
Awareness creation should be done in the media, like TV and radio. (Participant 
18) 
 
Strengthening of community awareness is very important. This should include 
both the male and female population; husbands also need to understand about 
the service. This should be done through the health extension workers or using 
mass media. In addition, strengthening of collaboration with agents is important 
for certain periods in order to sustain the service. (Participant 14) 
 
Activities should be done in the community to increase awareness, like TB and 
HIV. As we know, in the HIV epidemic everybody was shouting and working with 





Awareness creation strategy is necessary at all level; MOH should have 
responsibility because most of the women awareness is low, even in mass media 
awareness creation for the whole population should be consistently given. 
(Participant 3) 
 
I recommend strengthening of community awareness, collaboration with agents, 
working with health extension workers, practising community awareness through 
community leaders and religious leaders. (Participant 11)  
 
The MOH level needs to work hard, using mass media. Attention should be given 
to awareness creation strategies because most of the women‟s awareness is low. 
Increasing the commitment of the health service workers through training and 
incentives is also necessary. (Participant 5) 
 
5.4.10.2 Sub-theme 10.2: Strengthening of cervical cancer screening service  
 
The respondents recommended strengthening the available cervical cancer screening 
service. The health centres‟ provision service should be supported, monitored, and 
supervised by responsible agents like the MOH and NGOs in order to strengthen the 
service. According to respondents, 
 
Responsible agents should be available at national level. The MOH should 
assign a task force group for this case, because in our country it is known that the 
number of women affected by the disease is a great problem. (Participant 18) 
 
The Ministry of Health should give attention to the problem and supervision is 
also important from health management offices. In general, attention should be 
given to community awareness creation programme. (Participant 9) 
 
Attention should be given at all levels. The MOH, funding agents and NGOs 
should support the service. Research groups should identify and investigate the 
actual problem and action taken on the findings. (Participant 16) 
 
The regular health education programmes of health centres or all health facilities 
need attention and work to increase awareness. Collaboration with agents is 
necessary in order to get support for the health centres with equipment and 




evaluations. The service should also be strengthened with equipment, manpower 
and supplies. (Participant 7) 
 
Strengthening of collaboration with agents is important for certain periods in order 
to sustain the service. (Participant 14) 
 
I think it needs to work aggressively. Attention should be given to awareness 
creation strategies because most of the women‟s awareness is low. Well trained 
health professionals should be assigned. Even in the media, awareness creation 
for the whole population should be given consistently. (Participant 1)  
 
5.4.10.3 Sub-theme 10.3: Prompt action research to investigate the existing 
problem 
 
The respondents maintained that prompt action was needed to investigate the existing 
problem to improve cervical cancer screening uptake. Further research was also 
urgently needed. According to respondents,  
 
I think researching the existing problem would help to identify the problem. This 
will help to focus on the area which needs intervention. (Participant 6) 
 
I recommend that the MOH and universities should encourage research in this 
area. This will help to identify what the existing problem is in the community and 
interventions based on the findings. (Participant 8) 
 
The respondents stated that identifying existing problems through investigation and 
action research was essential to improve cervical cancer screening uptake. In addition, 
research would help to focus on areas that need intervention. 
 
Young (2015:91) maintains that research needs to be an essential part of any 
healthcare setting. Research relies on scientific and academic innovation. By posing 
new ideas and suggesting alternative answers to medical and social questions, we aim 






5.5 INTEGRATION OF QUANTITATIVE AND QUALITATIVE FINDINGS 
 
Integration is an intentional process by which the researcher brings quantitative and 
qualitative approaches together in a study. Quantitative and qualitative data then 
become interdependent in addressing common research questions and hypotheses 
(Guetterman, Fetters & Creswell 2015:2). 
 
In this study quantitative data was collected from clients attending maternal health 
services and qualitative data from health care providers (Creswell & Creswell 2018:44). 
The researcher used a convergent mixed methods approach to collect quantitative and 
qualitative data. The researcher incorporated both sets of data into the interpretation of 
the overall results. The quantitative data was statistically analysed to establish clear 
predictors, and then triangulated with the qualitative data to be used in the development 
of the guidelines. The researcher then developed the guidelines to improve utilisation of 













Figure 5.1  Process of the guidelines  development  
 
The researcher developed the guidelines in three stages as illustrated in Figure 5.1. 
 
5.6  SUMMARY  
 
This chapter discussed the qualitative data analysis and discussion. The qualitative data 
was collected from health service providers at the participating health centres.  
 
1 Quantitative findings from 
the patient survey to 
assess women‟s 
perceptions and 
experiences of cervical 
cancer screening 
2 Qualitative findings from 
health service providers‟ 
perceptions of and 
experience in cervical 
cancer screening 
3 Literature review  
External validation and 
evaluation of the 
guidelines by senior 
public health experts and 







Most of the views and experiences of health care provides were identified by different 
study conducted in the country and abroad. This exploration and description of the 
views and experiences of health care workers on cervical cancer screening services 
utilisation brought wide range of issues such as knowledge of the women, perception of 
the women about cervical cancer screening services, factors associated with cervical 
cancer screening service utilisation and challenges. 
 
This study has of a particular use to incorporate the views and experiences of women 
and health care workers to be develop a guideline. The next Chapter 6 presents the 
guidelines which were developed based on the quantitative and qualitative findings and 












Guidelines are recommendations intended to assist providers and recipients of health 
care and other stakeholders to make informed decisions (WHO 2012:1). 
 
The purpose of the study was to develop guidelines to improve the utilisation of cervical 
cancer screening by women in Ethiopia. In order to do so, the aim was to determine the 
factors that affected the uptake of cervical cancer screening among women in Addis 
Ababa, including socio-demographic and socio-economic circumstances, and 
perceptions that facilitated or prevented screening. 
 
The guidelines were based on the findings of the study and the literature review. The 
draft guidelines were reviewed by the study supervisor and senior public and maternal 
health experts to ensure feasibility and applicability. The researcher incorporated the 
experts‟ feedback and finalised the development of the guidelines.  The guidelines 
should assist policies, strategies and operating procedures for improved and effective 
cervical cancer prevention and screening service delivery. 
 
6.2 GUIDELINE DEVELOPMENT:  PASE 2 
 
6.3 SCOPE OF THE GUIDELINES  
 
The guidelines should assist policy makers, health services planners and health 
programme managers to plan and implement cervical cancer screening services at 
different levels of the health system. The guidelines are intended to improve utilisation 





6.4 PURPOSE OF THE GUIDELINES  
 
The purpose of the guidelines is to provide evidence-based guidance to policy makers, 
health care managers, and health service professionals to improve the utilisation and 
quality of cervical cancer screening services. The use of these guidelines would help, 





 Develop guidelines to improve the utilisation of cervical cancer screening by women 
in Ethiopia based on the finding from quantitative and qualitative data. 
 
6.4.2  Research question  
 
 What guidelines can be developed for health professionals, planners and 
policymakers to promote utilisation of cervical cancer screening services among 
women in Ethiopia? 
 
6.5 BASIS FOR THE DEVELOPMENT OF THE GUIDLINES  
 
The study found that the main determinants of cervical cancer screening practice were 
women‟s socio-demographic characteristics; reproductive health characterstics; 
knowledge of cervical cancer; perceptions of susceptibility, seriousness, benefits of and 
barriers to screening, and source of information, especially health service providers. 
This was done used quantitative approach of data collection. Moreover, the health 
professionals, on qualitative part of study identified several challenges in cervical cancer 
screening service provision in their health centres. The guidelines were based on the 
findings of the current study, relevant aspects of reviewed literature, the theoretical 
framework of the study and the researcher‟s insights; the adapted health belief model 
was used to categories the findings of the study. These guidelines are intended to 





Table 6.1 Findings used from quantitative and qualitative data for development 
of the guidelines  
 
Qualitative findings  Quantitative findings  
 There was a shortage of trained health service 
providers.  
 No responsible health service provider was 
permanently assigned to cervical cancer screening 
provision.  
 Regular awareness and education activities were 
not strong.  
 There were inadequate campaign sessions to 
increase community knowledge.  
 There were weak or no community awareness 
sessions.  
 There was little or no use of health extension 
workers (HEWs) in house-to-house health 
education practice. 
 Inadequately trained health professionals on 
cervical cancer screening.   
 Health service providers‟ lack of commitment was 
evident in poor awareness creation and counselling 
activities.  
 Health professionals did not provide health 
education 
 There were few training and capacity building 
opportunities for health professionals.  
 Many women did not have information on cervical 
cancer causes, risk factors, transmission and 
prevention.  
 Not screened women had little or no knowledge of 
the advantage of cervical cancer screening.  
 Most women had little or no perception of the 
advantage/benefit of cervical cancer screening.  
 Women did not perceive the disease as serious 
and that they were at risk.  
 Educated women were aware and came for 
screening. 
 Many women needed permission from their 
husbands or families for screening. 
 The health centres had no proper work plan, data 
management and reports. 
 There was no regular supervision from the 
responsible body (MOH). 
 The screened women were mainly in the age 
group of 25-44 years old.  
 The majority of the not screened women 
indicated that they did not know the causes of 
cervical cancer.  
 Most of the not screened women did not know 
where to get tested for cervical cancer. 
 Most of the not screened women did not know 
any methods of cervical cancer prevention. 
 Many of the not screened women did not know 
the transmission ways of HPV. 
 Several of the not screened women did not 
know about the treatment for cervical cancer. 
 Many of the not screened women did not know 
how often cervical cancer screening should be 
done. 
 Many of the not screened women did not know 
that smoking cigarettes was a risk for cervical 
cancer. 
 Most of the not screened women stated that 
they were not aware of any test for cervical 
cancer screening. 
 Regular cervical cancer screening decreases 
the risk of cancer. 
 Knowledge about cervical cancer, and women‟s 
perception of susceptibility, seriousness, 
benefits and barriers, and information from 
health providers were the strongest 
determinants of cervical cancer screening 
practice. 
 Enhancing community awareness is 
recommended. 
 Strengthening of cervical cancer screening service 
with human resources (staff), supplies and 
management. 
 Prompt action research is necessary to investigate 
the existing problem. 
 Attention from MOH, collaboration between the 
MOH and NGOs, and community leaders‟ 
involvement are needed.  
 Most of women (64.3%) indicated that best 
method of providing information about cervical 




Table 6.2 shows summary findings from quantitative and qualitative data used for 





6.6 VALIDATION AND EVALUATION OF THE GUIDELINES: PHASE 3  
 
6.6.1  Purpose 
 
The purpose of the validation and evaluation of the guidlenes is to authenticate the 
guidelines was to confirm that the guidelines were of a good, acceptable and attainable 
nature. 
 
6.6.2  Evaluation tool 
 
Criteria for evaluation of the interim Guidelines was distributed to experts to evaluate 
the draft guidelines. A criterion is a standard or principle used in evaluation as the basis 
for evaluative judgement. Accordingly, criteria consist of Clarity and presentation, 
Specificity, Reliability, Effectiveness, Validity, Achievability, Relevance and Applicability 
(OECD 2021:36) 
 
A Likert scale is used, which had four choices for evaluation, beginning with a strongly 
disagree, disagree, agree, and strongly agree. The evaluators were asked to use the 
key to assess and determine for each strategy met the criteria that have been adopted 
to achieve each strategy. When required, assessors were asked to provide their 
opinions on each strategy in a written comment and feedback. Scale key:  1: strong 
disagreement; 2: disagreement; 3: agreement; 4: strong agreement. 
 
6.6.3  Experts  
 
A group of experts in public health, midwifery, maternal and reproductive health and 
social psychology and in different positions were participated. 
 
6.6.4  Outcome of the validation and evaluation 
 
The evaluators commented that it is better to clear out a work description monitoring 
and evaluation mechanism for health workers. They also give more emphasis to the rule 
and regulation if someone does not adhere to the code of ethics and punishment 
mechanism should be stated. In addition, they recommended developing teamwork and 





Therefore, recommendation forwared were included in the final guidelines  
 
6.7 FINALISATION OF THE GUIDELINES  
 
The following guidelines are intended to facilitate and promote cervical cancer 
screening utilisation. 
 
Guideline 1: Prioritise cervical cancer screening services during performance 
review meetings 
 
Performance review meetings are meant to improve health services or centres‟ 
performance in key areas, identify challenges and problems, seek solutions to the 
identified problems, and develop action plans that will be implemented after the review 
meeting. Performance review meetings should focus on health services that are lagging 
behind or need special attention. The following interventions are proposed to prioritise 
cervical cancer screening service during performance review meetings:  
 
 Make all health facilities present their cervical cancer service performance 
records. 
 Make cervical cancer-related activities one of the staff appraisal indicators. 
 Discuss how to increase the utilisation of cervical cancer screening services. 
 Discuss problems and challenges in cervical cancer screening service. 
 Present best experiences among the meeting participants or best practices from 
other areas. 
 Set targets that can be achieved by facilities and evaluated during the next 
review meeting. 
 Develop action plans indicating where and when the programmes will be 






Guideline 2: Strengthen cervical cancer screening services 
 
In order to provide appropriate cervical cancer screening service, the service should be 
available and accessible to users. This study identified a need of improvement of the 
available cervical cancer service.  The following interventions are proposed to improve 
overall cervical cancer screening service: 
 
 Ensure the availability of supplies, materials and technical support for cervical 
cancer screening programmes. 
 Address the shortage of staff in the health centres. 
 Maintain regular monitoring and supervision of cervical cancer screening service 
activities. 
 Ensure short-term training of health service workers in cervical cancer screening. 
 Increase the number and accessibility of cervical cancer screening centres. 
 
Guideline 3: Provide health education and counselling services to women in all 
health delivery pointes 
 
Health education and counselling should be provided to women at all maternal health 
services, namely ANC, delivery, PNC, family planning, and immunisation; and other 
health delivery points that women can acess. The information should include the 
causes, transmission, prevention, and risk factors of cervical cancer, and the advantage 
of screening for cervical cancer. Health service providers need to effectively inform 
women about the availability of cervical cancer screening service.  
 
The following interventions are proposed to improve counselling and health education 
services provided to the women duringin all health seeking points:  
 
 Provide information on the availability of cervical cancer screening. 
 Provide information on causes of cervical cancer, transmission, prevention, risk 
factors and advantage of screening for cervical cancer. 
 Offer capacity building training to health care workers to provide comprehensive 





 Develop and use checklists to be used as reminders of what information should be 
communicated. 
 Ask the women about their concerns and respond appropriately. 
 Consider especial attention to women attending any maternal health services. 
 
Guideline 4: Strengthen regular health education programmes; incorporate 
cervical cancer screening as a main health education topic in the health sectors 
 
The study found that incorporating information about cervical cancer in regular health 
education programmes and activities at health centres increased cervical cancer 
screening. The following interventions are proposed to improve the overall counselling 
and health education services:  
 
 Incorporate topics on cervical cancer-related information in regular health 
education programmes. 
 Provide information on the availability of cervical cancer screening. 
 Provide information on causes, transmission, prevention and risk factors of 
cervical cancer, and the advantage of screening for cervical cancer. 
 Offer counselling and health education services to women visiting all health 
delivery services. 
 Integrate cervical cancer services with other health care services. 
 
Guideline 5: Strengthen and support the health extension programme  
 
The Community Health Extension Programme, 2003-2018 allowed Ethiopia to achieve 
significant improvements in maternal and child health, communicable diseases, hygiene 
and sanitation, knowledge and health care seeking. In some cases, women can utilise 
cervical cancer services through referral of health extension workers (Assefa, Gelaw, 
Hill, Taye & Van Damme 2019:24).  
 
Health extension workers (HEWs) assigned to kebeles around the health centres should 
increase house-to-house visitation and include education on cervical cancer screening 




in the community. The following interventions are proposed to strengthen the health 
extension programme:  
 
 Arrange technical support for health extension workers to integrate cervical cancer 
screening education and counselling. 
 Develop a home visit observation checklist at household level which includes 
offering cervical cancer screening education. 
 Offer capacity building training to health extension workers to provide counselling 
and health education services to women in the community. 
 Develop and implement a monitoring system for health extension workers‟ activities 
to ensure regular performance related to cervical cancer screening counselling. 
 Make random checks on households to monitor health extension workers‟ house-to-
house visitation. 
 Strengthen communication with the local community to assist health extension 
workers to remain at their duty in education about cervical cancer screening. 
 Motivate health extension workers to bring women to the health centres for cervical 
cancer screening. 
 Provide ICT materials to capacitate their information.  
 
Guideline 6: Address Health care workers’ capacity building 
 
Health care providers were a main source of information for women. The capacity of 
health care providers should be strengthened in order to improve women‟s and the 
community‟s perceptions and acceptance of cervical cancer screening. The following 
interventions are proposed to increase health care providers‟ capacity:  
 
 All health care professionals and health service managers should receive short-term 
training in cervical cancer screening services. 
 Mentoring and supportive supervision should be provided in cervical cancer 
screening programmes to strengthen service provision. 
 Trained health service professionals should be assigned to cervical cancer 
screening practice. 





 Offer available materials and manuals to health service workers. 
 Provide ICT materials to capacitate their information. 
 Consider insentives amd motivation means for those with better performance on 
cervical cancer screening service providers. 
 Develop teamwork and create sense of ownership. 
 
Guideline 7: Strengthen community level interventions 
 
Community mobilisation is a process of involving communities to produce support for 
essential health services, like cervical cancer prevention, and control activities (WHO 
2014a:88). The following interventions are proposed to strengthen community level 
interventions: 
 
 Improve community mobilisation to promote responsiveness to cervical cancer and 
cervical cancer screening, using health extension workers. 
 Encourage the community to maintain support for women on cervical cancer 
screening. 
 Organise community awareness campaigns and education programmes. 
 Involve community volunteers to demonstrate successful education programmes in 
the community. 
 Conduct community-based health education using health extension workers to 
improve community awareness and knowledge of cervical cancer screening 
services. 
 Conduct regular supportive supervision and meetings to strengthen communication 
with local government authorities. 
 Strengthen communication and work with donors and NGO partners working in the 
community. 
 
Gudeline 8: Strength awareness and education programmes 
 
There was a lack of knowledge and awareness of the importance of cervical cancer 
screening services. In Hamadan, Iran, education and awareness raising programmes 




Moeini & Poorolajal 2011:22). The following interventions are proposed for conducting 
education and awareness raising programmes:  
 
 Conduct community-based health education, using health extension workers to 
improve community awareness and knowledge of cervical cancer screening 
services. 
 Consider health facility-based morning health education, targeting cervical cancer 
screening services. 
 Utilise mass media to disseminate information on cervical cancer screening 
services. 
 Utilise available behavioural change communication tools to increase community 
knowledge and awareness of cervical cancer screening services. 
 Develop and utilise health message targeting the cultural and traditional practices 
being conducted in the community. 
 Prepare and use IEC materials on cervical cancer screening using the local 
language.  
 Engage partners, neighbours, religious leaders, community leaders and significant 
others to improve knowledge and perceptions of cervical cancer. 
 Organise population-based screening programmes to allow for a standardised 
approach to screening, follow-up, and treatment. 
 Conduct an advocacy campaign through mass media. 
 
Guideline 9: Develop a system to cervical cancer screening data management 
 
Cervical cancer services mostly rely entirely on existing national or organizational health 
information (HIS) structures to meet their data needs. When systems are unable to 
provide the basic information required controlling patients and coordinating the delivery 
of services, several programs develop ad hoc systems. Cervical cancer screening 
activities data are often uncoordinated and lack of standardisation, resulting in 
inconsistent data quality and availability and restricting the use of data for decision-
making and program planning. In order to ensure data quality, data generated by health 
services must be based on standard procedures and protocols which do not vary 




collection period. Data are reliable when they are measured and collected consistently 
(Drummond, Were, Arrossi and Wools‐Kaloustian2017:34). 
 
The following interventions are proposed for improving cervical cancer screening related 
data: 
 
 Introduce an electronic-based cervical cancer screening report system. 
 Conduct data quality assessment on a regular basis. 
 Conduct integrated supportive supervision to improve the data recording and 
reporting. 
 Provide regular feedback on data quality and recording and reporting procedure to 
lower levels. 
 
Guidliene 10: Address compassionate, respectful and caring services  
 
Compassionate care involves showing respect and understanding emotions and 
feelings; feeling of deep sympathy and sorrow for the suffering of others accompanied 
by a strong desire to alleviate the suffering. (FMOH 2018:2). Respectful healthcare 
increases patient satisfaction and affects community health-seeking behaviour. The 
following interventions are proposed to promote cervical cancer screening services 
provision in a caring, respectful and compassionate environment:  
 
 Foster leadership ownership and engagement at all levels of the system. 
 Provide on-going, continuous professional ethical training. 
 Listen to patients‟ feedback attentively. 
 Respond to patients politely. 
 Clarify any misunderstandings. 
 Offer help whenever a patient asks for support. 
 Encourage and foster health service providers‟ self-commitment to provide available 
cervical cancer screening service. 
 Conduct annual health professional recognition events. 
 Develop and introduce a framework to reinforce professional code of ethics 







In this chapter a preliminary guidline for each of the recognised cervical cancer related 
issues was developed. Afterwards, ten strategies were developed, which were validated 
by expertise and the final gudelines establish the monitoring and assessment system for 
cervical cancer screening services. The guidelines can be used by health professionals, 
policy makers, health service managers and researchers to improve cervical cancer 
screening service delivery and uptake. 
 
Chapter 7 briefly summarises the findings and limitations of the study and makes 











This chapter summarises the study, discusses the limitations and contribution of the 
study, and makes recommendations for practice and further research.  
 
7.2 SUMMARY OF THE STUDY 
 
In Ethiopia, cervical cancer is the second leading cancer among women. Most people 
with cervical cancer in developing countries, including Ethiopia, present late with 
advanced stage, at which time management treatment may involve multiple modalities, 
such as surgery, radiotherapy, and chemotherapy, which would lessen the chances of 
success. Early detection of cervical cancer can easily be made by an examination of 
swabs or smears from the cervix surface, which could be done at a gynaecological 
examination. If identified early, treatment and management of cervical cancer is simple, 
uncomplicated and effective. The national coverage of screening for the country was 
about 0.6% in the 18 to 69-year-old age group (Human Papilloma Virus [HPV] Centre 
2010:1). Guidline interventions are needed to increase the number of women who 
attend cervical cancer screening services.  
 
 Purpose of the study 
 
The purpose of the study was to investigate factors that affected cervical cancer 
screening among women in Addis Ababa, Ethiopia and develop guidelines to assist in 
promoting women‟s screening practice for cervical cancer screening. 
 
 Objectives of the study 
 





Phase 1: Quantitative approach 
 Identify and discuss the determining factors of screening practice for cervical cancer 
among women in Addis Ababa, Ethiopia. 
 
Phase 2: Qualitative approach 
 Explore and describe health professionals‟ perceptions of cervical cancer screening 
utilisation among eligible women in Addis Ababa, Ethiopia. 
 
Phase 3: Based on the finding  
 Develop guidelines to improve the utilisation of cervical cancer screening by 
women in Ethiopia based on the finding. 
 
The researcher conducted a literature review to be familarise with existing research on 
the topic, contextualise the study, and answer the research questions. The study was 
based on the conceptual framework of the Health Belief Model (HBM). The HBM is 
based on people‟s beliefs about whether or not they are susceptible to a disease or 
condition and how their perceptions of the benefits of trying to avoid it influence their 
readiness to act (National Cancer Institute (NCI) 2005:13). Health behaviour is based 
on perceived threat of disease (Rosenstock et al 1988:177). The HBM is a 
psychological health behaviour model generated to explain and anticipate health-related 
behaviours, and helps clarify why individuals may accept or reject preventive health 
services or adopt healthy behaviours (Day et al 2010b:4).  
 
A research design is the overall plan for addressing a research question, including the 
specifications for enhancing the integrity of the study (Polit & Beck 2014:741). The 
researcher selected a mixed methods research design for the study in order to collect 
quantitative and qualitative data (Creswell 2013:32). At the time of the study, 14 public 
health centres in Addis Ababa were providing cervical cancer screening free of charge. 
The study was conducted at six (6) selected public health centres that had started 
cervical cancer screening two years prior to data collection.  
 
The study collected quantitative data from women attending maternal health care and 
qualitative data from health care providers. Quantitative data was obtained from 233 
screened and 376 not screened respondents to identify determinants of cervical 




values, opinions, behaviours, and social contexts of particular populations (Moriarty 
2011:2; Creswell 2013:42).  Qualitative data was obtained from 18 selected health 
professionals (nurses, midwives, health officers) at the selected health centres by 
means of key informant interviews (Mack et al 2011:3). The purpose of the interviews 
was to obtain the respondents‟ perceptions of women‟s uptake of cervical cancer 
screening. The quantitative data analysed using the Statistical Package for Social 
Sciences (SPSS) Version 23. The researcher analysed the qualitative data by reading, 
categorising, and tabulating the transcribed interviews. Finally, based on the 
quantitative and qualitative findings and the literature reviewed, the researcher 
developed guidelines which could used to improve cervical cancer screening in 
Ethiopia. 
 
7.3 LIMITATIONS OF THE STUDY 
 
The limitations of a study refer to restrictions or problems in a study that may decrease 
the generalisability of the finding (Polit & Beck 2008:539). The study was restricted to 
six (6) selected public health centres that had started cervical cancer screening two 
years prior to data collection therefore the findings cannot be generalised to other health 
centres or the whole country.  
 
7.4 CONTRIBUTION OF THE STUDY  
 
The study findings provide information on women‟s knowledge and practices that affect 
utilisation of cervical cancer screening in order to detect the presence of disease at an 
early stage which was investigated using quantitative approach. The participant health 
care providers‟ experience and perceptions of cervical cancer screening utilisation 
identified using qualitative approach.  The convergent parallel mixed method design 
involved through quantitative and qualitative data collection and analysis at similar 
times, followed by an integrated analysis. The researcher incorporated both sets of data 
into the interpretation of the overall results. The quantitative data was statistically 
analysed to establish clear predictors, and then triangulated with the qualitative data to 
be used in the development of the guidelines.  
 
The researcher then prepared guidelines which were validated by expertise and the 




screening services. This study has therefore contributed immensely to the body of 
knowledge in cervical cancer screening utilisation in Addis Ababa, Ethiopia. The 
guidelines produced in this study are potentially can improve the quality and utilisation 
of cervical cancer screening services as well as help with screening and behavioural 
modification programs. Health professionals, planners, policy makers and cancer 
society association will be able to use the findings of the study to encourage women in 




On the basis of the study outcome, the researcher forwards the following 
recommendations for practice and further study.  
 
7.5.1 Recommendation to Ministry of Health 
 
The Ministry of Health and should: 
 
 Organise awareness campaigns and education programmes to inform the 
community and patients about cervical cancer, emphasising signs and symptoms, 
ways of transmission, risk factors, and prevention by means of screening. 
 Organise population-based screening programmes to allow for a standardised 
approach to screening, follow-up, and treatment. 
 Promote community mobilisation by means of health extension workers to promote 
responsiveness to cervical cancer and cervical cancer examination.  
 Regulate the integration of the cervical cancer screening programme with primary 
health care (PHC) service programmes. 
 Increase the availability of heath care providers in cervical cancer service. 
 Make provision for and introduce strong performance evaluation, data management, 
monitoring, and supervision systems in health facilities. 
 Expand the availability and accessibility of cervical cancer screening service 
facilities. 






7.5.2 Recommendation to health care providers  
 
Health care providers (phsiciance, health officers, nurses, midwives) should: 
 
 Keep up to date on the available cervical cancer screening services through 
attending seminars and workshops. 
 Take on responsibility to provide the available cervical cancer screening service 
with dedication.  
 Promote and present health education programmes on cervical cancer screening in 
their health centres. 
 
7.5.3 Recommendation on further research 
 
Further studies should be conducted on the following topics:  
 
 Observational study to assess the actual interaction between the service providers 
and the women. 
 How information cervical cancer screening is disseminated to women. 
 Partners‟ perceptions on cervical cancer screening. 
 Motivating and demotivating factors of health care workers working in the health 
centres need to be studied.  
 The health care workers approach and conduct in delivering the cervical cancer 
screening services need to be investigated. 
 It is also good for other studies measure the effects implementing the 
recommendations made under this study on cervical cancer screening services. 
 
7.6 CONCLUSION  
 
This chapter summarise of findings, conclusions, recommendations, contribution of the 
study, and its limitations. In this study as participants from health centres reported, there 
are some challenges on the implementation of cervical cancer service in the health 
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Annexure C: Questionnaire English version  
 
Questionnaire for the determinants factors of cervical cancer screening 
among women in Addis Ababa 
 
The aim of this study is to assess the determinants factors of cervical cancer screening 
in Addis Ababa. 
 




The interview should be conducted after an individual informed the aim of the interview 
get consent /agreement to be interview.   
 
My name is ……………………………………  I work for a research team from UNISA. I 
am going to conduct survey using questionnaire to study determinants factors for 
cervical cancer screening among women in Addis Ababa. To complete the 
questionnaire, I will ask your questions approximately lasting 30-45 minutes duration. 
Your responses are completely confidential, your name will not be written on the form 
and will never be used in connection with any of the information you provided.  
 
I would like to thank you in advance for your help.  
 
Are you willing to participate?  Yes 
          No  
 
If yes  1. Continue 
If no   2. Stop 
 
02. Result code 
1. Complete 
2. Refused 
3. Partially completed 




Questionnaire to assess the determinants factors of cervical cancer screening 
practice among women in Addis Ababa 
 
01. Site _____________________ 
 
02. Study participants  
1. screened  
2. not screened  
 
03. Result code 
1. Completed 
2. Refused 
3. Partially completed 
4. Other /specify/---------------------- 
 
Part I: Socio-demographic and health background information  




Question Coding category Skip Code 
102 Ethnic group  1. Amhara 
2. Oromo 
3. Tigrie 




104 Educational level  1. No education 
2. Primary 
3. Secondary 
4. College and above 
  
105 Occupation 1. Housewife 
2. Government employee 
3. Private employee 




106 Family income per month 1. <400 birr 
2. 400-999 birr 
3. 1000 & above 







Question Coding category Skip Code 





108 Have you been using birth 
control contraceptives  
1. Yes 
2. No 




109 Which type of 
contraceptives ever used 
(more than one answer can 
be given) 




5. Other specify ………… 
6. No response 
  




3. Two to Four 
4. Five and above 
5. No response 
  
111 What was your first age of 
menarche 
1. Less than 14 years 
2. 14 years to 15 years 
3. Above 15 years 
4. No response 
  
112 What was the age of first 
sexual intercourse 
1. Less than 15 years 
2. 15-18 years 
3. 18 years above 
4. No response 
  
113 What was your age of first 
pregnancy  
1. Less than 15 years 
2. 15-18 years 
3. Above 18 years 
4. No response 
  




3. No response 
  
115 Do you have more than one 
sexual partner  
1. Yes 
2. No 











Question Coding category Skip Code 
201 Have you heard of cancer of cervix   1. Yes 
2. No 
  
202 Do you know the cause for cervical cancer  1. Yes 
2. No 
  





204 Do you know any method to prevent cervical 









207 Is cervical cancer treatable    1. Yes 
2. No 
3. I don't know 
  






Part II-B: Knowledge about cervical cancer, symptoms, prevention, cervical 




Question Coding category Skip Code 
209 
 
What part of the body does 




3. Other specify 
4. Don‟t know 
 1 
210 What are the signs and 
symptoms of cervical 
cancer? (more than one 
answer can be given) 
 
1. Pain during intercourse 
2. Post coital bleeding 
3. Irregular vaginal bleeding 
4. Weight loss 
5. Foul smelling vaginal 
discharge 
6. Don‟t know 
 2 
211 The virus associated with 
cervical cancer is 
transmitted by... 
 
1. Sexual intercourse 
2. Maternal-fetal 
transmission 
3. Blood transfusion 
4. I do not know 
 1 
212 What does it mean by an 
abnormal cervical screening 
result?  
 
1. Precancerous cells 
2. Cervical cancer 
3. Sexually transmitted 
infection 







Question Coding category Skip Code 
213 How can a person prevent 
getting cancer of the 
cervix?   
(more than one answer can 
be given) 
 
1. Avoid multiple sexual 
partners 
2. Avoid early sexual 
intercourse 
3. Quit smoking 
4. vaccination of HPV 
vaccine 
5. Regular medical checkup 
for screening 
6. All of the above 
7. Other (please explain): 
 2 
214 How often should a woman 
be screened for cervical 
cancer?  
1. Annually 
2. Every 2-3 years 
3. Every 5 years 




216 What is the treatment for 
cervical cancer (more than 





5. Others (explain) 
6. I don‟t know 
 2 
217 Stage about cervical cancer 
cured  
1. Early 
2. Cannot be cured 
3. Any time 
4. Don‟t know 
 1 
 





Item  Yes No I don’t know 
218 Having multiple partners    
219 Having sex at an early age    
220 Smoking cigarettes    
221 Use of contraceptives    
222 Having sexually transmitted infection    
223 Acquiring human papillomavirus infection    
224 Family history of cervical cancer    




Part III: Practice of cervical cancer screening  
 
301 Have you ever had cervical cancer screening? If yes go to Q. no 302 
1. Yes  
2. No 
3. No response  
 
302 When was the last screening? 
1. In the last one year  
2. Two years ago 
3. Five years ago  
4. No response 
 
Part IV: Perception on cervical cancer and screening  
 
Section A: Perceived susceptibility to cervical cancer  
 
Please respond to the following questions by ticking strongly agree (SA), agree (A), 















401 I worry about getting cervical cancer       
402 I worry about getting human papilloma virus the virus which 
cause cervical cancer   
     
403 I believe that I am at risk of developing cervical cancer      
404 It is beyond my personal control, because all women have 
an equal chance of developing cervical cancer  
     
405 My chances of getting cervical cancer are high       
406 My chances of contracting human papilloma virus are low       
407 I have the ability to avoid cervical cancer       





Section B: Perceived seriousness of cervical cancer 
 
Please state whether these statements are “true” or “false” 
 
SR 










409 I will not screen for cervical cancer because of fear of the 
results 
   
410 There is very little that one can do about cervical cancer    
411 I would rather screen for cervical cancer     
412 All women who develop cervical cancer must have their 
uteruses removed 
   
413 Early detection can increase survival chances     
414 Loss of cervix or uterus through surgery would affect my 
sexuality 
   
415 Among the diseases I can imagine getting cervical cancer is 
among the most serious 
   
417 Cervical cancer is a life-threatening disease    
418 Cervical cancer would threaten my relationship with my 
husband/partner 
   
419 Most women who develop cervical cancer will die from it.    
420 My whole life would change if I had cervical cancer    
 
Section C: Perceived benefits of cervical cancer screening 
 















421 Cervical cancer can be diagnosed at an early stage    
422 Cervical cancer screening would save life if detected at an 
early stage 
   
423 Cervical cancer is often curable with early detection and 
proper medical treatment 
   
424 Regular cervical cancer screening decreases the risk of 
cancer 



















425 I don't want to be seen in a cervical cancer screening clinic 
by my friends or colleagues 
   
426 Cervical cancer Screening is humiliating    
427 I have no time for doing test    
428 I am not aware of any test    
429 Do not know where the test is done    
430 Don‟t know how much it cost     
431 I am still too young for the test    
432 My partner is uncomfortable     
434 I don‟t have risk of getting to have cervical cancer, 
therefore, I don‟t want to screen  
   
 
Section E: Cues to action  
 
435 If you know about cervical cancer screening services, what is your source of information? 
(More than one can be given)  
1. Tutors/school 
2. Friends/neighbors/other people 
3. Health care provider  
4. Media  
 
436 What do you think are the best methods for providing information about cervical cancer and 
screening?  
1. Campaign advertisement on television  
2. Campaign advertisement on radio  
3. Health talks by health care providers  
4. Health talks by community leaders 









Annexure D: Questionnaire Amharic version  
 
የጥናት መጠይቅ 
በአዱስ አበባ ከተማ ሇሚገኙ ሴቶች የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ ሇማዴረግ     
የሚወስኑ ሁኔታዎች ሊይ የሚያጠና ጥናት መጠይቅ 
 
01 የጥናቱ ቦታ --------------------------------------------- 
02 የጥናቱ ተሳታፉዎች  
 1. የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራውን ያዯረጉ  
 2. የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራውን ያሊዯረጉ 
03 የውጤት ኮዴ 
1. የተጠናቀቁ 
2. ያሌተስማሙ 
3. በከፉሌ  
4. የተጠናቀቁ 
5. ላሊ ካሇ ይገሇፅ----------------------------- 
ክፌሌ 1 አጠቃሊይ የግሇሰብ መረጃ   
 
101.  ዕዴሜዎ ስንት ነው ?  ----------------------- (በአመት)    
          
ተ.ቁ ጥያቄ መሌስ ይሇፌ  ኮዴ  
102 ብሄር/ብሄረሰብዎ  1. አማራ  
2. ኦሮሞ 
3. ትግሬ 
4. ዯቡብ ህዝቦች  
5. ላሊ /ይጠቀስ/-------------- 
  
103 ሀይማኖት     
104 የትምህርት ዯረጃ  1. ማንበብ/መፃፌ የማይችለ 
2. ማንበብ መፃፌ የሚችለ 
3. ከ1-8 ክፌሌ  
4. ከ9-12ክፌሌ 
5. ዱፕልማና ከዛ በሊይ   
  
105 ስራ   1. የቤት እመቤት  
2. የመንግስት ሰራተኛ 
3. የግሌ ስራ  
4. የቀን ሰራተኛ 
5. ላሊ/ይጠቀስ/  
  
106 የቤተሰብ የወር ገቢ? 1. ከ400ብር በታች  
2. ከ400-999ብር  
3. ከ1000 በሊይ  
4. በትክክሌ አይታወቅም 
  
107 የጋብቻ ሁኔታ ? 1. ያሊገባች  
2. በሇትዲር 
3. የተፊታች/የተሇያዩ 
4. የሞተባት  
  
108 የወሉዴ መከሊከያ መንገድች 
ይጠቀማለ/ተጠቅመው 
ያውቃለ? 
1. አዎ     
2. ተጠቅሜ አሊውቅም  





109 ምን አይነት መከሊከያ ? 1. በእንክብሌ  
2. በመርፋ 
3. በክንዴ የሚቀበር 





ተ.ቁ ጥያቄ መሌስ ይሇፌ  ኮዴ  
5. ላሊ/ይገሇፅ 
6. መሌስ የሇም 
110 ስንት ሌጆች አሇዎት ? 1. የሇኝም 
2. አንዴ  
3. ከ2-4ሌጆች  
4. ከ4በሊይ  
5. መሌስ የሇም  
  
111 የመጀመሪያውን የግብረ ስጋ 
ግንኙነት ሲያዯርጉ 
እዴሜዎ ስንት ነበር? 
1. ከ15ዓመት በታች  
2. ከ15-18ዓመት 
3. ከ18ዓመት በሊይ 
4. መሌስ የሇም  
  
112 ከአንዴ ጊዜ በሊይ ውርጃ 
ነበርዎ? 
1. አዎ     
2. አሌነበረኝም 
3. መሌስ የሇውም 
  
113 የመጀመሪያ የወር አበባዎን 
በስንት አመትዎ አዩ? 
 
1. ከ15ዓመት በታች  
2. ከ15-18ዓመት 
3. ከ18ዓመት በሊይ 
4. መሌስ የሇም 
  
114 የመጀመሪያ እግዝናዎ 
በስንት እዴሜዎ ነበር  ? 
1. ከ15ዓመት በታች  
2. ከ15-18ዓመት 
3. ከ18ዓመት በሊይ 
4. መሌስ የሇም 
  
115 ከአንዴ በሊይ ሰው ጋር 
የግብረስጋ ግንኙነት 
ነበረዎት? 
1. አዎ     
2. አሌነበረኝም 
3. መሌስ የሇውም 
  
 
ክፌሌ 2-ሀ  ስሇ የማህፀን በር ጫፌ ካንሰር መንስኤ፤መከሊከያና ህክምናውን/መዴሀኒትን ግንዛቤን በተመሇከተ  
 
ተ.ቁ ጥያቄ መሌስ ይሇፌ ኮዴ 
201 ስሇ የማህፀን በር ጫፌ ካንሰር ሰምተው 
ያውቃለ ? 
1. አዎ  
2. አሌሰማሁም 
  
202 የማህፀን በር ጫፌ ካንሰር መንስኤ ያውቃለ ? 1. አዎ  
2. አሊውቅም 
  
203 ሇበሽታው የሚያጋሌጡ ሁኔታዎች ምን 
እንዯሆኑ ያውቃለ ? 
1. አዎ  
2. አሊውቅም 
  
204 የማህፀን በር ጫፌ ካንሰር መከሊከያ መንገድችን 
ያውቃለ ? 
1. አዎ  
2. አሊውቅም 
  
205 የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ 
ሰምተውያውቃለ ? 
1. አዎ  
2. አሊውቅም 
  
206 የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ 
እንዳት እንዯሚገኝ ያውቃለ ? 
1. አዎ  
2. አሊውቅም 
  
207 የማህፀን በር ጫፌ ካንሰር መዴሀኒት/ህክምና  
አሇው ? 
1. አዎ  
2. አሊውቅም 
  
208 የማህፀን በር ጫፌ ካንሰር በሽታ የተያዘ ሰው 
ያውቃለ ? 






ክፌሌ 2-ሇ ስሇ ማህፀን በር ጫፌ ካንሰር፡ ምሌክቶቹ ፡ መከሊከያ መንገድች ፤የቅዴመ ካንሰር ምርመራዎችና፡ የህክምና 
አማራጮች ና የሚያጋሌጡ ሁኔታዎች  ዕውቀትን የተመሇከቱ ጥያቄዎች   
 
ተ.ቁ ጥያቄ መሌስ ይሇፌ ኮዴ 
209 የማህፀን በር ጫፌ ካንሰር የሚያጠቃው 
የሰውነት ክፌሌ ምንዴነው  
1. የማህፀን በር/ማህፀንን  
2. ጭንቅሊትን  
3. ላሊ ይጠቀስ  
4. አሊውቅም 
  
210 የማህፀን በር ጫፌ ካንሰር ምሌክቶች 
ምንዴ ናቸው (ከአንዴ በሊይ መመሇስ 
ይቻሊሌ) 
1. በወር አበባ ጊዜ ከፌተኛ  ህመም 
መሰማት  
2. ከግንኙነት በኋሊ መዴማት  
3. ያሌተስተካከሇ የማህፀን 
መዴማት 




211 የማህፀን በር ጫፌ ካንሰር የተያያዘ 
የበሽታ ተዋህስ የሚተሊሇፇው 
በምንዴነው ? 
1. በግብረ ስጋ ግንኙነት  
2. ከእናት ወዯ ሌጅ  
3. በዯም ንክኪ 
4. አሊውቅም  
  
212 ጤናማ ያሌሆነ የማህፀን በር ጫፌ 
ቅዴመ ካንሰር ውጤት ምን ማሇት ነው 
1. ቅዴመ ካንሰር የሚጠቁም ህዋስ 
መኖሩን  ያመሇክታሌ 
2. የማህፀን ካንሰር እንዲሇ ያሳያሌ  
3. አባሇዘር በሽታን የሳያሌ 
4. አሊውቅም  
  
213 የማህፀን በር ጫፌ ካንሰርን እንዳት 
መከሊከሌ ይቻሊሌ(ከአንዴ በሊይ 
መሌስመስጠት የቻሊሌ ) 
1. ከብዙ ግብረ ስጋ ተጓዲኞች 
በመታቀብ  
2. ሇአቅመ ሄዋን ከመዴረስ በፉት  
ግብረስጋ ግንኙነት አሇማዴረግ  
3. ሲጋራ ባሇማጨስ 
4. በክትባት 
5. በየጊዜው የህክምና 
ክትትሌበማዴረግ  
6. አሊውቅም 
7. ላሊ/ ካሇይገሇፅ/ 
  
214 አንዱት ሴት የማህፀን በር ጫፌ 
ቅዴመ ካንሰር ምርመራ በየስንት 
ጊዜው ማዴረግ አሇባት (አንዴ ምሊሽ 
ብቻ) 
1. በየአመቱ 
2. በየሁሇት አመት 
3. በየሶስትአመት 
4. በየአምስት አመት    
5. አሊውቅም  
  
215 አንዱት ሴት የማህፀን በር ጫፌ 
ቅዴመ ካንሰር ምርመራ መቼ 
መጀመር አሇባት  
1. በ21 አመቷ 
2. የግብረ ስጋ ግንኙነት ከጀመረች 
ከ3አመት በኋሊ 
3. አሊውቅም  
  
216 የማህፀን በር ጫፌ ካንሰር ህክምናዎች 
ምን ምን ናቸው  ናቸው  
1. ጨረር 
2. ኦፕሬሽን/ቀድ ህክምና  
3. ፀረ ካንሰር መዴሀኒት  
4. አሊውቅም  
5. ላሊ / ይጠቀስ/  
  
217 የማህፀን በር ጫፌ ካንሰር ሉዴን 
የሚችሌበት የህመም ዯረጃ ምንዴነው  
1. ቀዯም ብል/በሽታው  ሳይባባስ  
2. በየትኛውም ዯረጃ መዲን 
አይችሌም 













ክፌሌ 3 ስሇማህፀን በር ቅዴመ ካንሰር ምርመራ ማዴረግን በተመሇከተ  
301 . የማህፀን በር ቅዴመ ካንሰር ምርመራ አዴርገው ያውቃለ 
1. አዎ 
2. አሊዯረግሁም  
3. አሊውቅም 
 
302. ሇ301 ጥያቄ መሌስ አዎ ከሆነ መቼ ነው ያዯረጉት  
1. ባሇፇው አንዴ አመት  
2. ባሇፈት አምስት አመታት 
3. ከአምስት አመት በፉት  
4. አሊውቅም  
 
ክፌሌ 4 በማህፀን በር ጫፌ ካንሰር አስተሳሰብ   
4-ሀ  ሇማህፀን በር ጫፌ ካንሰር  ተጋሊጭነት በተመሇከተ ያሇ አስተሳሰብ  
እባክዎን ከዚህ በታች ሇተጠየቁት ጥያቄዎች በጣም እስማማሇሁ(በእስ) ፤እስማማሇሁ(እስ) ፤ከሁለም 
አይዯሇሁም(ከአ)፤አሌስማማም(አሌ) ፤በጣም አሌስማማም(በአሌ) በማሇትይመሌሱ  
 
ተ.ቁ ጥያቄዎች  በእሰ አስ ከአ አሌ በአሌ 
401 የማህፀን በር ጫፌ ካንሰር ይይዘኛሌ ብዬ አስባሇሁ /እጨነቃሇሁ      
402 ሇማህፀን በር ጫፌ ካንሰር መንስኤ የሆነው ሂዩማን ፓፒልማ ቫይረስ 
ይይዘኛሌ ብዬ አስባሇሁ  
     
403 ሇማህፀን በር ጫፌ ካንሰር ሇመያዝ ተጋሊጭነኝ ብዬአምናሇሁ 
 
     
404 ማንኛዋም  ሴት ሇማህፀን በር ጫፌ ካንሰር የመያዝ እኩሌ እዴሌ 
አሊት ይህ ከኔ ቁጥጥር ውጪ ነው   
     
ተ.ቁ ጥያቄዎች  አዎ አይዯሇም አሊውቅም 
218 ብዙ የግብረ ስጋ ጓዯኞች ማፌራት    
219 ሇአቅ መሄዋን እዴሜ ከመዴረስ በፉት የግብረ ስጋ 
ግንኙነት  
   
220 ሲጋራ ማጨስ    
221 የእንክብሌ የወሉዴ መቆጣጠሪያ መጠቀም    
222 በአባሇዘር በሽታዎች መያዝ     
223 በሁማን ፓፒልማ ቫይረስ መያዝ     
224 በዘር የማህፀን በር ጫፌ ካንሰር መኖር    




405 ሇማህፀን በር ጫፌ ካንሰር የመያዝ እዴልቼ ከፌተኛ ናቸው       
406 ሂዩማን ፓፒልማ ቫይረስ የመያዝ እዴላ ዝቅተኛ ነው       
407 ሇማህፀን በር ጫፌ ካንሰር እንዲይዘኝ ማዴረግ  እችሊሇሁ      
408 ሂዩማን ፓፒልማ ቫይረስ እንዲይዘኝ ማዴረግ እችሊሇሁ      
 
 
4-ሇ የማህፀን በር ጫፌ ካንሰር በሽታን  ከባዴነት  የሚያመሇክት አስተሰሳብ  
 
ተ.ቁ ጥያቄዎች  አዎ አይዯሇም  አሊውቅም 
409 እኔ የማህፀን በር ካንሰር ቅዴመ ምርመራ አሊዯርግም ምክንያቱም 
ውጤቱ ስሇሚያስፇራኝ  
   
410 ስሇ ማህፀን በር ጫፌ ካንሰር አንዴ  ሰው ማዴረግ የሚችሇው ትንሽ 
ነገር ብቻ ነው  
   
412 የማህፀን በር ጫፌ ካንሰር ቅዴመ ምርመራ አዯርጋሇሁ    
413 የማህፀን በር ጫፌ ካንሰር ያጋጠማቸው ሴቶች በሙለ ማህፀናቸውን  
በኦፕሬሽን ማስወጣት ግዳታ አሇባቸው   
   
414 ቀዯም ብል የተዯረገ የማህፀን በር ጫፌ ካንሰር ቅዴመ ምርመራ 
በህይወት የመቆየት እዴሌን ይጨምራሌ  
   
415 የማህፀን በርን ወይም ማህፀንን በኦፕሬሽን ማጣት ወዯፉት በሚኖረኝ 
ፆታዊ ግንኙነት ሊይ ተፅዕኖ/ጉዲት  አሇው  
   
416 ከማስባቸው በሽታዎች ሁለ የማህፀን በር ካንሰር በሽታ በጣም አዯገኛ 
ነው  
   
417 የማህፀን በር ጫፌ ካንሰርን መከሊከሌ ይቻሊሌ     
418 የማህፀን በር ጫፌ ካንሰር ህይወትን የሚፇታን በሽታ ነው     
419 ማህፀን በር ጫፌ ካንሰር በሽታ ከትዲር ወይም ከፆታ አጋሬ ጋር 
በሚኖረኝ ግንኙነት ችግር ይፇጥርብኛሌ  
   
420 ማህፀን በር ጫፌ ካንሰር የያዛቸውአብዛኛዎቹ ሴቶች ይሞታለ    






4-ሐ ስሇ ማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ ያሇው አስተሳሰብ  
እባክዎ ከተሰጡት መጠይቆች ትክክሌ መሆናቸውን  ወይም አሇመሆናቸውን ይሇዩ 
 
ተ.ቁ ጥያቄዎች  አዎ አይዯሇም አሊውቅም 
422 የማህፀን በር ጫፌ ካንሰር ገና ሲጀምር ቀዯም ብል በምርመራ 
ማወቅ ማወቅ ይቻሊሌ  
   
423 የማህፀን በር ጫፌ ካንሰር ቀዴሞ ከታወቀ ሇህይወት አስጊ 
አይሆንም 
   
424 የማህፀን በር ጫፌ ካንሰር ቀዴሞ ከታወቀና  ክትትሌ ያሇው 
ህክምና ከተዯረገሇት ሉዴን ይችሊሌ   
   
425 በየጊዜው በመዯበኛነት የሚዯረግ የማህፀን በር ጫፌ ቅዴመ 
ካንሰር ምርመራ በካንሰር የመያዝ እዴሌን ይቀንሳሌ  
   
 
4-መ የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ ሊሇማዴረግ የሚያግደ ሁኔታዎችን በተመሇከተ ያሇ 
አስተሳሰብ 
  
ተ.ቁ ጥያቄዎች  አዎ አይዯሇም አሊውቅም 
425 የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ ክፌሌ ውስጥ 
የማውቃቸው ሰዎች ወይም ጓዯኞቼ እንዱያዩኝ አሌፇሌግም   
   
426 የማህፀን በር ጫፌ ካንሰር     
427 የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራሇማዴረግ ጊዜ የሇኝም     
428 ስሇ ማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ  የማውቀው 
የሇኝም  
   
429 የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ የት እንዯሚዯረግም 
አሊውቅም 
   
430 ሇማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ ስንት እንዯሚከፇሌ 
አሊውቅም  
   
431 የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ ሇማዴረግ ገና ሌጅ 
ነኝ   
   
432 የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ ሇማዴረግ ቤተሰቦቼ 
አይመቻቸውም /ዯስተኛ አይዯለም  
   
433 የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ በጣም ያማሌ ወይም 
ያስጠሊሌ  
   
434 እኔ የማህፀን በር ጫፌ ካንሰር ሉይዘኝ አይችሌም ስሇዚህ 
የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ አያስፇሌገኝም  





4-ሠ ቅዴመ ካንሰር ምርመራውን ሇመውሰዴ የሚያነሳሱ ሁኔታዎች  
 
435. ስሇ የማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ አገሌግልት ከአወቁ ከየት ሰሙ  
1. ከመምህራን  
2. ከጓዯኞቼ  
3. ከጤና  ባሇሙያ  
4. ከሚዱያ  
5. ከመፅሀፌ/መፅሄት 
436. ስሇ ማህፀን በር ጫፌ ቅዴመ ካንሰር ምርመራ መረጃ ሇመስጠት  ሇማሳወቅ የትኞቹ  መንገድች 
የተሻለ  ናቸው   
   1. በቴላቪዥን የቅስቀሳ ስራ መስራት  
   2. በሬዱዮ የቅስቀሳ ስራ መስራት  
   3. በጤና ባሇሙያዎች የሚሰራ የማስተማር ስራ 
   4. በማህበረሰብ መሪዎች የቅስቀሳ ስራ መስራት 






Annexure E: Consent form for questionnaire to participants  
 
University of South Africa 
Department of Health studies 
Participant information sheet and informed consent form 
 
My name is ……………………………………  I work for a research team from UNISA. I 
am going to conduct survey using questionnaire to study determinants factors for 
cervical cancer screening among women in Addis Ababa, which is conducted to 
complete a doctoral degree on health studies at University of south Africa. The purpose 
of this study is to assess the determinants factors influencing the screening practice of 
cervical cancer among women in Addis Ababa. 
 
To complete the questionnaire, I will ask your questions approximately lasting 20-30 
minutes duration. No harm is imposed to you except the time you commit for interview 
but some of the question may look too personal but it is helpful for the study. In addition, 
there is no payment for participation even though the result of the study may benefit as 
a citizen. The questionnaire participation in this study is voluntary, you have the right to 
refuse or withdraw from the study at any time for any reason without penalty. However, 
your honest answers to these questions are important since it provides relevant 
information to design interventions that aims to improve the practice of cervical cancer 
screening. 
 
Your responses are completely confidential, your name will not be written on the form 
and will never be used in connection with any of the information you provided. The 
information you provide is confidential and it will be used only for study purpose and it 
will not be disclosed to anyone. A code number will be used to identify the participant 
therefore, writing your name is not needed. If you have something that is not clear about 
the study, please contact the principal investigator Seble Tiku with phone number 
0911675341 
 
Are you willing to participate in this study?  1. Yes        2. No  
Signature of data collector certifying verbal informed consent ____________ 
 




Annexure F: Amharic version consent for questionnaire to participants 
 
የደቡብ አፍሪካ ዩኒቨርስቲ 
ሄሌዝ ስተዲ ዲፓርትመንት (Health Studies) 
የመረጃ ቅጽ 
መግቢያ 
ጤና ይስጥሌኝ ስሜ -------------------------------   ይባሊሌ በአዲስ አበባ ከተማ ሇሚገኙ ሴቶች 
የማህፀን በር ጫፍ ቅድመ ካንሰር ምርመራ ሇማድረግ የሚወስኑ ሁኔታዎች በተመሇከተ 
በተዘጋጀው ጥናት መረጃ በመሰብሰብ ሊይ ነኝ፡፡ 
የጥናቱ ዓሊማ፡ በአዲስ አበባ ከተማ ሇሚገኙ ሴቶች የማህፀን በር ጫፍ ቅድመ ካንሰር ምርመራ 
ሇማድረግ የሚወስኑ ሁኔታዎች ሊይ የሚያጠና ማግኘትና ሇተገኙ ችግሮች መፍትሄ በመፈሇግ  
የሚሰጠውን የቅድመ ማህፀን ጫፍ ካንስር ምርመራ አገሌግልት ሇማሻሻሌ ነው ፡፡ 
 
ይህንን ፕሮጀክት ሇማከናወን እርስዎ በፈቃደኝነት እንዲሳተፉ የተጋበዙ ሲሆን ፍቃደኛ ከሆኑ 
በአማርኛ በተዘጋጀው መጠይቅ ሊይ ሉመሌሱሌን ይችሊለ፡፡ የሚሰጡት መረጃ ሚስጢራዊነቱ 
የተጠበቀ ነዉ፡፡ስምዎም ሆነ ላሊ መረጃ በፍጹም ሇማንም አይነገርም፡፡ይህንን መጠይቅ 
ሇመሳተፍ ቢበዛ ከ 20-30 ደቂቃ ይፈጃሌ፡፡ ሆኖም ሊሇ መሳተፍ ከፈሇጉ ጥናቱን ከጀመሩም 
በኋሊ ሆነ በፊት ማቋረጥ መብትዎ ነው፡፡መጠይቁ በአማርኛ ስሇተዘጋጀ ውይይቱ የሚደረገው 
በሚያውቁት ቋንቋ ነው፡፡ በዚህ ጥናት በመሳተፍዎ የማህፀን በር ጫፍ ቅድመ ካንሰር ምርመራ 
ሇማድረግ የሚወስኑ ሁኔታዎች ሊይ ችግር በመሇየት ሇችግሮች መፍትሄ በመፈሇግ  
የሚሰጠውን የቅድመ ማህፀን ጫፍ ካንስር ምርመራ አገሌግልት እንዲሻሻሌ በማድረግ 
እራስዎን፤ቤተሰብዎንና ህብረተሰቡን ተጠቃሚ ያደርጋለ፡፡ በዚህ ጥናት ሊይ በመሳተፍዎ 
ጊዜዎን ከመሰዋትዎ ውጭ ምንም የሚያመጣው ጉዳት የሇም፡፡ ነገር ግን የእርስዎ ተሳትፎ 
ሇነፍሰጡር እናቶች የጤና ትምህርት ጉዳይ ሊይ ተያያዥ መረጃ ሇማመንጨት ጠቃሚ ነው፡፡ 
በዚህ ጥናት በመሳተፍዎ የሚሰጥ ምንም ዓይነት ክፍያ አይኖርም፡፡ 
 
ከእርስዎ የተገኘዉ መረጃ ሇማንም ባሇመግሇጽ ሚስጢራዊነቱ ይጠበቃሌ፡፡ በመረጃዉ ስምዎ 
ሳይጠቀስ መሇያ ቁጥር በመጠቀም በሚስጥር የሚቆሇፍ ቦታ ይቀመጣሌ፡፡ በዚህ ጥናት 
ያሇመሳተፍ መብትዎ የተጠበቀ ከመሆኑም ባሻገር ከመጀመሩም በኋሊ ሆነ በፊት መቀጠሌ 
ካሌፈሇጉ በሙለ ወይም በከፊሌ ማቋረጥ ይችሊለ፡፡ይህንን በማድረግዎ በጤና አገሌግልትም 
ሆነ በላሊ አገሌግልት ሊይ ምንም አይነት ተጽእኖ አየደርስብዎትም፡፡ ስሇዚህ ምርምር ሉጠይቁ 




ጥያቄ ሇዋናው የጥናቱ ባሇሙያ ሰብሇ ትኩ በስሌክቁጥር 09111675341 ደዉሇዉ መጠየቅ 
ይችሊለ፡፡ ይህ ጥናት በደቡብ አፍሪካ ዩንቨርስቲ ሄሌዝ ስተዲስ ዲፓርትመንት እና በአዲስአበባ 
ጤና ቢሮ የምርምርና ሥነ-ምግባር ቦርድታይቶ ፀድቋሌ፡; 
ከሊይ የተገሇጹትን መረጃዎች በመገንዘብ በጥናቱ ሇመሳተፍ ፍቃደኛ ነዎት? 
 
አዎ  ------------------------------- ወደ ቃሇ መጠይቁን ይሇፉ 
 





Annexure G: Semi-structure interview guide  
 
Qualitative study  
 





Age in years___________________ 
Profession/educational level _________________ 
Position ______________________ 
Service year in the health profession ____________________ 
  
Q. 1 Have you been involved in any form of cervical cancer screening service provider? 
 
Q. 2  Can you describe available strategies/ activities to prevent cervical cancer in your 
organisation? 
 
Q. 3  Can you tell me about the response of women to have cervical cancer screening? 
 
Q. 4.  What is your opinion about knowledge of women on the advantage of cervical cancer 
screening test? 
 
Q. 5.  What your opinion about the perception of women on cervical cancer screening test? 
 
Q. 6.  What reasons are given by women to have cervical cancer screening? 
 
Q. 7.   What reasons are given by women not to have cervical cancer screening? 
 
Q. 8.  What are the challenges in cervical cancer screening service in your organization? 
 
Q. 9.  What are your suggestions to address these challenges? 
 






Annexure H: Letter from the language editor 
 
Cell/Mobile: 073-782-3923     53 Glover Avenue 
        Doringkloof 
        0157  Centurion 
 





   TO WHOM IT MAY CONCERN 
 
 
I hereby certify that I have edited Seble Tiku Ayka‟s doctoral dissertation, Determinants 
of screening practice for cervical cancer among women in Addis Ababa, Ethiopia, 













Annexure I: Originality turnitin report 
 
 
 
 
 
 
 
 
